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In Escherichia coli, the twin arginine translocase (Tat) is one of the major protein 
translocation mechanisms. The Tat system has the ability to transport folded proteins 
across the inner membrane. Therefore, it has the ability to discriminate between folding 
states. However, it is not well understood how the Tat system senses the folding state of a 
substrate. In this study we probed the Tat proofreading mechanism and we investigated 
whether Tat substrates in E. coli are translocated by the Tat system due to their rapid 
folding kinetics. 
We demonstrate that the E. coli Tat machinery can process a de-novo designed substrate 
(BT6 maquette). Moreover the Tat proofreading mechanism can discriminated between 
different folding states of this substrate. This data and the fact that this simple four helix 
artificial substrate offers a lot of engineering freedom, suggests that BT6 is an ideal 
candidate to study the Tat proofreading mechanism (chapter 3).  
In chapter 4, we focussed on the Tat systemÕs proofreading ability by substituting substrate 
surfaces of BT6 maquette. Mutants with substituted surface properties were expressed in 
order to understand what Tat senses as folded. Expression assays showed whether the 
mutants were accepted or rejected by Tat. We propose that the proofreading system does 
not sense a global unfolded state of the substrate but has the ability to sense localised 
unfolded regions. 
Finally, we tested whether Tat substrates fold co- or post-translationally to determine the 
speed of the folding kinetics by using an arrest peptide-mediated force measurements assay 
(chapter 5). This study was to increase our understanding about the rationale for using the 
Tat system.  
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Cells are the building blocks of life. Within each individual cell, various essential 
biochemical processes take place to maintain the cell. Cellular life can be divided into 
three domains: archaea, bacteria and eukaryotes. Eukaryotes have a more complex 
construction with different organelles, such as a cell nucleus. Archaea and bacteria both are 
prokaryotes, which donÕt have a cell nucleus. However, archaea differ from bacteria in 
many structural, biochemical and physiological characteristics, such as the lack of 
peptidoglycan in their cell wall. Bacteria can be divided into two groups: Gram-positive 
and Gram-negative. The difference between Gram-negative and Gram-positive is caused 
by a difference in the structure of the cell wall. Gram-positive bacteria have a thick 
peptidoglycan layer that is less impenetrable than the relatively thin peptidoglycan layer 
(inner membrane) of Gram-negative bacteria. However, the structure of Gram-negative 
cells is more complex compared to Gram-positive cells. A second membrane is located 
outside the thin peptidoglycan layer. The outer membrane contains lipopolysaccharides 
(LPS), which offers the cell an extra protection. The two membranes form an extracellular 
compartment called the periplasm.  
 
Figure 1. Schematic comparison of Gram-negative and Gram-positive cells 
This figure demonstrates the difference between the cell walls of Gram-negative and 
Gram-positive cells. The peptidoglycan layer is shown in blue, the inner membrane in 
orange and the outer membrane in red. Both type of cells contain an inner cell membrane 
and a peptidoglycan layer. However, the peptidoglycan layer of Gram-positive cells is 
much thicker. Gram-negative cells have an additional outer membrane build out of 
lipopolysaccharides (LPS). 
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The periplasmic compartment contains many periplasmic proteins that are involved in 
different biochemical pathways, such as peptidoglycan synthesis, electron transport and 
cell division. Optimal protein trafficking is essential as more than one third of the 
proteome of Gram-negative cells are secreted across or inserted into the inner and outer 
membrane (Economou, 2010a). There are three major pathways to transport proteins from 
the cytoplasm to the periplasm or to insert proteins into the inner membrane; Tat 
translocase (Tat), secretory (Sec) translocase and YidC insertase.  
 
1.1 Protein targeting 
 
Proteins are synthesized by ribosomes in the cytosol and many need to be transported 
across or into the inner membrane. Therefore, they need to be recognised and targeted by 
the Tat or Sec translocase embedded in the inner membrane (Driessen and Nouwen, 2008, 
Rapoport, 2007).  
 
1.1.1 The signal peptide  
 
Precursor proteins possess an amino-terminal (N-terminus) signal peptide (SP) to direct the 
translocation or membrane insertion (Blobel, 1975). Although the sequence and length of 
signal peptides are highly variable between different substrates and organisms, they do 
have a homologous tripartite structure consisting of a positively charged hydrophilic N-
terminus, a hydrophobic core (h-region) and a polar carboxyl-terminal (C-terminus) 
domain containing the signal peptidase cleavage site (von Heijne, 1987). Figure 2 shows a 
schematic comparison of the Tat and Sec N-terminal signal peptides. Hydrophobic as well 
as electrostatic interactions take place between the signal peptide and the membrane 
components of the translocase. Previous studies demonstrated the importance of the signal 
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peptideÕs hydrophobicity. The hydrophobic amino acids span the membrane as an α-helix 
loop (Briggs et al., no date). Moreover, alterations of single hydrophobic residues to 
charged residues in the signal peptide blocked the export of the secretory maltose binding 
protein (MBP) (Bedouelle et al., 1980). The positively charged N-terminal domain has 
been suggested to interact with the negatively charged phospholipid head groups of the 
inner membrane (Nesmeyanova et al., 1997). During or shortly after translocation, the C-
terminal domain is recognized by type I signal peptidase (SPase) that cleaves the signal 
peptide from the mature secretory protein (Paetzel et al., 2002). Type I SPase binds small, 
uncharged residues at the -1 and -3 position of the C-terminus, typically AxA (von Heijne, 
1983).  
 
Figure 2. Schematic overview of Tat signal peptides vs. Sec signal peptides 
(A) The N-terminal Tat and Sec signal peptides are displayed. Both signal peptides have a 
homologous tripartite structured consisting of a hydrophilic n-region (blue), a hydrophobic 
h-region (red) and a polar c-region (green) containing the signal peptidase cleavage site 
(typically AxA). (B) The sequences of TorA and SufI, the two most commonly used signal 
peptides in studies on the Tat pathway. The Tat specific RR-motif is demonstrated in 
purple and underlined. The type I signal peptidase cleavage site is displayed in green.  
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Sec precursor proteins do not contain a Sec specific signal sequence motif except for the 
cleavage site. The sec components recognise the tripartite structure of the Sec precursor 
protein. The h- and n- regions are critical structural elements. SRP (Signal Recognition 
Particle) binds to the h-region via hydrophobic interactions. Studies have demonstrated 
that increased hydrophobicity promotes SRP binding (Peterson et al., 2003, Lee and 
Bernstein, 2001). The binding affinity of the motor protein SecA for signal peptides 
increases with the number of positive charges in the n-region (Cunningham and Wickner, 
1989). 
 
1.1.2 The Tat signal sequence  
 
Like most other bacterial secretory proteins, Tat substrates possess an N-terminal signal 
sequence to direct the precursor proteins to the periplasm. Tat signal peptides possess the 
previously described tripartite structure with the type I signal peptidase cleavage site on the 
polar c-region (figure 2). Although the structures of Sec and Tat signal peptides share 
similarities, Tat signal peptides differ from Sec signal peptides.  
 
Tat signal peptides (figure 2) are 26 Ð 58 amino acids long, whereas Sec signal peptides are 
18 Ð 26 amino acids long. The n- and h-region of Tat signal peptides are larger than Sec 
signal peptides (von Heijne, 1985, Berks, 1996). The overall hydrophobicity of the Tat 
signal peptide plays an important role in Tat dependent translocation. The h-region of Tat 
signal peptides is in general less hydrophobic than h-regions of Sec signal peptides. It has 
been demonstrated that secretory proteins can be redirected to the Sec translocase when the 
hydrophobicity of the Tat signal peptide increases (Cristbal et al., 1999).  
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Besides the differences in length and hydrophobicity, the Tat signal peptides are 
recognised by a conserved Twin-Arginine motif. The name giving twin arginine motif was 
defined as S-R-R-x-F-L-K and is located at the n-region of the Tat signal peptide (Berks, 
1996). Although the RR-motif was initially thought to be invariant, paired arginine 
residues are not an absolute requirement. Numerous studies have shown that the first 
arginine residue can be substituted for a lysine residue without blocking tat dependent 
export (Stanley, Palmer and Berks, 2000). Moreover, a natural substrate is known were the 
signal peptide is harbouring a KR-motif. The signal peptide of the TtrB subunit of the 
tetrathionate reductase of Salmonella enterica is Tat dependent but contains a single 
arginine motif (Hinsley et al., 2001). Other studies demonstrated that the substitution of a 
single arginine either by a Lys, Asn or Gln is tolerated by the Tat translocase (DeLisa et 
al., 2002). The substitution of the two arginine residues to lysines completely abolishes 
translocation (Buchanan et al., 2002). 
 
In addition to these Tat specific signal peptide features, the Tat signal peptides usually 
possess one or more positively charged residues in the c-domain. These residues are rarely 
found in Sec signal peptides and prevent interactions with the Sec translocase (Bogsch et 
al., 1997). The presence of these positively charged residues functions as the so-called 
ÔSec-avoidance signalÕ. The charge of the c-region of Tat signal peptides is on average 
+0.5, whereas the average charge of Sec signal peptides is +0.03 (Berks et al., 2003).  
 
Other studies have suggested that a positive charge in the first amino acids of the mature 
protein is also important in ÔSec avoidanceÕ. This suggests that several Tat substrates that 
do not contain cofactors or form multimers are Tat dependent because they require 
positively charged N-terminal residues to function which abolishes recognition by the Sec 
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translocase (Tullman-Ercek et al., 2007). It thus appears that, the twin arginine motif, 
overall hydrophobicity and charge are important determinants for Tat specific targeting. 
 
1.2  The Secretory translocase 
 
The Sec translocase is the most described translocon and is located in the inner membrane. 
It is present in bacteria, archaea, the thylakoid membrane of plant chloroplasts and in the 
endoplasmic reticulum (ER) of eukaryotic cells (Muiz et al., 2001). The sec translocase 
acts as a transporter of unfolded proteins to the periplasm as well as a mechanism to insert 
proteins into the lipid bilayer of the inner membrane. In bacteria, a multimeric protein 
complex, known as SecYEG, forms the protein-conducting channel (PCC). SecYEG 
interacts with the peripherally associated motor domain, ATPase SecA, which is the motor 
of the translocation reaction. Another multimeric membrane protein complex, SecDFyajC, 
interacts with SecYEG to facilitate protein translocation (Veenendaal et al., 2004). In 
addition, YidC is an integral membrane protein that is involved in the insertion of proteins 
into the inner membrane. Figure 3 represents an overview of protein transport by the Sec 
machinery.  
 
1.2.1 The Sec components 
 
The two integral membrane proteins SecY and SecE form the core of the protein-
conducting channel. Although, SecG is not essential for protein translocation it interacts 
with the SecYE complex, resulting in the SecYEG complex formation (Figure 3).  




Figure 3. Schematic overview of the Secretory (Sec) pathway 
The co-translational protein insertion pathway is listed on the left. (1) SRP, in bacteria Ffh, 
binds the N-terminal signal peptide, resulting in an SRP-bound ribosome complex. This 
complex than binds to the bacterial SRP receptor (SR), denoted as FtsY. (2) The 
Ribosome-SR complex associates with the SecYEG complex. (3) In combination with the 
hydrolysis of GTP, the insertion of the nascent membrane protein into the inner 
membrane takes place. During protein insertion, YidC can cooperate with the Sec system. 
The post-translational protein translocation pathway is displayed on the right. (A) 
Following translation, the N-terminal signal sequence of the unfolded precursor protein 
binds to the cytosolic chaperone SecB. (B) SecB mediates the precursor protein to the 
ATPas SecA. Once the precursor protein and SecA bind to the SecYEG complex, the 
protein can be transported across the inner membrane by repeated cycles of ATP 
hydrolysis. (C) Shortly after translocation, SPase I cleaves the signal peptide from the 
protein. The protein will fold in the periplasm to form a mature protein. 
 





The largest SecYEG component is SecY, which is a highly hydrophobic 48 kDa protein 
and it spans the membrane with 10 transmembrane segments (TMSs) of which five are 
exposed in the periplasm and six in the cytoplasm including the N- and C-terminal regions 
(Akiyama and Ito, 1987). The fifth cytoplasmic loop (C5) plays an important role in SecA-
dependent translocation. To allow SecA insertion and protein translocation, SecY activates 
the ATPase activity by interacting with SecA (Matsumoto et al., 1997) Mutagenesis 





In most bacteria, SecE is a single membrane spanning protein of which the third 
transmembrane segment (TMS3) and the second cytoplasmic loop (C2) are homologous to 
E. coli SecE (Schatz et al., 1989). In E. coli, SecE is a 14 kDa clamp-like protein 
composed of three TMSs and an amphipathic helix (Frauenfeld et al., 2012). Despite the 
three TMSs, only one of the three is sufficient for cell survival. Truncation of the first two 
TMSs does not affect cell viability and protein translocation (Schatz et al., 1991). Highly 
conserved residues of TMS3 and C2 are essential for protein translocation as it contributes 
to the stability of the SecYE complex. C2 forms an amphipathic helix structure which 
might be important in the formation of a pore and for the stability of the SecYE complex. 
TMS3 serves as a membrane anchoring domain to C2 (Pohlschrder et al., 1996). 
 
 





In E. coli, SecG is a 12 kDa protein and acts as a core-associated and stimulatory 
component of the PCC. It compasses two TMSs linked by a weaker cytosolic exposed 
linker (Nishiyama et al., 1996). SecG plays an important role in SecA translocation 
ATPase activity and stimulates SecYE mediated protein translocation. Although SecG is 
not essential for cell viability, deletion of SecG results in a cold-sensitive phenotype. 
Studies have shown that SecG plays a critical role in protein translocation as deletion of 
the gene impairs translocation at temperatures below 37 ¡C (Nishiyama et al., 1994). 
Furthermore, in vitro assays revealed that secG is essential for the stimulation of protein 
translocation in the absence of the proton motive force (PMF). These observations suggest 
that SecG plays an important role in protein translocation in the absence of PMF and/or at 




SecYEG interacts with an accessory hetrotrimeric membrane complex, called SecDFyajC, 
which comprises SecD, SecF and YajC (Duong and Wickner, 1997). In E. coli, SecD and 
SecF are two separate 67 and 35 kDa proteins, which share a similar topology. Both Sec 
components contain 6 TMSs and an additional large periplasmic domain. In E. coli, yajC is 
a 12 kDa single spanning protein with a large cytosolic domain. It has been suggested that 
the SecDFyajC complex is thought to play a role in the biogenesis of membrane proteins as 
well as the translocation and folding of secreted proteins (Schlegel et al., 2014).  
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1.2.2 Post-translational targeting 
 
Secretory proteins that are translocated after they have been fully synthesised are targeted 
post-translationally (Figure 3). Most secreted proteins are associated with the cytosolic 
chaperone SecB in a post-translational manner as they are targeted to the membrane after 
synthesis has been completed (Driessen and Nouwen, 2008, Rapoport, 2007). SecB is a 
cytosolic chaperone, which is involved in the translocation of secretory proteins. It is a 17 
kDa acidic homotetrameric soluble protein (Xu et al., 2000). The precursor protein is 
targeted and stabilised by the SecB after most residues of the nascent precursor protein 
have emerged form the ribosome exit tunnel (Driessen, 2001). SecB has two functions: it 
stabilises the precursor and it passes the precursor protein on to the ATPase SecA. 
Although SecB maintains precursor proteins in an unfolded and translocation competent 
state, it is not essential for protein translocation (Tsirigotaki et al., 2017). Protein folding 
of substrates that require an oxidative environment will also be prevented in the reducing 
environment of the cytoplasm (Economou, 2010). Moreover, it has been demonstrated that 
the N-terminal signal peptide delays the folding of fast folding mature domains (Beena et 
al ., 2004).  
 
Translocation of secretory proteins from the cytoplasm to the periplasm requires the input 
of an energy source. Protein translocation via the Sec system can be driven by chemical 
energy (ATP, GTP) and electrochemical energy (proton motive force, PMF). GTP is a 
driving force for polypeptide elongation during translation by the ribosome. ATP is the 
main energy source during post-translational translocation and initiates the translocation 
event. ATP facilitates the movement of substrates through the protein conducting channel 
(PCC) and coordinates the opening and closure of the PCC (Wickner, 1994). SecA is the 
ATP-dependent force generator, however soluble SecA exhibits a low ATPase activity 
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(Van Der Wolk et al., 1997). Once precursor proteins and the SecYEG complex bind to 
SecA, the activity is stimulated (Lill et al., 1990). SecA consists of two nucleotide-binding 
sites (NBS), one is located in the N-terminal domain and has a high ATP affinity (NBS-I) 
and one has a low ATP affinity (NBS-II) and is located in the C-terminal domain 
(Papanikolau et al., 2007). ATP binding facilitates translocation of the signal sequence and 
the N-terminal mature region of the precursor protein. Once the first residues (20 Ð 30 
residues) of the precursor protein are inserted the protein will be released from SecA by 
hydrolysis of the ATP molecule at NBS-I (Schiebel et al., 1991). Following the release the 
precursor protein, SecA will be released from the membrane by hydrolysis of the second 
ATP molecule at NBS-II. The release of SecA allows the translocation intermediate to 
bind a new SecA molecule. In the absence of rebinding to SecA, the precursor protein will 
move backwards. Binding to a new SecA molecule and hydrolysis of ATP drives the 
translocation of another 20 Ð 30 residues. Multiple cycles take place to complete the 
translocation of the whole protein (Natale et al., 2008). The PMF can prevent the precursor 
protein to move backwards and complete the translocation (Driessen & Wickner, 1991).  
 
1.2.3 Co-translational targeting  
 
The biogenesis of inner membrane proteins (IMP) in Gram-negative bacteria follows a co-
translational pathway (Figure 3). The pathway can be divided in three steps: targeting, 
insertion and folding/quality control. Membrane-integrated proteins are targeted during 
their translation as ribosome- bound nascent chains (RNCs) in a different pathway 
involving the signal recognition particle (SRP). SRP is a ribonucleoprotein that is involved 
in co-translational targeting of integral membrane and secretory proteins to the ER 
membrane in eukaryotes and the inner membrane in prokaryotes.  The E. coli SRP is the 
simplest SRP variant and is composed of one Ffh (fifty-four homolog) protein and a 
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relatively small 4.5S RNA component. SRP binds with high selectivity to the first 
hydrophobic segment of the nascent protein chain (signal anchor sequence), which 
subsequently is mediated to the Sec translocon (Luirink et al., 2005). Cleavable signal 
peptides of most proteins translocated across the inner membrane are in general less 
hydrophobic than signal anchor sequences. Therefore they are targeted via the SecB 
pathway as there is less affinity for SRP binding (Randall and Hardy, 2002). Despite the 
specificity for IMPs, some secretory proteins containing a cleavable signal peptide can be 
targeted via the SRP pathway. The signal peptide of the periplasmic disulfide bond 
oxidoreductase (DsbA) is significantly more hydrophobic than other Sec signal peptides. 
Furthermore, the post-translational pathway is relatively slow compared to the co-
translational pathway. It has been suggested that DsbA might be directed to the SRP 
pathway because of its rapid folding in the cytoplasm (Schierle et al., 2003). Other studies 
have shown that secretory proteins can be redirected to the SRP pathway when the 
hydrophobicity of the signal peptides is increased (Bowers and Lau, 2003, Lee and 
Bernstein, 2001). Surprisingly, two secretory proteins (Hbp and SecM), which do not 
contain an exceptional hydrophobic signal peptide, are targeted via the SRP pathway. 
However, they both contain an unusually long signal peptide (Sijbrandi et al., 2003, 
Nakatogawa and Ito, 2001). The SRP interacts with the RNC in a relatively early stage 
when the first trans membrane segments (TMs) are exposed outside the ribosome (Houben 
et al., 2005).  
 
Once the SRP targets the RNC, the E. coli SRP receptor (SR) binds to the ribosome-SRP 
complex. The E. coli SR is known as FtsY, and can be found both in the cytosol as in the 
inner membrane (Luirink et al., 2004). FtsY targets proteins to the membrane, which are 
required for cell division. Therefore, depletion of FtsY leads to a cell division defect.  
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 Membrane associated FtsY supports targeting to the inner membrane through its affinity 
for lipids and the sec translocon component SecY (Angelini et al., 2005). 
 
The SRP-mediated co-translational protein targeting is regulated by GTP binding and 
hydrolysis in both the SRP and FtsY (Luirink and Sinning, 2004). Both the SRP and FtsY 
have to be in a GTP-bound state for SRP-SR complex formation. Once the SRP interacts 
with the ribosome the GTP binding affinity is increased (Bacher et al., 1996). At this stage, 
the binding of the signal anchor sequence inhibits GTP hydrolysis. The GTP bound SRP 
and FtsY stimulate each other to form a SRP-SR complex formation (Powers and Walter, 
1995). GTP hydrolysis dissociates the SRP-SR complex after the signal anchor sequence 
has been released (Connolly et al., 1991).  
 
The insertion and assembly of integral membrane proteins have been studied intensely in 
the past decades, however the entire process is highly complex and has still not been fully 
understood. Once the RNC is targeted to the translocon, the first transmembrane segment 
(TMS) of the nascent membrane protein enters the interior of the channel of the 
heteromeric membrane complex SecYEG (Veenendaal et al., 2004). Through a lateral gate 
each TMS can leave the channel into the lipid bilayer one by one or in pairs (Luirink et al., 
2005). It is assumed that the gate continuously opens and closes, which brings the TMS in 
equilibrium between the hydrophilic environment in the channel and the lipid. The TMS 
could first intercalate between the TMSs forming the lateral gate and then be released in 
the lipid bilayer phase (Rapoport et al., 2004). By gaining more insight in the insertion 
mechanisms research has also focused on how TMSs are actually recognized by the 
translocon (White and von Heijne, 2008). An in vitro expression system has already 
explored the hydrophobicity requirements for the insertion of transmembrane helices 
(TMHs) (Hessa et al., 2005). Based on the integration propensity of a designed TMH, the 
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free energy for the insertion of each naturally occurring amino acid was calculated, 
resulting in a biological hydrophobicity scale. Furthermore, it could be shown that the free 
energy was dependent on the position of the amino acids within a test TMH (Hessa et al., 
2007). These observations suggest that translocon recognition requires a direct interaction 
between the emerging TMH and the surrounding lipid. It has been shown that some 
membrane proteins can also integrate via the membrane-integrated YidC insertase (Van 
Der Laan et al., 2005, Dalbey and Kuhn, 2004).   
 
1.3 The Twin Arginine Translocase  
 
As previously described, the Sec translocase transports unfolded proteins across the inner 
membrane. In contrast, the twin arginine translocase (Tat) transports folded proteins across 
membranes. Tat is located on the inner membrane of bacteria, archaea, thylakoid 
membranes of plant plastids and mitochondria of plants (Bogsch et al., 1998). The energy 
force that is required for Tat dependent translocation is the previously mentioned PMF. 
Transport of folded proteins is mainly carried out by three integral membrane proteins: 
TatA, TatB, and TatC. In Gram-positive bacteria and archaea, TatA and TatC form a 
TatAC substrate-binding complex. TatA, TatB and TatC form a TatABC substrate-binding 
complex in Gram-negative bacteria and plant chloroplasts (Figure 4).  
 
Although the rationale for using Tat remains unclear, three main reasons have been 
identified. Many Tat dependent substrates fold around a co-factor in the cytoplasm which 
bypasses an extra mechanism to export the cofactor to the periplasm (Berks, 1996). 
Another reason is avoidance of competition between metal ions that compete for insertion 
into the active site of Tat dependent substrates. The periplasmic metalloprotein MncA 
binds Mn2+ to avoid competition of periplasmic metal ions (Tottey et al., 2008). The third 
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rationale for the use of Tat is that some tat dependent proteins form hetero-oligomeric 
complexes in the cytoplasm. This so-called hitchhiker co-translocation occurs when a 
subunit binds a twin arginine containing subunit to form a dimeric protein. The bacterial 
periplasmic nickel-binding hydrogenase 2 (HYD2) is composed of a 30 kDa small subunit 
(hybO) and a 60 kDa large subunit (hybC). The small subunit contains an N-terminal Tat 
specific signal peptide, whereas the large subunit does not contain an N-terminal signal 
peptide. However, it does contain additional C-terminal residues that are involved in 
keeping the subunit in a co-factor insertion competent conformation. This additional C-
terminal tail is cleaved upon co-factor insertion by a cytoplasmic protease. This event 
results in a conformational change, which allows interaction with hybO to form the hetero-
oligomeric HYD2 complex. The formation of HYD2 triggers translocation of the complex 
to the periplasm (Rodrigue et al., 1999). In archaea, Tat exports monomers and cofactor-
less proteins because of their fast folding kinetics due to a high cytoplasmic salt 
concentration (Rose et al., 2002).  
 
Tat substrates play an important role in energy metabolism, formation of the cell envelope, 
iron and phosphate acquisition, cell division and cell motility. Because they are involved in 
biogenesis of the cell envelope, the phenotype of Δtat deletion strains can be characterised 
by the formation of long cell chains (Hinsley et al., 2001).  
 
Since Tat exports fully folded proteins, it consists of a proofreading and a quality control 
mechanism. Due to this unique capacity it is likely that the Tat system has a natural 
tendency to produce high quality, active products. This is particularly relevant for 
biotechnological exploitation. Various studies have shown the Tat systemÕs ability to reject 
unfolded proteins (Robinson et al., 2011, Maurer et al., 2009).  Emerging evidence 
suggests that quality control involves more than the proofreading as misfolded substrates 
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rapidly degrade after interaction with the Tat components (Matos et al., 2008). Other 
studies have shown that the Tat system tolerates minor structural changes (Alanen et al., 
2015). Furthermore, studies seem to suggest a hydrophobicity sensor employed by the Tat 
apparatus rather than assessment of the folded state of substrates (Richter et al., 2007). 
 
 
Figure 4. Organisation of the Tat translocase system in Gram-negative bacteria 
(A) The integral membrane proteins TatA/E, TatB and TatC are expressed from the 
tatABC operon. A fourth gene is expressed downstream of the tatABC operon, tatD. The 
monocistronic tatE gene encodes TatE. (B) TatA, TatE and TatB are single spanning 
integral membranes that consist of an N-terminal TMS, a amphipathic helix and an 
unstructured C-terminal region. Compared to TatA and TatE, TatB has a longer 
amphipathic helix and C-terminal region. TatC contains 6 TMSs with both the N- and C-
termini located in the cytoplasm. TMS5 and TMS6 are too short to completely span the 
membrane.  
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1.3.1 The Tat components 
 
Two types of membrane proteins assemble the Tat translocase: a hexahelical TatC-type 
protein and TatA-type single spanning proteins, TatA, TatB and TatE. In E. coli, three 
integral membrane proteins TatA, TatB and TatC are expressed form the tatABC operon, 
which contains a downstream tatD gene encoding the cytosolic TatD component (Figure 4) 
(Wexler et al., 2000). The TatA component forms a pore or a channel in the inner 
membrane to allow translocation of folded substrates from the cytoplasm to the periplasm. 
TatB and TatC form a stable TatBC complex and is the initial receptor of the Tat 
translocase pathway (Patel et al., 2014). Translocation of Tat substrates is initiated by the 
interaction of the TatBC complex with Tat substrates via their twin arginine signal peptides 
(Cline and Mori, 2001). Binding of the signal peptide to the TatBC complex requires the 




Compared to other Tat components, TatA is synthesised at the highest level (Palmer and 
Berks, 2001). TatA is a 9.6 kDa single spanning integral membrane protein and it consist 
of an N-terminal TMS, a partially membrane-embedded amphipathic helix (AMP) and an 
unstructured C-terminal region (Figure 4)(Chan et al., 2011). It has the ability to form a 
pore in the inner membrane by homo-oligomerization with other TatA components. Two 
regions of high sequence conservation are essential for TatA activity: (i) the interdomain 
hinge between the N-terminal TMS and the amphipathic helix and (ii) an invariant 
phenylalanine residue within the amphipathic helix (Hicks et al., 2003). Furthermore, 
studies showed that the truncation of 40 C-terminal amino acids did not affect the TatA 
activity (Lee et al., 2002). NMR studies have determined the structure of the orthologous 
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TatAd in Bacillus subtilus in bicelles containing phospholipids as a membrane-mimicking 
environment. The relatively short 14 amino acids long N-terminal TMS was deeply 
inserted into the inner membrane and is tilted by 13¡. Because the TMS is relatively short, 
it pulls the N-terminus of the APH into the membrane. This causes the hinge region and 
the N-terminal part of the APH to be immersed into the lipid bilayer in a tilt angle and was 
thought to posses a higher mobility than the N-terminal TMS (Torsten et al., 2010). Single-
particle electron microscopy studies support the hypothesis that TatA forms the PCC of the 
Tat translocase. TatA is facing a challenging task since Tat dependent substrates range in 
size from less than 10 kDa to 150 kDa. TatA forms homo-oligomeric complexes to form 
pores of variable diameters to allow translocation of Tat dependent substrates. A lid 
formed by the APHs to maintain the ionic permeability barrier of the membrane gates the 
cytoplasmic end of the pores (Gohlke et al., 2005, Palmer and Berks, 2012). It has been 
suggested that the walls of the pores are formed by interactions between the TMSs. Ile12 
and Val14 arrangements between TMSs were observed in homo-oligomeric TatA 
complexes. The Ile12 residue, located on the side of the TatA TMS, was found to contact 




TatB functions as a mediator between substrate recognition and translocation events. It is a 
18.5 kDa single spanning TatA-like Tat component and has evolved into a functionally 
independent protein due to a gene duplication of TatA (Yen et al., 2001). Despite sharing 
20% sequence identity and being structural homologous to TatA, there are functional and 
structural differences. Both TatA and TatB comprise an N-terminal TMS, a partially 
membrane-embedded amphipathic helix (AMP) and an unstructured C-terminal region. 
However, TatB is larger than TatA and has a longer APH and a longer C-terminal tail 
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(Figure 4) (Hicks et al., 2003). Like TatA, the region between the TMS and the APH are 
important for the function of TatB. Moreover, site-directed mutagenesis studies 
demonstrate the importance of glutamic acid residues in the APH (Hicks et al., 2003).  
 
Although no single mutation has been identified to inactivate the TatB function, it is 
essential for the translocation of endogenous Tat substrates in E. coli (Frobel et al., 2012). 
In contrast, studies have demonstrated low levels of export of an artificial Tat substrate 
containing a twin arginine signal peptide in ΔTatB mutant stains (Ize et al., 2002). These 
findings might be an indication for a Tat-B-like activity of E. coli TatA. In addition, Gram-
positive bacteria posses TatAC-systems, which lacks TatB. Therefore, Gram-positive 
bacteria possess a bifunctional TatA component, which has the ability to mediate between 
substrate recognition and translocation events, and it fulfils the pore-forming function of 
TatA. Furthermore, it has been demonstrated that substitutions in TatA of Gram-negative 
bacteria can compensate for the absence of TatB, suggesting that the bifunctionality of 




TatC is the largest and most conserved Tat component and it is the only Tat component 
with multiple transmembrane domains (Figure 4). The primary site of interaction between 
a twin arginine signal peptide and the Tat translocase is TatC. This component is 28.9 kDa 
and exhibits 6 TMSs with the N- and C- termini located in the cytoplasm (Behrendt et al., 
2004). 3D crystallisation studies on TatC from the thermophilic bacterium Aquifex 
aeolicus have revealed that TatC resembles a concave-shaped structure that faces the 
periplasm because TMS5 and TMS6 are too short to span the membrane (Rollauer et al., 
2013). They are relatively shorter than the other TMSs resulting in the membrane to be 
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slanted inwards at the ends of TMS5 and TMS6. This causes thinning of the membrane 
around TatC, which might be required for translocation of Tat dependent substrates across 
the membrane or to accommodate TatB. The two periplasmic loops form a structured 
periplasmic cap that stabilises the position and tilted orientations of the TMSs. Site-
directed mutagenesis studies demonstrated that the N-terminus, the first cytoplasmic loop 
and the two periplasmic loops are essential for TatC activity (Allen et al., 2002, Buchanan, 
et al., 2002). In addition, site-directed mutagenesis of TMS5 also inactivates TatC, 
probably because there is a specific contact site between TMS5 of TatC and the TMS of 




The tatABC operon expresses a fourth gene downstream, tatD, encoding the soluble 
cytoplasmic 28.9 kDa TatD component. Although the function of TatD is largely 
unknown, it is not essential for Tat dependent translocation. However, the co-transcription 
of tatD with three essential genes for Tat translocation strongly suggests an involvement of 
TatD in the Tat translocase system. TatD has a high affinity for metal ion-binding and 




Some bacteria, including E. coli, express a TatA like component, TatE, that is encoded by 
a monocistronic tatE gene (Figure 4). Whilst TatB emerged from TatA by an relatively 
early gene duplication event, TatE evolved by a late gene duplication event (Yen et al., 
2002). Despite TatE sharing 53% sequence identity with TatA, it is 7 kDa and much 
shorter (Sargent et al., 1998). Beside the structural similarities, previous studies suggested 
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that TatE is a functional paralog of TatA. In ΔtatA strains, overexpressed TatE can 
facilitate efficient translocation of several Tat substrates (Sargent et al., 1999). However, 
this was thought to be insufficient to persist TatE during evolution. Despite 3D density 
maps of purified TatE demonstrating ring-shaped structures, the TatE complexes are much 
smaller and discrete (Baglieri et al., 2012). Recent studies revealed that TatE interacts with 
TatA, TatB and TatC, suggesting that TatE is a regular constituent of the Tat (A)BC-
complex. In contrast to TatE being a functional surrogate of TatA it is now thought to 
cooperate with TatA. TatE and TatA assembling into hetero-oligomeric complexes and it 
was confirmed that TatE cross-links with a common binding site of TatA to TatC (Eimer et 
al., 2015). Recently, it has been demonstrated that TatE and TatB share functional 
similarities.  
 
Unlike TatA, TatB can counteract premature processing of translocation- incompetent 
substrates (Frbel et al., 2012). TatE shares the ability to counteract premature processing, 
albeit with less efficiency (Eimer et al., 2018).  
 
1.3.2 The Tat (A)BC-complex 
 
The Tat signal peptide contains a twin arginine signal peptide (1.1.2), which is recognised 
by a TatBC complex (figure 5). This event triggers the proton motive force-dependent 
recruitment and oligomerization of TatA and TatB to form the Tat(A)BC-complex (Rose et 
al., 2013, Alami et al., 2003). As discussed in section 1.3.1, the individual Tat components 
have the tendency to form homo-oligomeric complexes. For the assembly of the Tat 
translocase in E. coli and other Gram-negative bacteria, the TatA, TatB and TatC proteins 
form the hetero-oligomeric TatABC-complex (figure 5). TatB and TatC are the most stable 
components and form the substrate receptor complex. Both components associate in a 1:1 
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ratio and due to homo-oligomerisation a functional TatBC complex consists of several 
TatBC dimers. TatA is less associated and interacts with the complex by binding to TatC 
(Bolhuis et al., 2001).  
 
The TatBC complex recognises and binds to Tat dependent twin arginine signal peptides. 
The cytosolic N-terminus and the first cytosolic loop of TatC play a role in recognition and 
binding to the RR-motif of the signal peptide (Buchanan, et al., 2002). Crosslinking 
between the twin arginine motif of the signal peptide with residues on the N-terminus and 
first cytosolic loop were observed in a PMF independent manner. In addition, several 
single residues that cross-links with the RR-motif of the signal peptide also cross-link to 
TatB (Zoufaly et al., 2012). Other studies suggested that the K residue within the 
SRRxFLK consensus motif, interacts with a conserved EE motif within the TatC cavity 
(Ramasamy et al., 2013). Once the signal peptide is recognised by the TatC complex it 
inserts into the central cavity of TatC in a hairpin loop-like conformation. (Fincher et al., 
1998, Berks et al., 2014). The insertion of the signal peptide triggers the TMS of TatB to 
bind to TMS5 of TatC by the formation of a site-specific disulphide bond (Kneuper et al., 
2012).  





Figure 5. The topology of the Tat(A)BC complex 
The TatC components are displayed in blue, TatB components in green, TatA 
components in orange and the substrate in red. The binding of the twin arginine signal 
peptide to the TatBC receptor complex is displayed on the left. The signal sequence is 
embedded between helices of TatC and TatB. Insertion of the signal peptide into the inner 
membrane by TatC triggers TatB to interact to the TatC TMS5. The formation of the 
precursor-TatBC-complex recruits TatA components resulting in the hetero-oligomeric 
TatABC-complex.  
 
In the presence of the PMF, the signal peptide is accommodated in a concerted TatBC-
binding groove. A deep hairpin loop-like insertion between TatB and TatC, results in a 
TatBC-binding pocket that prevents premature cleavage by signal peptidase. Studies have 
demonstrated that a Tat translocase lacking TatB, allows premature removal of the signal 
sequence of a translocation incompetent precursor substrate (Frbel et al., 2012). Besides 
the twin arginine consensus motif, TatB also contacts the hydrophobic h-region of the 
signal peptide (Maurer et al., 2010). Recent studies provided evidence that the cytosolic 
domains of TatB interact with the first residues of the folded mature protein (Ulfig and 
Freudl, 2018). These findings suggest that TatB supports the binding of Tat substrates to 
the TatBC substrate receptor complex. Substrate binding to TatBC triggers the recruitment 
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of TatA in a PMF dependent manner (Mori and Cline, 2002). TatA oligomers facilitate 
protein translocation by forming a size-fitting translocation pore (trap-door model) or by 
weakening the membrane (Gohlke et al., 2005, Rodriguez et al., 2013).  
 
 
Figure 6. Cytoplasmic overview of the Tat(A)BC-complex 
A schematic overview of the TatABC complex in the inner membrane after substrate 
binding. The TatC components are displayed in blue, TatB components in green, TatA 
components in orange and the substrate in red. TatA inserts between two TatC 
components to increase the diameter of the TatBC complex. TatB forms a bridge between 
two TatC components by interacting with TMS5 and TMS2. 
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1.3.3 The Tat system of Gram-positive bacteria 
 
Although this study is focussed on the most frequently studied Tat system in E. coli, the 
understanding of the Tat system in Gram-positive bacteria, such as Bacillus subtilis and 
Staphylococcus aureus has largely increased. This has gained insight in some strong 
similarities and potential differences between Gram-positive and Gram-negative bacteria 
(Goosens et al., 2014). 
 
A major difference is the lack of a TatB component, suggesting that the TatA-like 
components of Gram-positive bacteria perform the functions of both TatA and TatB. 
Gram-positive bacteria possess a minimal Tat system, composed of two TatA-like 
components and one TatC component. In B. subtilis, three TatA-like components and two 
TatC variants have been described, denoted TatAd, TatAy, TatAc, TatCd and TatCy. 
Previous studies revealed that B. subtilis contains two active TatAC- systems named 
TatAdCd and TatAyCy (Jongbloed et al., 2004). The TatAdCd system only exports a 
single substrate, PhoD, to the periplasm under conditions of phosphate starvation 
(Jongbloed et al., 2000). The TatAyCy system is constitutively expressed and exports 
various substrates including, EfeB (YwbN), QcrA, and YkuE, in all conditions (Jongbloed 
et al., 2004). Despite the fundamental differences between the TatABC and TatBC-
systems, the TatAd component of the B. subtilis Tat-system is able to compensate for the 
absence of components of the E. coli Tat system (Barnett et al., 2011). TatAc is the third 
TatA-like component of B. subtilis and its function remains unknown. However, it has 
been suggested that it can form active Tat translocase systems with TatCd and TatCy 
(Monteferrante et al., 2012). In addition, TatAc can functionally replace the E. coli TatA 
and TatE components, suggesting that TatAc has a relevant role in protein translocation 
(Beck et al., 2013).  
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To ensure correct folding and co-factor insertion, protein interactions between substrate 
specific chaperones take place. However, the understanding of the B. subtilis Tat systemÕs 
quality control and proofreading remains unknown, protein interactions between substrate 
specific chaperones have been observed. Proteomics studies showed that the protease 
WprA is important for the translocation of YwbN by TatAyCy and that HemAT and CsbC 
are overexpressed during the translocation of PhoD by TatAdCd (Monteferrante et al., 
2013). Moreover, the chaperones DnaJ and SufS that are potentially associated with 
quality control were highlighted during proteomics studies (Goosens et al., 2013). 
Unfortunately, no Gram-positive specific chaperones that are associated with quality 
control and proofreading have been identified. 
 
1.3.4 The Tat translocase mechanism 
 
While the understanding of protein targeting and association of Tat substrates with 
Tat(A)BC-complexes has significantly increased, the actual translocase mechanism 
remains to be the least understood step of the Tat pathway. Two translocation mechanism 
models have been proposed: the trap-door model and the membrane-weakening model 
(figure 7) (Patel et al., 2014). The two proposed models are listed in figure 7. 




Figure 7. The Tat translocation mechanisms 
The figure shows the two proposed models for protein translocation by the TatA complex 
before and during translocation. (A/C) A substrate containing a twin arginine signal 
peptide is recognised by the TatBC complex. (B) The trap-door model is based on the 
hypothesis that the amphiphatic helix of the TatA component has a dual topology. The 
amphipathic helix flips into the membrane resulting in a hydrophilic pore to translocate 
substrates in the presence of the proton motive force. (D) The membrane-weakening 
model hypothesises that the formation of a precursor-TatBC-complex induces the APH to 
disrupt the lipid bilayer, which permits translocation of the substrate.  
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1.3.4.1 Trap-door model 
 
Although the translocation mechanism is not well understood, it is known that TatA 
permits translocation of the substrate by the formation of an integral pore (Gohlke et al., 
2005). The TatA forms pores of variable diameters to allow translocation of substrates. 
The walls of the pores are formed by the TMSs whereas the APHs form a cytoplasmic lid 
to gate access to the translocase whilst maintaining the ionic permeability barrier of the 
membrane (White et al., 2010).  
 
The trap-door model is based on the ability of the APHs of TatA to adopt different 
topologies (figure 7B) (Gouffi et al., 2004). It has been suggested that the APHs form a 
hydrophilic pore by obtaining a membrane spanning topology. Another study suggested a 
Ôcharge zipper mechanismÕ (Walther et al., 2013). This mechanism is based on the fact that 
the sequence of charges of the C-terminal region of TatA is complementary to the charge 
pattern on the APH. The two complementary sequences of charges can assemble via a 
Ôcharge zipperÕ resulting in the formation of a hairpin. Interaction of the substrate with the 
TatA hairpins triggers the hairpins to flip into the membrane to form a hydrophilic pore.  
 
1.3.4.2 Membrane weakening model 
 
In contrast to the Ôtrap-door modelÕ, the Ômembrane-weakening modelÕ is based on the idea 
that TatA destabilises the lipid bilayer (figure 7D). It has been hypothesised that TatA 
components accumulate in an unordered manner resulting in destabilisation of the 
membrane (Brser and Sanders, 2003). This hypothesis was supported by NMR studies 
suggesting that the hinge between the APH and TMS lacks the flexibility to allow the 
formation of a hairpin. Furthermore, the APH is partially embedded in the membrane 
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which might have a lipid disrupting effect (Torsten et al., 2010). Electron microscopy 
studies of the B. subtilis TatAd component showed that TatAd can not form the 
translocation channel. In contrast to TatA pore complexes of 7.5 Ð 9 nm diameter in E. 
coli, TatAd forms relatively small pores of 2.5 Ð 3 nm diameter. Furthermore, TatAd does 
not exhibit the heterogeneity of TatA but can only form homogeneous pores (Beck et al., 
2013). The fact that the TatA TMS and TatC TMS5 and TMS6 are too short to completely 
span the membrane might also cause disruption of the lipid bilayer (Rodriguez et al., 2013, 
Rollauer et al., 2013). During translocation TatC pulls the substrate across the destabilised 
membrane in a PMF dependent manner (Kudva et al., 2013).  
 
The phage shock protein PspA in E. coli is believed to be involved in protein translocation 
(DeLisa et al., 2004). It has been suggested that PspA maintains export competence and 
enhances translocation efficiency. In addition, it plays an important role in maintaining 
PMF efficiency under cellular stress conditions (Michiel Kleerebezem, 1996). It has been 
suggested that cellular stress induced by membrane destabilisation recruits PspA to 
counteract membrane stress (Mehner et al., 2012).  
 
1.3.5 Proofreading and quality control of Tat substrates 
 
Tat dependent substrates are exported via the Tat pathway because they require the 
enzymatic insertion of cofactors in the cytoplasm or form a hetero-oligomeric complex in 
the cytoplasm (Patel et al., 2014). The Tat pathway exports correctly folded substrates by a 
remarkable proofreading and quality control mechanism. Various studies have shown the 
Tat systemÕs ability to reject unfolded proteins (Robinson et al., 2011, Maurer et al., 
2009). In addition, emerging evidence suggests that quality control involves more than the 
proofreading as misfolded substrates rapidly degrade after interaction with the Tat 
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components (Matos et al., 2008). The incorporation of cofactors is mediated by the quality 
control mechanism whereas the assessment of the overall folding state is done by the 
proofreading mechanism (figure 8).  
 
Figure 8. Tat proofreading and quality control 
The Tat quality control mechanism is listed. In the membrane the Tat translocase complex 
is depicted containing: TatA (Blue), TatB (Red) and TatC (orange). (1) A chaperone 
(yellow) associates with the Twin arginine signal peptide of a precursor substrate (green). 
In some cases a second chaperone may bind to the mature region of the precursor 
substrate. (2) The binding of one or more chaperones allows cofactor insertion needed for 
substrate assembly. Following cofactor insertion the chaperones are released and the 
fully assembled precursor substrate is targeted by the Tat components for translocation.   
 
To ensure that cofactors are correctly assembled, specific chaperones (redox enzyme 
maturation protein (REMP)) are involved. The most well-characterised REMPs are TorD, 
DmsD, HyaE and NapD (Frobel et al., 2012). Trimethylamine N-oxide (TMAO) reductase 
acquires the redox cofactor, molybdenum guanine dinucleotide (MGD), to be correctly 
folded prior to export. The third gene of the torCAD operon encodes the cytoplasmic 22.5 
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kDa TorD protein, which interacts specifically with the unfolded Tat substrate, 
Trimethylamine-N-Oxide reductase (TorA) (Pommier et al., 1998). TorD associates with 
the TorA protein by recognising two TorD-binding sites, the N-terminal TorA signal 
peptide which is unique to TorA and the mature region of the protein (Jack et al., 2004). 
Although a monomeric form of TorD associates with TorA, TorD dimerization has been 
observed. The binding of a single TorD chaperone to TorA facilitates efficient insertion of 
the MGD cofactor into the unfolded TorA precursor protein. The structure of precursor 
TorA is composed of four domains (I-IV), with domain I-III in a folded conformation and 
the C-terminal domain IV presented to the TorD chaperone. TorD prevents premature 
closing of domain IV to allow MGD insertion. Moreover, co-factor insertion allows 
domain IV to fold correctly which triggers TorD release and subsequent translocation of 
the now correctly folded export competent TorA substrate (Dow et al., 2013). It has been 
suggested that TorA-TorD interactions are mediated in a GTP-dependent manner (Guymer 
et al., 2010). Besides facilitating MGD insertion and preventing premature translocation, 
studies have demonstrated that TorD also has the capability to reduce proteolysis and to 
facilitate oligomerization of protein subunits. It has been demonstrated that the 
translocation of the heterologous co-factor less Green Fluorescent Protein (GFP) 
containing a TorA signal peptide was enhanced possibly by reducing the proteolysis of 
precursor GFP (Li et al., 2006). Moreover, TorD was required for the assembly of the Tat 
dependent heterodimer hydrogenase-2 (NiFe) (Jack et al., 2004).  
 
DmsD is related to the TorD family and is the REMP associated with dimethylsulfoxide 
(DMSO) reductase, which is a heterotrimeric redox enzyme. DMSO comprises the 85.8 
kDa MGD cofactor containing DmsA, the 23.1 kDa membrane-associated iron-sulphur 
protein DmsB, and the 30.8 kDa DmsC which acts as a membrane anchor (Ray et al., 
2003). DmsD can interact with the hydrophobic region of the twin arginine signal peptide-
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containing precursor DmsA and precursor TorA (Winstone et al., 2013). Studies suggested 
that DmsD is involved in the biogenesis of DMSO rather than the functioning of the signal 
peptide (Oresnik et al., 2001). It has been suggested that DmsD guides DmsA through a 
cascade of chaperone assisted protein biogenesis as it interacts with several chaperones, 
such as DnaK, DnaJ, GrpE and GroEL (Li et al., 2010). In addition it also interacts with 
several proteins that play a role in the MGD biosynthesis pathway, such as MoaA and 
MoeB (Chan and Turner, 2015).  
 
HyaE and HybE are the REMPs associated with the heterodimers hydrogenase-1 and -2 
(NiFe) (Dubini and Sargent, 2003). Hydrogenase-1 is a heterotrimeric substrate consisting 
of a core heterodimer of a Fe-S-binding β-subunit (HyaA) and a NiFe-cofactor binding α-
subunit (HyaB). The core dimer associates with a third integral membrane cytochrome b γ-
subunit (HyaC). Hydrogenase-2 comprises the HybOC complex containing the α-subunit 
HybC and the β-subunit HybO. The hydrogenase-1 and -2 β-subunits are equipped with 
the N-terminal twin arginine signal peptide (Rodrigue et al., 1999). HyaE and HybE 
prevent premature translocation or interaction with the Tat components before the 
biogenesis process has been completed. Moreover, they play an important role in the NiFe 
cofactor insertion of the α-subunits prior to dimerization with the β-subunits. In addition 
the Fe-S clusters must be assemble in the β-subunits prior to dimerization with the α-
subunits (Magalon and Bck, 2000). HybE associates with both the signal peptide 
containing subunit as well as the second subunit of hydrogenase-2. In contrast, HyaE only 
interacts with the signal peptide containing β-subunit, HyaA, of the hydrogenase-1 
substrate (Dubini and Sargent, 2003).  
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NapD is the REMP that associates with the nitrate reductase A enzyme (NapA) and they 
both are encoded in the seven-gene NapFDAGHBC operon. NapA is a 90 kDa substrate 
that binds a Fe-S cluster and accommodates a MGD cofactor (Jepson et al., 2007). NapD is 
a small 9.3 kDa cytoplasmic chaperone that associates with the n- and h-regions of the N-
terminal signal peptide of the NapA precursor substrate. Moreover, significant changes in 
NapA signal peptide conformation have been demonstrated (Grahl et al., 2012). Studies 
suggested that NapD plays an important role in the insertion of the MGD cofactor to 
complete the maturation of NapA (Dow et al., 2014). Beside NapD, NapA is targeted by 
another cytoplasmic chaperone, NapF. Like NapD, NapF is a quality control related 
chaperone which plays an important role in protein assembly prior to translocation 
(Nilavongse et al., 2006). 
 
Beside the ability to carry out chaperone-mediated proofreading, the Tat pathway can also 
differentiate between folded and unfolded substrates by a proofreading mechanism. This 
was demonstrated in studies using alkaline phosphatase (PhoA) fused to Tat specific signal 
peptides. PhoA requires disulfide bonds for proper folding and therefore it was not 
exported by the Tat system because the proteins were unfolded in the reducing cytoplasm 
that perturbs the formation of disulfide bonds, which are required for folding. It was 
demonstrated that PhoA can serve as a Tat substrate when expressed in E. coli strains with 
an oxidising cytoplasm (DeLisa et al., 2003). Similar studies demonstrated efficient export 
of active, correctly folded disulfide bonded therapeutic proteins to the periplasm such as: 
PhoA, anti-interleukin 1β (scFv) and human growth hormone (hGH) (Matos et al., 2014). 
In contrast, other studies have shown that the Tat system tolerates minor structural changes 
in disulfide-bonded therapeutic proteins (Alanen et al., 2015). Several disulfide bond-
containing proteins, such as human interferon α2b (IFN), hGH, scFv and an antibody VH 
domain, are efficiently exported in the absence of cytoplasmic disulfide bond formation. In 
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addition, it was demonstrated that hGH can even be exported by the Tat system when 
disulfide bond formation is perturbed by substitution of the cysteine residues involved. 
This data suggest that the substrates adopt a near-native structure in the absence of 
disulfide bond formation that enables them to avoid the Tat proofreading mechanism. A 
better understanding of the margin for error remains to be elucidated. 
 
A hydrophobicity sensor employed by the Tat apparatus rather than assessment of the 
folded state of substrates has been suggested (Richter et al., 2007). The hydrophobic 
interior of a substrate could be revealed in unfolded or poorly folded substrates. There is a 
possibility that the Tat components sense the hydrophobic interior, which is normally 
sequestered in correctly folded state. Studies demonstrated that introducing hydrophobic 
surface patches abolish translocation by the Tat system (Richter et al., 2007). Strikingly, 
other studies demonstrated that the Tat system tolerates significant changes in substrate 
surface hydrophobicity (Jones et al., 2016). More recent studies suggested that the Tat 
systems proofreading mechanism has the ability to sense conformational flexibility rather 
than changes in surface charge or hydrophobicity (Jones et al., 2016). We have recently 
shown that the Tat translocase is able to recognize and distinguish the folding state of a de 
novo-designed heme protein, denoted as BT6 maquette (Sutherland et al., 2018). Because 
of the simple and repetitive protein structure this is a suitable candidate to study the Tat 
systems proofreading mechanism. 
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1.4 Recombinant protein production in Escherichia coli  
 
The overall market value of the biopharmaceutical industry had an estimated sales value of 
$140 billion in 2014. Of all biotherapeutics licensed to date, E. coli is responsible for the 
production of more than 30% of the expression of therapeutic recombinant proteins 
(Overton, 2014). To produce therapeutic proteins in E. coli, several strategies have been 
used including: expression of soluble proteins in the cytoplasm, expression as soluble 
inclusion bodies, expression in the cytoplasm followed by export to the periplasm. For the 
latter, extraction of the protein can be done more easily and contaminating proteins, DNA 
and general debris is minimised. Moreover, the periplasm is essential for efficient 
disulphide bond formation. This is the only oxidising compartment in wild type cells. 
Many therapeutic proteins and antibody fragments contain disulphide bonds. 
Approximately 30% of all currently licensed, recombinantly expressed biotherapeutic 
products are produced to the periplasm by the general Secretory ÔSecÕ pathway. However, 
there are many heterologous proteins that cannot be exported by the Sec pathway. The Sec 
pathway is unable to export these proteins due to their rapid folding which makes it 
impossible to transport these folded proteins through a relatively narrow pore in a folded 
state. In contrast to the Sec pathway, the Tat pathway exports fully folded proteins. The 
Tat pathway is a powerful alternative by means of export of proteins that cannot be 
exported by the Sec pathway (Walker et al., 2015). Besides, the Tat system does not only 
export folded proteins; it consists of a proofreading and a quality control mechanism 
(Palmer and Berks, 2012). Due to this unique capacity it is likely that the Tat system has a 
natural tendency to produce high quality, active products. This is particularly relevant for 
biotechnological exploitation. 
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1.5 Aims of this project 
 
The overall aim of this study was to gain inside in the E. coli Tat proofreading ability 
based on the folding state and folding kinetics of Tat dependent secretory proteins. As 
described in this chapter, the Sec and Tat systems are the two general secretory pathways 
to transport proteins from the cytoplasm to the periplasm. The most described translocase 
system is the Sec machinery. Unfortunately, the Sec system is unable to transport proteins 
with rapid folding kinetics within the cytoplasm as the proteins are translocated via a 
relatively narrow pore. In contrast to the Sec system, the Tat system has the ability to 
discriminate between folding states. Therefore only fully folded proteins will be exported 
from the cytoplasm to the periplasm. It is not well understood how the Tat system senses 
the folding state of a substrate. The project will focus on the Tat systemÕs proofreading 
ability by altering substrate surfaces to determine what Tat senses as Ôcorrectly foldedÕ in 
the substrate. 
 
Furthermore, we were also interested to determine whether Tat substrates fold co- or post-
translationally and whether they start interacting with the Tat translocase already during or 
after their synthesis. It is known that Tat dependent proteins use the Tat system because of 
their rapid folding kinetics. However, it is not known at what stage of the protein synthesis 
Tat substrates start to interact with the Tat complex. It is also not clear whether Tat 
dependent proteins prefer to fold post- or co-translationally. Cotranslational nascent chain 
force measurements provided insight into the folding kinetics of Tat dependent proteins.













Materials and methods 
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Fisher Scientific UK (Thermo Fisher Inc, USA), Sigma (Sigma-Aldrich, USA) or 
Formedium (UK) supplied all chemicals used in this study unless otherwise stated. L-
[35S]-methionine was obtained from PerkinElmer.   
 
2.1 DNA techniques  
 
2.1.1 Preparation of plasmid DNA 
 
Plasmid DNA was extracted and purified using the QIAprep spin miniprep kit (Qiagen, 
Hilden, Germany). The purifications were performed according to manufactureÕs 
instructions. The samples were eluted in 30 µl Elution buffer (10mM Tris-Cl pH 8.5) and 
the DNA concentration and purity was measured using NanoDrop 2000c (Thermo Fisher 
Scientific Inc, USA). The Plasmid DNA samples were stored at -20 ¡C. 
 
2.1.2  Amplification Polymerase Chain Reaction (PCR) 
 
PCR reaction mixes were prepared using Q5¨ High-Fidelity DNA Polymerase (New 
England Biolabs, NEB, UK). PCR solutions were made using 1 ng DNA, 5x Q5 reaction 
buffer, 0.4 µl 10mM dNTPs, 0.8 µl of the forward and reverse primer (10 µM), 0.1 µl Q5 
High-Fidelity DNA Polymerase and dH2O to a final volume of 20 µl. The PCR reaction 
was performed in a Biometra T3 Thermocycler (Biometra Anachem, UK) and analysed by 
agarose gel electrophoresis (2.1.4). The following thermocycling conditions were used for 
DNA amplification:  
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1= 98.0 ¡C 1:00 min 
2= 98.0 ¡C 20 sec 
3= 60.0 ¡C 10 sec 
4= 72.0 ¡C 20-30 sec/kb 
6= 4.0 ¡C Pause 
 
2.1.3 Primers used for PCR 
 
Eurofins MWG Operon Inc supplied all oligonucleotides used in this study. Table 1 lists 
primers for the polymerase chain reaction, the template DNA used and the resultant 
constructs. The restriction enzyme sites of the enzymes used in this study are underlined. 
  
Table 1 Primers used for the polymerase chain reaction 
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2.1.4 Agarose gel electrophoresis 
 
To prepare 1% agarose gels, 1% (v/w) agarose (Bio-Rad Laboratories Ltd, USA) was 
dissolved in 1x TAE buffer (0.04 M Tris-acetate, 0.001 M EDTA, pH 8.2).  The gel was 
submerged in 1x TAE buffer after it was polymerised. 4 µl of the DNA samples (PCR or 
restriction digest product) was mixed with 1 µl SYBR Green Nucleic Acid Gel stain (20x 
in DMSO, Invitrogen, Thermo Fisher Scientific Inc, USA) and 1 µl 6x Gel Loading Buffer 
(Thermo Fisher Scientific Inc, USA). Agarose gel electrophoresis was carried out at 150V 
for 30 minutes or until the dye front was at least half way through the gel. The DNA bands 
were visualised using Bio-Rad Gel doc (Bio-Rad Laboratories Ltd, USA).  
 
2.1.5 Purification of DNA from agarose gels 
 
DNA from agarose gels was excised from the UV transluminator. The DNA of interest was 
then purified using a QIAprep Gel Extraction kit (Qiagen, Germany according to 
manufacturerÕs instructions. The concentration of the extracted DNA was measured using 
NanoDrop 2000c (Thermo Fisher Scientific Inc, USA) and samples were used immediately 
or stored at -20 ¡C 
 
2.1.6 Restriction digest of DNA 
 
Restriction digest reaction mix was prepared to digest DNA following the manufacturerÕs 
instructions (New England Biolabs, UK.). The first restriction enzyme was incubated at 37 
¡C for 30 minutes before further incubation with the second restriction enxyme for another 
60 minutes. Table 2 shows restriction enzymes used in this study. The digested DNA 
products were isolated using agarose gel electrophoresis and DNA purification form 
agarose gels (2.1.4 and 2.1.5). 
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Table 2 Restriction enzymes used in this study 







2.1.7 Ligation of DNA fragments into plasmid vector backbone 
 
In this study, all ligation reactions were performed using T4 DNA ligase (Roche, Sussex, 
UK). The ligation reaction mix contained 1 µl ligase buffer, 1 µl T4 ligase and the insert 
and vector were ligated in a 3:1 (9 µl insert to 3 µl vector) ratio. The samples were 
incubated overnight at 4 ¡C and 10 µl ligation reaction was transformed into E. coli DH5α, 
XL1 blue or NEB Turbo competent cells (2.2.5).  
 
2.1.8  Site-directed DNA mutagenesis 
 
Site-specific DNA mutagenesis Site-specific DNA mutagenesis was carried out by using 
Q5¨ High-Fidelity DNA Polymerase (New England Biolabs, NEB, UK) as described in 
section 2.1.2. The thermocycling reaction generates circular DNA. To exclude methylated 
DNA, 0.5 µl DpnI (New England Biolabs, NEB, UK) was added to 20 µl of amplified 
DNA samples. The samples were incubated overnight at 37 ¡C. After DpnI digestion, 3 µl 
of the amplified DNA was transformed into 30 µl competent E. coli NEB turbo cells 
(section 2.2.5).  
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The mutagenesis occurred due to primers that were designed containing a mismatch in the 
centre of the forward primers. The forward primers included 12 nucleotides 
complementary to the plasmid at the 5Õ end. The desired nucleotide changes were 
incorporated in the centre of the primer followed by complementary nucleotides on the 3Õ 
side of the substitution. The number of nucleotides on the 3Õ side was based on an 
annealing temperature of ± 60 ¡C. The 5Õ end of the reverse primer was designed next to 
the 5Õ end of the forward primer and preceded in the opposite direction on the 
complementary strand. Table 3 shows the primers used for Site-specific DNA mutagenesis. 
The desired nucleotide sequence is underlined.  
 
Table 3 Primers used for Site-specific DNA mutagenesis 
Primer Sequence (5' to 3') 
 QCTorARRfor  TTTCAGGCATCACGTCGGCGTTTTCTGGCACAACTCGGC 
 QCTorAKKfor  TTTCAGGCATCAAAGAAACGTTTTCTGGCACAACTCGG 
 QCTorAKKRRrev  TGATGCCTGAAAGAGATCGTTATTGT 
 QCSufIRRfor  ATGTCACTCAGTCGGCGTCAGTTCATTCAGGCATCGGGG 
 QCSufIRRrev  ACTGAGTGACATGGTATATCTCCTTCTTAAAGTT  
 Arrest-Cterm-FW  ATCCGTGCTGGCTAGGGGAGCGATTACATCAAGCGC 
 Arrest-FW  ATCCGTGCTGGCTAGGGGAGCTCCGATAAGCAAGAAG 
 Arrest-RV  GCCAGCACGGATGCCT 
 FL-Cterm-FW  ATCCGTGCTGGCGCAGGGAGCGATTACATCAAGCGC 
 FL-FW  ATCCGTGCTGGCGCAGGGAGCTCCGATAAGCAAGAAG 
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2.1.9 Primers used for truncation PCR  
 
To delete nucleotides in a specific plasmid region, forward primers were designed that 
flank the region to be deleted. The forward primers included 12 nucleotides 
complementary to the plasmid at the 5Õ end of the to be truncated region. The 12 
nucleotides were followed by complementary nucleotides on the 3Õ side of the to be 
truncated region. The number of nucleotides on the 3Õ side was based on an annealing 
temperature of ± 60 ¡C. The 5Õ end of the reverse primer was designed back-to-back to the 
5Õ end of the forward primer and preceded in the opposite direction on the complementary 
strand. Table 4 shows the primers used for truncation PCR.  
 
Table 4 Primers used for truncation PCR 
Primer Sequence (5' to 3') 
 Trunc_L50_FW  TCAGGATCGGGCGACAACAGCGCGGACAGC 
 Trunc_L55_FW  TCAGGATCGGGCATGGGCGACAACCGCGA 
 Trunc_L40_FW  TCAGGATCGGGCTGCCGGAAGCGAATTGG 
 Trunc_L30_FW  TCAGGATCGGGCTACCCATACGATGTTCCAGATTACGCT 
 Trunc_BT6_RV  GCCCGATCCTGACAATTGCTTCA 
 Trunc_SufI_RV  GCCCGATCCTGACGGTAC 
 Tunc_hGH_RV  GCCCGATCCTGAGAAGCCAC 
 BT6_L26_FW  CTGAAGCAATTGTACCCATACGATGTTCCAGATTACGCT 
 BT6_L26_RV  CAATTGCTTCAGATCTTCAAATTGGTTCAGC 
 hGH_L26_FW  AGCTGTGGCTTCTACCCATACGATGTTCCAGATTACGCT 
 hGH_L26_RV  GAAGCCACAGCTGCCCTCC 
 SufI_L26_FW  AATCCGGTACCGTACCCATACGATGTTCCAGATTACG 
 SufI_L26_RV  CGGTACCGGATTGACTAACAGT 
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2.1.10 Primers used for insertion PCR  
 
To insert nucleotides in a specific plasmid region, forward primers were designed that 
flank the region to be inserted. The forward primers included 12 nucleotides 
complementary to the plasmid at the 5Õ end of the to be inserted region. The desired 
nucleotides to be inserted were incorporated in the centre of the primer followed by 
complementary nucleotides on the 3Õ side of the to be inserted region. The number of 
nucleotides on the 3Õ side was based on an annealing temperature of ± 60 ¡C. The 5Õ end of 
the reverse primer was designed back-to-back to the 5Õ end of the forward primer and 
preceded in the opposite direction on the complementary strand. Table 5 shows the primers 
used for insertion PCR. The to be inserted region is underlined.  
 
Table 5 Primers used for insertion PCR 







 pING_BT6_RV GCCCGATCCTGACAATTGCTTCA 
 pING_hGH_RV GCCCGATCCTGAGAAGCCAC 
 pING_SufI_RV GCCCGATCCTGACGGTACC 
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2.1.11 Gibson assembly 
 
Constructs (insert) were transferred into pING, pET or pEXT22 plasmids (vector) by using 
Gibson assembly. By using Q5¨ High-Fidelity DNA Polymerase (New England Biolabs, 
NEB, UK) insert and vector fragments were amplified and linearized as described in 
section 2.1.2. Methylated DNA was digested by adding 0.5 µl DpnI (New England 
Biolabs, NEB, UK) to 20 µl of amplified DNA samples. The samples were incubated 
overnight at 37 ¡C before both fragments were then joined using Gibson assembly¨ 
(Gibson et al., 2009). 240 aliquots were prepared from 1.2 ml Gibson reaction mix and 
stored at -20 ¡C. The 1.2 ml Gibson reaction mix contained, 320 µl 5x isothermal (ISO) 
reaction buffer (25% PEG-8000, 500 mM Tris-HCl pH 7.5, 50 mM MgCl2, 50 mM DTT, 
1mM of the 4 different dNTPs and 5 mM NAD), 0.64 µl of 10 U/µl T5 exonulease, 20 µl 
of 2 U/µl Phusion polymerase, 160 µl of 40 U/µl Taq ligase and 700 µl dH2O. To assemble 
the overlapping DNA fragments, 1.25 µl of the vector and 1.25 µl of the insert were added 
to 5 µl Gibson reaction mix and incubated for 1 h at 50 ¡C. 3 µl of the ligated DNA 
samples was transformed into 30 µl competent E. coli NEB turbo cells (section 2.2.5).  
 
2.1.12 Primers used for Gibson assembly 
 
To amplify the insert fragment, overhang oligonucleotides were used with 25 nucleotides 
to either the 5Õ and 3Õ ends of the sequence. This overhang was designed to be 
complementary with the respective 5Õ and 3Õ ends of the vector. To linearize the vector, 
standard forward and reverse primers were designed that flank the region of the insert. 
These primers were complementary to the overhang region of the primers to amplify the 
insert fragments. The preferred annealing temperature of the primers was 60 ¡C. In 
preparation of the co-translational folding studies, the primers used to amplify the insert 
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fragments for co-translational folding studies are shown in table 6. The primers to linearize 
and amplify the vector fragments are listed in table 7. To engineer constructs into pEXT22 
for fractionation assays, the primers used to amplify the insert are shown in table 8. The 
primers to linearize and amplify the vector fragments are listed in table 9. 
 
Table 6 Primers to amplify the insert fragments for co-translational folding studies 
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Table 7 Primers to amplify the vector fragments for co-translational folding studies 












Table 8 Primers to amplify the insert fragments for fractionation assays 
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Table 9 Primers to amplify the vector fragments for fractionation assays 




2.1.13 Sequencing of plasmid DNA  
 
Subsequent sequencing was done to confirm successful site-directed mutagenesis and 
Gibson assembly. The sequencing was carried out by GATC sequencing service. The 
primers used for sequencing are shown in table 9. 
 
Table 10 Primers used for sequencing 
Primer Sequence (5' to 3') 
 T7-forward  TAATACGACTCACTATAGGG 
 T7-reverse  CTAGTTATTGCTCAGCGGT 
 Ptac-forward  GAGCGGATAACAATTTCACACAGG 
 Ptac-reverse  AAAAGGCCATCCGTCAGGATG 
 pING-forward  GAAGCAGAAAGAAGGTAAGAAACG 
 pING-reverse  CCTTTCGTCTTCAAGAATTCC 
 
2.1.14 Plasmids used in this study 
 
The plasmids used and engineered in this study are shown in the appendices. The plasmids 
used in the BT6 variants studies are shown in appendix I. The BT6 constructs used in this 
are all in a pEXT22 plasmid containing a pTac promoter, which is IPTG inducible 
(appendix III). The pEXT22 plasmids contain a kanamycin resistance cassette. The 
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constructs used in the co-translational folding studies can be found in appendix II. These 
constructs are in pING (appendix V) or pET plasmids (appendix IV) that both contain an 
ampicillin resistance cassette and are inducible with arabinose.  
 
2.2 Growth and maintenance of E. coli cultures 
 
2.2.1 E. coli strains used in this study 
 
The E. coli strains presented in table 11 were used in this study.  
 
Table 11 Strains used in this study 
Strain Description Reference 
W3110 lambda-IN(rrnD-rrE)1 rph-1 (Hayashi et al., 2006) 
W3110 
TE2 
W3110 carrying a ptac promoter upstream of tatABCD E. (Browning et al., 
2017) 
MC1061 araD139 Del(araA-leu)7697 Del(lac)X74 galK16 
galE15(GalS) lambda- e14- mcrA0 relA1 rpsL150(strR) 
spoT1 mcrB1 hsdR2 
(Casadaban and 
Cohen, 1980) 
DH5α supE44 ΔlacU169(ϕ80lacZΔM15) hsdR17 recA1 endA1 
gyrA96 thi-1 relA1 
ThermoFisher 
Scientific, UK 









 ∆lacZM15 / fhuA2  ∆(lac-
proAB)  glnV galK16 galE15  R(zgb-210::Tn10) 
Tet
S
  endA1 thi-1 ∆(hsdS-mcrB)5   
NEB, UK 
  





For growth of E. coli in liquid media, Luria Bertani (LB) medium (10 g/L sodium chloride, 
10 g/L tryptone and 5 g/L yeast extract) was frequently used. For growth on agar plates, 
Luria Bertani agar (LBA) (10 g/L sodium chloride, 10 g/L tryptone, 5 g/L yeast extract and 
10 g/L bacto-agar) was used. In section 2.8.1, the E. coli cells were grown in M9 medium 
(1x M9 salts, 0.1 mM CaCl2, 0.2% casamino acids, 0.2% thiamine, 2% fructose and 2 mM 
MgSO4). Suitable antibiotics to the vector were used at the following concentrations: 
Ampicillin (100 µg/mL) and Kanamycin (50 µg/mL).  
 
2.2.3 Glycerol stocks 
 
The constructs used in this study were transformed in NEB Turbo cells and stored as 
glycerol stocks at Ð 80 ¡C. Glycerol stocks were prepared by adding stationary phase cells 
to LB media containing 17% glycerol.  
 
2.2.4 Preparation of competent cells 
 
To prepare the cells to be made competent, 5 mL of LB was inoculated and incubated 
overnight at 37 ¡C shaking at 220 rpm. 10 mL LB was inoculated with 100 µl of the 
overnight culture and incubated at 37 ¡C shaking at 220 rpm until OD600 = 0.3 Ð 0.4. Once 
the cells reached the desired OD600 they were centrifuged for 10 min at 3000g at 4 ¡C 
(Thermo Scientific Heraeus Megafuge 16R, UK). The pellet was resuspended in 100 mM 
ice cold MgCl2, and incubated on ice for 5 min. The cells were repelleted as in the previous 
step and resuspended in 1 mL ice cold 100 mM CaCl2 and incubated for 2 Ð 24 hours at 4 
¡C. The cells were used fresh or stored at -80 ¡C. 
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2.2.5 Transformation of competent cells 
 
In a pre-cooled Eppendorf tube, 0.3 µl of plasmid DNA was gently mixed with 30 µl of 
competent cells (section 2.2.4 and 2.2.1) and incubated on ice for 20 minutes. Following 
incubation, the cells were transferred to a 42 ¡C water bath for 45 sec, after which they 
were shortly incubated on ice. After the heat shock, 0.3 mL of LB was added to the cells 
followed by incubation at 37 ¡C for 20 min. Following incubation, the cells were harvested 
by centrifugation at 7000 rpm for 2 minutes (Eppendorf centrifuge, 5417R, Hamburg), the 
supernatant was removed and the resuspended pellet was plated on LBA plates containing 
the appropriate selective antibiotics (section 2.2.2). The LBA plates were incubated 
overnight at 37 ¡.  
 
2.3 Protein production 
 
2.3.1 Culture of E. coli and plasmid induction 
 
Prior to fractionation, E. coli strains carrying the respective plasmids were grown in 5 ml 
LB medium containing the appropriate antibiotics (section 2.2.2) by inoculating with a 
single colony and grown overnight at 37 ¡C, shaking at 220 rpm. 50 mL of fresh LB 
medium containing the appropriate antibiotics was then inoculated with the overnight 
culture to OD600 = 0.05. Cultures were then grown at 37 ¡C, 200 rpm to OD600 = 0.5 
followed by induction with IPTG. Typically 3 hours post induction, an amount equivalent 
to OD600 = 10 was collected and fractionated into Cytoplasm (C), Membrane (M), and 
Periplasm (P) fractions (section 2.3.2). The periplasmic fraction was collected using the 
EDTA/lysozyme/cold osmotic shock and centrifugation method (Matos et al., 2014). Cells 
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used in the BT6 variant studies were induced with 0.5 mM IPTG and cells used for co-
translational folding studies were induced with 100 µM IPTG. 
 
2.3.2 Fractionation of the E. coli cells 
 
After the induction period, the cells equal to OD10 were harvested by centrifugation at 
3000 rpm for 10 min at 4 ¡C (Eppendorf centrifuge, 5417R, Hamburg). The pellets were 
resuspended in ice cold 500 Buffer 1 (100 mM Tris-acetate pH 8.2, 500 mM sucrose, 5 
mM EDTA). In addition, 500 µl ice cold MilliQ H2O and 40 µl lysozyme (from egg-white, 
1 mg/mL stock (Sigma Aldrich, UK)) was added and the suspension was incubated on ice 
for 5 min. To prevent contamination of the periplasmic fraction (P) from the spheroplast, 
20 µl 1 M MgSO4 was added to stabilise the inner membrane. The samples were 
centrifuged at 14.000 rpm for 2 min at 4 ¡C. The spheroplast pellet was then washed by 
resuspension in 1 mL ice cold buffer 2 containing 50 mM Tris-Acetate (pH 8.2), 250 mM 
sucrose and 10 mM MgSO4 and centrifuged at 14,000 rpm for 5 min at 4 ¡C. The 
supernatant was discarded and the resulting pellet was then resuspended in ice cold buffer 
3 containing 50mM Tris-Acetate, 2.5 mM EDTA (pH 8.2) and sonicated for 6 x 10 s, 8 µm 
amplitude (Soniprep 150plus, Sanyo Gallenkamp, Loughborough, UK). The sonicated 
samples were then centrifuged at 70,000 rpm, 4 ¡C, 30 min (Beckmann TL100, TLA100.3 
rotor). The supernatant was taken as the cytoplasmic fraction (C) and the pellet was 
resuspended in buffer 3 containing 50 mM Tris-Acetate, 2.5 mM EDTA (pH 8.2) to obtain 
the Membrane fraction (M). All cell fractions were stored frozen at Ð 20 ¡C.  
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2.3.4 Time course assay 
 
Samples were cultured in LB containing the appropriate antibiotics and induced with IPTG 
as described in section 2.3.1. 1, 3 and 5 hours post induction, an amount equivalent to 
OD600 = 10 was collected and fractionated into Cytoplasm (C), Membrane (M), and 
Periplasm (P) fractions (section 2.3.2).  
 
2.3.4 Export assay for purification of BT6 variants 
 
W3110 ÔTat ExpressÕ E. coli strains carrying the respective plasmids were grown in 50 ml 
LB medium overnight at 37 ¡C, 200 rpm (Browning et al., 2017). 400 mL fresh LB 
medium containing the appropriate antibiotics was inoculated with the overnight culture to 
OD600 = 0.05. Cultures were then grown at 30 ¡C, 200 rpm to OD600 = 0.5 before induction 
with 0.5 mM IPTG and cultures were incubated for 24 h. Following incubation, the cells 
were harvested by centrifuging at 4000 rpm for 20 min at 4 ¡C (Beckman Avanti J-25, JA-
10 rotor). To obtain the periplasmic fraction, cells were resuspended in 10 mL buffer 
containing 100 mM Tris-acetate pH 8.2, 500 mM sucrose, 5 mM EDTA pH 8.0 and 10 mL 
ice-cold dH2O before the addition of 800 µl hen egg white lysozyme (1 mg/mL). The 
samples were then incubated on ice for 10 min. To stabilise the inner membrane 800 µl 1 
M MgSO4 was added to the solution before centrifuging at 4000 rpm for 20 min at 4 ¡C 
(Beckman Avanti J-25, JA-25.5 rotor). The supernatant was taken to collect the 
periplasmic fraction. The spheroplast pellet was resuspended in 10 mL 0.5 M 
Sodiumphosphate buffer (pH 7.3) and a protease inhibitor (cOmplete Mini Protease 
Inhibitor, Roche) was added. The cells were sonicated for 6 x 30 s, 8 µm amplitude 
(Soniprep 150plus, Sanyo Gallenkamp, Loughborough, UK) and centrifuged (14,000 rpm, 
20 min, 4 ¡C). The supernatant was collected as the spheroplast fraction.  
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2.4 Protein purification 
 
2.4.1 Immobilised Metal Affinity Chromatography (IMAC), Nickle 
 
An IMAC Sepharose Fast Flow Column (GE Healthcare) was used to purify the BT6 
variants. After equilibration of the column with 20 mM Sodium Phosphate, periplasmic or 
spheroplast fractions were applied to the column. The column was washed with 20 mL of 
buffer containing 25 mM imidazole, 0.5M NaCl, 20mM Sodiumphosphate, pH 7.3. BT6 
variants were eluted with 9 mL buffer containing a gradient of 100 Ð 200 mM imidazole, 
50 mM EDTA, 20 mM Sodiumphosphate pH 7.3. The elution fractions were collected and 
concentrated using Vivaspin centrifugal concentrators (Sartorius). 
 
2.4.2 Protein quantification assay 
 
Proteins of interest were purified as described in section 2.3.4 and 2.4.1. The protein 
concentration was quantified by a Bradford assay (Bio-Rad DCª Protein Assay, Herts, 
UK) according to the manufacturerÕs instructions. In several cases the protein 
concentration was calculated by using the molar extinction co-efficient and reading A280 
from a quartz cuvette (Starna Scientific Ltd, Essex, UK).  
 
2.4.3 De-salting IMAC peak fractions 
 
In order to de-salt the IMAC peak fractions, by dialysis tubing, samples were dialysed 
overnight at 4 ¡C into 50 mM sodium phosphate buffer overnight at 4 ¡C (SnakeSkin¨ 
dialysis tubing, Thermo scientific). To de-salt smaller volumes (0.5 mL to 3 mL), dialysis 
cassettes were used (Slide-A-Lyzer¨ Dialysis Cassette, Thermo Scientific, UK). 
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2.4.4 Concentrating IMAC peak fractions 
 
Dialysed IMAC peak fractions were concentrated to an end volume between 0.5 and 1.0 
mL by centrifuging the samples in VIVASPIN 20 10,000MWCO columns (Santorius, 
Gloucestershire, UK) at 3000 rpm.  
 
2.5 Protein resolution 
 
2.5.1 SDS poly-acrylamide gel electrophoresis (SDS-PAGE) 
 
Protein separation was carried out using the PROTEAN¨ Tetra System (Bio-Rad, UK) 
according to the manufacturerÕs instructions. The 15% 1.5 mm thick separation gel 
contained: 15% acrylamide, 0.3% bis-acrylamide (37.5:1, Bio-Rad, UK), 375 mM Tris-
HCl pH 8.85, 0.1% SDS, 0.1% APS and 0.06% TEMED. The 5% stacking was composed 
of: 5% acrylamide, 0.0375% bis-acrylamide, 125 mM Tris-HCl pH 6.8, 0.1% SDS, 0.6% 
APS and 0.06% TEMED. Proteins samples were prepared by diluting aliquots 6:1 with 6x 
loading dye (125 mM Tris-HCl pH 6.8, 20% glycerol, 4% SDS, 0.02% bromophenol blue, 
5% β-mercaptoethanol) and heated at 95 ¡C for 10 min. The gels were run at 60 mA until 
the dye front migrated off the gel, typically 50 min. The protein gel running buffer was 
composed of 25 mM Tris, 192 mM glycine and 0.1% SDS.  
 
2.5.2 Detection of proteins with Coomassie 
 
The separated protein bands were visualised with Coomassie stain (0.05% w/v Coomassie 
Brilliant Blue R-250 (Bio-Rad, UK), 50% Ethanol, 1.74 M Acetic acid). The gels were 
stained with Coomassie stain for 1 hour at room temperature on a shaker. Following 
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staining, the gels were destained by incubating at room temperature on a shaker with D-





Protein samples separated by SDS-PAGE as described in section 2.5.1, were transferred to 
a PVDF membrane (GE healthcare, UK) using a Mini Trans-Blot¨ Cell system (Bio-Rad, 
UK) with transfer buffer composed of 192 mM glycine, 25 mM Tris, 10% ethanol). The 
PVDF membrane was prepared by soaking in methanol prior to contact with the gel. The 
transfer was carried out for 1 hour at 80V and after transfer the membranes were 
submerged in blocking milk (2.5% skimmed mild powder in 0.1% PBS-Tween20, 3% 
BSA) and incubated for at least 1 hour at 4 ¡C. 
 
The blocked membranes were washed with 1x PBS-tween20 (0.1%) before incubation 
with 3.5 µl 6x-His C-terminal Tag HRP antibody (New England Biolabs, UK) in 20 mL 1x 
PBS tween20 (0.1%) for 1 hour. Membranes were washed and proteins were visualised 
using an ECL (enhanced chemiluminescence) kit (Biorad, Herts, UK) according to the 
manufacturerÕs instructions. A Bio-Rad chemiluminescence imager and corresponding 
software was used to develop the membranes.  
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2.7 1D-1H-NMR spectra 
 
1D-1H NMR spectra of BT6, BT6M1, TorA-BTM0 and BT6-2Asp were acquired on a 
Bruker Advance III 600MHz spectrometer with a cryogenically cooled probe at 298K. 
Water supressed spectra were acquired using a Double Pulse Field Gradient Selected 
Excitation Experiment (DPFGSE) (Hwang and Shaka, 1995). All experiments were 
acquired with the same parameters. Spectra were acquired using 2048 complex points with 
a spectral width of 9615Hz, an inter-scan delay of 1s and 2048 repetitions for improved 
signal to noise. Data were processed in topspin 3.5pl7. All spectra were zero filled once, 
apodised with an exponential function (LB=3) and the residual water signal was supressed 
with a convolution based solvent filter (quadrature Gaussian window of width 0.2ppm) 
(Marion et al., 1989). 
 
2.8 Pulse labelling analysis  
 
2.8.1 In vivo pulse labelling analysis 
 
Competent E. coli MC1061 cells were transformed with the respective pING1 plasmid 
(Dalbeys and Wickner, 1986) and grown overnight at 37¡C in M9 minimal medium 
(section 2.2.2). Cells were diluted into fresh M9 medium to an OD600 of 0.1 and grown 
until an OD600 of 0.3. Expression of the constructs was induced with 0.2% (w/v) arabinose 
and continued for 5 min at 37¡C. Proteins were then radiolabeled with 35S-methionine for 2 
min at 37¡C before the reaction was stopped by adding ice-cold trichloroacetic acid (TCA) 
to a final concentration of 10%. Samples were put on ice for 30 min and precipitates were 
centrifuged for 10 min at 14.000 rpm at 4¡C (Eppendorf centrifuge, 5417R). After one 
wash with ice-cold acetone, centrifugation was repeated and pellets were subsequently 
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solubilized in Tris-SDS buffer (10 mM Tris-HCl pH 7.5, 2% (w/v) SDS) for 5 min while 
shaking at 1300 rpm at 37¡C (Thermomixer comfort, Eppendorf). Another centrifugation 
for 5 min at 14.000 rpm was performed to remove insoluble material. The supernatant was 
then added to a buffer containing 50 mM Tris-HCl pH 8.0, 150 mM NaCl, 0.1 mM EDTA-
KOH, 2% (v/v) triton X-100, and supplemented with GammaBindª G Sepharoseª (GE, 
Healthcare, UK). After 15 min incubation on ice, proteins that bind un-specifically to G 
Sepharose were removed by centrifugation as before. The supernatant was used for 
immunoprecipitation using G Sepharose an anti-HA. 11 Epitope Tag antibody (Nordic 
BioSite, Sweden). The incubation was carried out at 4¡C whilst rolling. After 
centrifugation for 1 min immunoprecipitates were washed with 10 mM Tris-Cl pH 7.5, 150 
mM NaCl, 2 mM EDTA and 0.2% (v/v) triton X-100 and subsequently with 10 mM Tris-
Cl pH7.5. Samples were spun down again and pellets were solubilized in SDS sample 
buffer (67 mM Tris, 33% SDS, 0.012% bromophenol blue, 10 mM EDTA-KOH pH 8.0, 
6.75% glycerol, 100 mM DTT) for 10 min while shaking at 1300 rpm. Additionally, 
solubilized proteins were incubated with 0.25 mg/ml RNase for 30 min at 37¡C and 
subsequently separated by using SDS-PAGE. Gels were fixed in 30% (v/v) methanol and 
10% (v/v) acetic acid) and dried by using the Bio-Rad gel dryer model 583. Radiolabelled 
proteins were detected by exposing dried gels to film plates, which were scanned in a Fuji 
FLA-3000 scanner. Band intensities were generated and quantified with ImageJ and 
EasyQuant, respectively. Data was collected from two independent biological replicates, 
and standard errors were calculated. 
 
2.8.2 In vitro pulse labelling analysis 
 
In vitro translation was performed using the PURE system (NEB, UK) following the 
manufacturerÕs instructions. PCR products were used as the template DNA by using the 
primers listed in table 12. Amplification of the template DNA fragments was carried out as 
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described in section 2.1.2. 35S-methionine labelled proteins were separated by SDS-PAGE 
and analysed by phosphor imaging as described in section 2.8.1.  
 
Table 12 Primers used for in vitro pulse labelling analysis 
Primer Sequence (5' to 3') 
T7 promoter primer  CCCGCGAAATTAATACGACTCACTATAGGG 
T7 Terminator  GCTAGTTATTGCTCAGCGG 










 Probing the quality control mechanism of the twin-arginine 
translocase with folding variants of a de novo-designed heme 
protein. 
  





Escherichia coli is used for the production of more than 30% of recombinant therapeutic 
proteins. To produce therapeutic proteins in E. coli, several strategies have been used. 
Export to the periplasm is preferred because extraction of the protein can be done more 
easily and contaminating proteins, DNA and general debris is minimised. Approximately 
30% of all currently licensed, recombinantly expressed biotherapeutic proteins are 
translocated to the E. coli periplasm by the general Secretory ÔSecÕ pathway. However, 
there are many heterologous proteins that cannot be exported by the Sec pathway. The Sec 
pathway can only transport proteins in their unfolded state since more bulky conformations 
cannot fit through a relatively narrow channel of the Sec translocon. In contrast to the Sec 
pathway, the Twin-arginine translocase (Tat) exports fully folded proteins. Therefore, the 
Tat pathway is known for exporting periplasmic proteins, which require co-factor insertion 
in the cytoplasm, such as FeS and molybdopterin. (Berks, 1996).  
 
In E. coli the Tat translocase consists of three integral membrane proteins TatA, TatB and 
TatC. Tat dependent substrates are characterised by an N-terminal signal peptide 
containing a twin arginine (RR) motif. After translocation of the precursor substrate to the 
periplasm, the signal peptide is cleaved off by signal peptidase. Alterations of the RR motif 
to a lysine pair perturbs Tat-dependent export to the periplasm (Alami et al., 2003, Stanley 
et al., 2000). 
 
The Tat system consists of a proofreading and a quality control mechanism, which only 
allows export of folded proteins. Various studies have demonstrated the Tat systemÕs 
ability to reject unfolded proteins (Robinson et al., 2011, Maurer et al., 2009). However, 
emerging evidence suggests that quality control involves more than the proofreading of the 
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substrates folding state as misfolded substrates rapidly degrade after interaction with the 
Tat components (Matos et al., 2008). Other studies have shown that the Tat system 
tolerates minor structural changes (Alanen et al., 2015). Furthermore, studies seem to 
suggest a hydrophobicity sensor employed by the Tat apparatus rather than assessment of 
the folded state of substrates (Richter et al., 2007). However, other studies demonstrated 
that the Tat system tolerates significant changes in substrate surface hydrophobicity (Jones 
et al., 2016). Evidently, the Tat proofreading mechanism is not well understood.  
 
The aim of this study was to test whether the E. coli Tat system could recognize and export 
a de novo designed di-heme protein. De novo designed proteins can be designed containing 
specific sequence information for a given function but are much simpler than natural 
substrates as natural substrates have accumulated structural complexity by undergoing 
natural selection (Degrado et al., 1989, Edelman and Gally, 2001). Altering natural 
substrate residues can have unpredictable effects on protein function and conformation; 
whereas the effect of altering residues of a de novo designed substrate is more predictable. 
The first de novo designed maquette family was designed in order to study proton coupling 
to heme oxidation/reduction. To create a model substrate with oxidoreductase capabilities, 
a family of simplified model proteins was designed based on a heptad repeat four-helix 
bundle with inserted cofactor ligation sites (Shifman et al., 1998). These four-helix bundle 
substrates are composed of two identical di-helical subunits accommodating one heme per 
subunit by bis-histidine ligation. Two di-helical subunits linked by a disulfide bond 
formation form the four-helix bundle (Grosset et al., 2001). More recently, four α-helix 
maquette substrates were designed where the disulfide bond was removed and the N-
terminus of one subunit was fused to the C-terminus of the second subunit (Lichtenstein et 
al., 2013). 




Figure 9 Structural models of BT6 proteins used in this study 
(A) BT6 coordinates two heme b (red) cofactors. (B) BT6M1 coordinates a single heme b 
due to removal of one coordinating histidine residue. (C) BT6M0 coordinates no heme b 
due to removal of two coordinating histidine residue. 
 
The so-called BT6 substrate is entirely synthetic and is not adapted from nature. The 
structure of the maquette BT6 substrate we use is shown in figure 9A. BT6 shares no 
sequence identity with natural proteins and the complexity was minimized to increase 
engineering freedom (Farid et al., 2014). The protein is water-soluble and consists of four 
α-helix loops that form a hydrophobic cavity that accommodates two cofactors. The BT6 
interior maintains bis-histidine ligation sites for binding heme b. BT6 needs to fold and 
acquire its heme b cofactors in the cytoplasm prior to interaction with the Tat translocase 
in order to be accepted by the Tat proofreading mechanism. The sequences of the BT6 
maquette variants used in this study are listed in table 13. By substituting the heme 
coordinating histidine residues, the four-α-helix bundle BT6 maquette proteins were 
engineered to bind two, one or no heme b cofactors, to perturb folding (Figure 9). This was 
Chapter 3: BT6 folding variants 
 
 65 
assessed with spectroscopic analysis and one-dimensional 1H-NMR spectroscopy of 
purified maquette heme binding variant proteins. An N-terminal TorA signal peptide was 
fused to the BT6 variants for the Tat system to recognise them as Tat dependent substrates. 
The data suggest that the Tat system can sense the folding conformation and 
conformational flexibility of the BT6 substrates due to the observed correlation between 
the export efficiency and the folded state of the proteins. We proposed that the de novo-
designed BT6 substrate is an ideal candidate to study the Tat systems proofreading 
mechanism. 
 
Table 13 Amino acid sequences of maquettes 


















No heme  
 





The Tat system can recognize and export a de novo designed di-heme protein 
 
The first aim of this study was to test whether the E. coli Tat system could recognize and 
export a de novo designed BT6 maquette protein. Furthermore we wanted to test if the Tat 
proofreading mechanism can sense conformational differences. Two BT6 variants were 
designed to test whether the Tat system can recognize and export a de novo designed BT6 
maquette protein, coordinating 2 (BT6) or no (BT6M0) heme b co-factors (Table 13). 
Figure 9A and C show the predicted secondary structure of the BT6 variants. BT6M0 was 
created in order to perturb folding by substituting two histidine residues to alanine 
(H53A/H88A).  In table 13 the histidine residues that ligate heme are highlighted in bold. 
In order to be recognized and translocated by the Tat system, an N-terminal TorA-signal 
peptide was fused to the BT6 maquette protein followed by a C-terminal 6xHis tag (Table 
13). The BT6 maquette variants were cloned into a low copy pEXT22 vector and 
expressed in E. coli W3110 cells. Sutherland et al., (2018) showed that the expression of 
BT6 in a high copy plasmid massively increased the production of recombinant BT6 
protein resulting in contamination of the periplasm with BT6 protein.  
 
The expression of the BT6 variants was induced with 0.5 mM IPTG. 3 hours post 
induction the cells were harvested and fractionated into cytoplasmic, membrane and 
periplasmic fractions (C/M/P). Figure 10 shows that the di-heme binding BT6 was 
efficiently exported to the periplasm whereas the no heme binding BT6 variant was 
rejected by the Tat system. There is a mature sized band of BT6 (17 kDa) observed in the 
periplasmic fraction (P). A faint unprocessed precursor BT6M0 band (21 kDa) is observed 
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in the cytoplasmic (C) fraction. The overall weak signal intensity of the precursor band is 
presumably due to degradation in the cytoplasm.  
 
However, in order to determine whether the Tat system rejected BT6M0 system, additional 
experiments are required. There is a possibility that the BT6M0 substrate aggregated and is 
present in inclusion bodies. The fractionation procedure used in this study does not 
visualise the insoluble fraction separately. Possible insoluble proteins are now present in 
the membrane fraction.  By using a different fractionation procedure a fourth cell fraction 
can be separated from the other three fractions, the insoluble fraction.  
 
Previous studies have shown that the Tat system tolerates Tat dependent signal peptides 
with a RR or KR motif. However, it does not recognize the signal peptides when the twin 
arginine motif is substituted by, a twin lysine motif (Buchanan et al., 2002). In order to 
confirm that the export of BT6 was mediated by the Tat system, a signal peptide with a KR 
(R12K) and a KK motif (R12K/R13K) were made. These TorA signal peptide variants 
were fused to the N-terminus of the di-heme binding BT6 variant. These constructs are 
denoted as TorA-KR-BT6 and TorA-KK-BT6. Table 14 lists the amino sequences of the 
TorA signal peptides used in this study. The different RR, KR and KK motifs are in bold 
and the mature regions are underlined.  
 





Figure 10. The export of BT6 and BTM0 determined by western blotting 
The two samples on the left display the expression of the di-heme binding BT6 3 and 5 
hours post induction, whereas the third sample demonstrates the expression of the no 
heme binding BT6M0 3 hours post induction. The cells were fractioned to cytoplasmic (C), 
membrane (M) and periplasmic (P) fractions. (A) The fractions were immunoblotted using 
a C-terminal His antibody. The molecular mass markers (kDa) are shown on the left and 
the expected size of precursor and mature bands on the right side of the blot. BT6 shows 
a mature sized band (17kDa) in the periplasmic fraction (P). A faint precursor-sized band 
(21 kDa) can be seen in the cytoplasmic fraction, which is, BT6M0 maquette precursor 
protein. (B) Coomassie-stained gel of C/M/P fractions with the molecular mass markers 
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Table 14 Amino acid sequence of TorA signal peptides used in this study 
Name Sequence 
TorA MNNNDLFQASRRRFLAQLGGLTVAGMLGPSLLTPRRATAAQA 
TorA (R12K) MNNNDLFQASRKRFLAQLGGLTVAGMLGPSLLTPRRATAAQA 
TorA (R12K//R13K) MNNNDLFQASRKKFLAQLGGLTVAGMLGPSLLTPRRATAAQA 
 
The TorA-KR and TorA-KK variants were expressed as described previously and the cells 
were fractionated into cytoplasmic, membrane and periplasmic fractions (C/M/P). Figure 
11 illustrates a very faint unprocessed precursor TorA-KK-BT6 band (21 kDa) in the 
cytoplasmic (C) fraction. The TorA-KR-BT6 variant as a mature sized band of BT6 (17 
kDa) was observed in the periplasmic fraction (P). This data shows that the Tat system can 
recognize and export a fully folded de novo designed BT6 maquette but rejects an 
incompletely folded variant. Thus, the Tat system has the ability to recognize and export a 
de novo designed BT6 maquette protein and the Tat proofreading mechanism can 
discriminate between a folded and misfolded state. Furthermore, Tat dependent 
translocation by the tat system was completely abolished when BT6 variants contain an N-
terminal TorA-KK signal peptide. All the data together indicates that BT6 can acquire the 
heme b cofactors in vivo to complete folding and that this folding event and the presence of 
a twin arginine TorA signal peptide can be detected by the Tat system.  





Figure 11. The export of TorA-KK-BT6 and TorA-KR-BT6 determined by immunoblotting. 
The left side displays the expression of TorA-KK-BT6 whereas the right side demonstrates the 
expression of TorA-KR-BT6. The cells were fractioned to cytoplasmic (C), membrane (M) and 
periplasmic (P) fractions. (A) The fractions were immunoblotted using a C-terminal 6xHis 
antibody. The molecular mass markers (kDa) and the expected size of precursor and mature 
bands are indicated alongside of the blot. A faint precursor-sized band (21 kDa) can be seen 
in the cytoplasmic fraction, which represents TorA-KK-BT6 maquette precursor protein. A 17 
kDa-sized band, which represents mature TorA-KR-BT6 can be observed in the periplasmic 
fraction (P). (B) Coomassie-stained gel of C/M/P fractions with the molecular mass 
markers shown on the left. 
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Export efficiency decreased with increasing conformational flexibility  
 
In order to test whether the Tat proofreading system can sense differences in 
conformational flexibility, a partially folded BT6 heme binding variant was designed 
(BT6M1). For BT6M1 (H53A) one heme was substituted to alanine in order perturb the 
ligation of one heme b cofactor (figure 9B). Expressions assays with the BT6 and BT6M1 
substrates were performed to test whether the Tat proofreading mechanism has the ability 
to sense differences in substrate conformation. Similar as described previously, BT6 and 
BT6M1 were constructed with a TorA signal peptide and they were expressed from the 
same plasmid and cell line. The cells were induced with 0.5 mM IPTG and 3 hours post 
induction the cells were harvested and fractionated into cytoplasmic, membrane and 
periplasmic fractions (C/M/P).  
 
The presence of the substrates in the cell fractions was determined by immunoblotting 
(figure 12). As demonstrated before, the di-heme binding BT6 was efficiently exported to 
the periplasm as a 17 kDa mature sized band was observed in the periplasmic fraction (P). 
For the one heme binding partially folded BT6M1 variant a faint 17 kDa mature sized band 
was observed in periplasmic fraction (P). Compared to BT6, considerably less BT6M1 
protein was translocated to the periplasm by the Tat system indicating weaker export 
efficiency. Because the export efficiency decreased with increasing conformational 
flexibility we suggest that the Tat system is not only able to recognise whether BT6 is 
folded or largely unfolded but also has the ability to discriminate between partial folding 
states of BT6 substrates.  
 




Figure 12 Export of BT6 heme binding variants by the Tat system determined by 
immunoblotting 
The left side displays the expression of the di-heme binding BT6 whereas the right side 
demonstrates the expression of the one heme binding BT6M1 (H53A). The cells were 
fractioned to cytoplasmic (C), membrane (M) and periplasmic (P) fractions and the 
fractions were immunoblotted using a C-terminal 6xHis antibody. The molecular mass 
markers (kDa) and the expected size of precursor and mature bands are indicated 
alongside of the blot. A mature-sized band (17 kDa) can be seen in the cytoplasmic 
fraction, which represents BT6 maquette precursor protein. A faint 17 kDa-sized band, 
which represents mature BT6M1, can be observed in the periplasmic fraction (P). 
Precursor bands (21 kDa) representing both BT6 and BT6M1 are present in the 
cytoplasmic and membrane fractions (Data provided by Alex Jones, University of Kent).  
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The heme content has an effect on the conformational flexibility of BT6 maquette  
 
Following the export assays using three BT6 maquette variants, accommodating 2 (BT6), 1 
(BT6M1) or 0 (BT6M0) heme b cofactors, the conformational flexibility of the substrates 
was assessed. The BT6 variants were expressed in E. coli BL21 (DE3) cells and the 
proteins were purified from the cytoplasmic fraction by immobilized metal affinity 
chromatography (IMAC). Conformational changes in tertiary structure upon heme binding 
to the maquette variants were determined by using one-dimensional proton (1H) NMR 
spectroscopy (work carried out by George Sutherland at University of Sheffield).  
 
Figure 13 Proton NMR resonances of apo-BT6, apo-BT6M1 and apo-BT6M0 
The figure shows a blow-up of the amide proton region between 9.5 and 12.5ppm for 
each of the 1D spectra. The NMR resonances of apo-BT6M0 (black), apo-BT6M1 (blue) 
and apo-BT6 (red) are displayed. The spectra of all maquette scaffolds indicate limited 
tertiary folding because the dispersion of resonances is limited (work carried out by 
George Sutherland at University of Sheffield). 
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Figure 13 displays proton NMR resonances of apo-BT6 (red), apo-BT6M1 (blue) and apo-
BT6M0 (black). In the absence of heme, the three 1H NMR spectra are distinctive for a 
protein with limited tertiary structure. Broadening of the peaks is indicative of tertiary 
folding.  
 
Figure 14 shows resonances of BT6, BT6M1 and BT6M0 with (dashed line) and without 
(solid line) bound heme. The addition of heme b to BT6 resulted in a stable tertiary 
structure due to heme b cofactor binding to the BT6 scaffold as significantly broader peaks 
are observed (Figure 14A). Furthermore, heme binding to BT6 results in a larger 
dispersion in the amide proton region and at around 10ppm more peaks can be observed. 
For BT6M1, following the addition of heme, the same resonance dispersion was observed 
albeit to a reduced level (figure 14B). In contrast to BT6 and BT6M1, the NMR resonance 
for BT6M0 showed no significant changes in amide proton dispersion (figure 14C). In 
addition, Sutherland et al., demonstrated an increase in the methyl proton region for BT6 
and BT6M1. In addition to the NMR experiments, Sutherland et al (2018) tested whether 
the number of bound hemes has an effect on the thermostability of the proteins using 
temperature-dependent CD spectroscopy. This data indicated an increase stability of the 
four-helix bundle structure of BT6 maquette when the number of bis-histidine ligated 
hemes increased.  
 
Together, the 1H NMR spectroscopy and CD spectroscopy data confirm the ligation of 
heme into the BT6 and BT6M1 variants and suggest an increase in protein folding upon 
ligation. Thus, the ligation of heme results in changes in the extent of substrate 
conformation of the maquette variants. The 1H NMR spectra suggest a folded structure for 
the di-heme binding BT6, an intermediate structure for one heme binding BT6M1, and a 
limited tertiary structure for the no heme binding BT6M0.  






Figure 14 NMR resonances in the absence and presence of heme b cofactor. 
Comparisons of the NMR spectra for BT6 (A), BT6M1 (B), BT6M0 (C) with (dashed line) 
and without (solid line) are shown. In the presence of heme, changes in the amide proton 
resonance dispersion are demonstrated for BT6 and BT6M1. For BT6M0 no changes 
were observed. The changes indicate a heme binding event in correlation with a change 
in protein conformation (work carried out by George Sutherland at University of Sheffield). 
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Tat-dependent localization in the periplasm depends on heme ligation into BT6 maquette 
 
Previously we demonstrated that heme ligation into BT6 was necessary for tertiary 
structure formation resulting in translocation to the periplasm by the Tat system. The 
number of bound hemes to the BT6 maquette variants was verified by absorption 
spectroscopy. The BT6 variants had a C-terminal 6xHIS tag and were expressed on a 
larger scale in E. coli W3110 Tat Express cells (Browning et al., 2017). Following 
expression, the cells were fractionated and BT6 and BT6M1 proteins were purified from 
the periplasmic fraction by immobilized metal affinity chromatography (IMAC). BT6M0 
was purified from the cytoplasmic fraction by IMAC. The purified maquette protein 
eluates were concentrated after which extensive colour differences were observed (figure 
15). The fully folded (2 heme binder) purified BT6 sample has an intense red color, the 
partially folded (1 heme binder) BT6 sample has an orange color and the unfolded (no 
heme binder) is colorless. The intense red color is indicative for bound heme, as this color 
is caused by porphyrin complexes in heme.  
 
Figure 15 shows the absorption spectra normalized to absorbance at 280 nm. The spectra 
demonstrate that both BT6 (black) and BT6M1 (blue) bind heme. For these BT6 variant a 
peak around 412 nm was observed which is indicative for bound heme as heme absorbs 
light at 412 nm. No peak at 412 nm was observed for BT6M0 (red), suggesting that no 
heme was bound to BT6M0. Sutherland et al., tested the absorption spectra of an in vitro 
heme reconstituted BT6 maquette to confirm that the two heme binding sites of BT6 were 
fully saturated. No difference was demonstrated between the spectra of the in vivo 
exported heme-loaded BT6 maquette and the in vitro reconstituted BT6 maquette. This 
data confirms that the two heme binding sites of the by Tat-transported BT6 purified from 
the periplasmic fraction are fully saturated. 





Figure 15 Spectroscopic analysis of purified maquette proteins 
UV-visible absorption spectra of BT6 (black), BT6M1 (blue) and BT6M0 (red) normalized 
at 280 nm. A peak at 412 nm indicates bound heme. Compared the one heme binding 
BT6M1, the measured absorbance at 412 nm for the di-heme binding BT6 variant was 
more abundant. In addition, the figure shows the colour difference of the BT6 protein 
eluates. The purified di-heme binding BT6 sample has an intense red colour, whereas the 
one heme binding BT6M1 variant has a less intense red colour. The non-heme binding 
purified BT6M0 elution sample has no visible colour.  
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Although mature BT6 maquette proteins exhibit a molecular weight of ~17 kDa, they have 
the tendency to run slightly differently on a SDS-PAGE gel. Immediately after 
purification, we analysed the BT6 maquette protein after purification from the periplasm, 
using mass spectrometry to define the protein more precisely. The mass spectrometry data 
shows a mass that corresponds to the predicted molecular weight of BT6 (16,981.29 Da) 
(figure 16).  
 
 
Figure 16 Mass spec data verifying purified di-heme binding BT6 
The spectra of the electrospray mass spectrometry analysis of di-heme binding BT6 
purified from the periplasmic fraction. The 16980.8 Da peak corresponds to the molecular 
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Protein trafficking is essential as more than one third of the proteome of Gram-negative 
bacteria are secreted across the inner and outer membrane (Economou, 2010a). The twin 
arginine translocase (Tat) is one of the major pathways to transport proteins from the 
cytoplasm to the periplasm. Many substrates that are targeted by the Tat system fold 
around a co-factor in the cytoplasm which bypasses an extra mechanism to export the 
separate cofactor to the periplasm (Berks, 1996). Thus, the Tat system only transports 
folded proteins across membranes. Therefore, Tat has the ability to discriminate between 
folded and unfolded proteins because it consists of a proofreading mechanism. It is not 
well understood how the Tat proofreading mechanism is able to determine that a protein is 
folded and export competent.  
 
In this study we investigated whether the Tat proofreading mechanism is capable of 
discriminating between different conformational states of a de novo designed substrate, 
denoted BT6 maquette. BT6 maquette is an artificial four α-helix water-soluble protein 
encompassing a hydrophobic interior that accommodates two heme b cofactors. A TorA 
signal peptide was fused to the N-terminus for periplasmic localization by the Tat system 
and for immunodetection a 6xHis tag was fused to the C-terminus. To perturb the folding 
state of BT6 maquette the number of heme cofactors was reduced. Therefore, two BT6 
folding variants, BT6M1 and BT6M0, were generated by point mutations affecting the 
heme binding sites to counteract the ligation of 1 or two heme cofactors. UV-visible 
absorption spectra confirmed the reduced numbers of heme in BT6M1 and BT6M0 (figure 
15).  
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Exported assays revealed that the Tat system has the ability to recognize and export an 
artificial cofactor binding substrate (figure 10). Moreover, there is a correlation between 
the conformational flexibility and the export efficiency of BT6, BT6M1 and BT6M0. 
When targeted for export by the Tat system, the export efficiency decreased with 
increasing conformational flexibility (figure 12). The Tat proofreading mechanism rejected 
the unfolded BT6M0 (figure 10). Compared to the fully folded di-heme binding BT6, the 
partially folded one heme binding BT6M1 substrate was exported in a less efficient 
manner (figure 11).  
 
1H NMR spectroscopy analysis showed that the heme content has an effect on the 
conformational flexibility of BT6 maquette proteins (figure 14). This data showed a 
correlation between the number of bound heme cofactors and the folding state of the BT6 
proteins. In addition, Sutherland et al., tested whether the number of bound hemes has an 
effect on the thermostability of the proteins using temperature-dependent CD spectroscopy. 
This data demonstrated that the four-helix bundle structure was significantly stabilized by 
the bis-histidine ligation of hemes within the BT6 maquette cavity. Together, the 1H NMR 
spectroscopy and CD spectroscopy data show consequent effects of heme content on 
substrate conformation.  
 
This data shows that the Tat system is able to recognize the artificial designed BT6 
maquette proteins. Moreover, it does not only recognise the substrate but the proofreading 
mechanism can discriminate between folded states. The intermediate folded BT6M1 was 
translocated differently compared to a fully folded BT6 and unfolded BT6M0. This 
suggests that the Tat proofreading pathway involves interactions between Tat components 
and the substrate at the membrane surface to sense the structural flexibility and overall 
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export competence of a substrate. This cascade of interactions can sense flexible 
conformations, resulting in the rejection of an unfolded substrate.  
 
This study shows that the de novo-designed BT6 substrate, which the native E. coli Tat 
system will never encounter, is an ideal candidate to study the Tat systems proofreading 
mechanism. Due to this ability, the Tat system has a natural tendency to produce high 
quality, active proteins. Improving our understanding of this remarkable proofreading 
mechanism is relevant for biotechnological exploitation. Expanding this proof-of-concept 
study will contribute to the current knowledge about the proofreading mechanism. By 
using the same principle we can probe the tolerance of the Tat systems proofreading 
mechanism. 
 













The twin-arginine proofreading ability of Escherichia coli can 
sense localized unfolded regions of a man-made maquette 
protein variant. 
  





In E. coli, the Tat system consists of a proofreading and quality control mechanism, which 
only allows export of folded proteins. Due to this unique capacity it is likely that the Tat 
system has a natural tendency to produce high quality, active proteins. Various studies 
have demonstrated the Tat systemÕs ability to reject unfolded proteins (Robinson et al., 
2011, Maurer et al., 2009). Other studies have shown that scFv and hGH substrates lacking 
disulphides were translocated by Tat which indicates that the Tat system tolerates minor 
structural changes (Alanen et al., 2015). This was also observed in chapter 3, where it was 
demonstrated that a partially folded one heme binding BT6 variant was translocated by Tat 
albeit less efficiently (Sutherland et al., 2018). Furthermore, studies seem to suggest a 
hydrophobicity sensor employed by the Tat apparatus rather than assessment of the folded 
state of substrates (Richter et al., 2007). Strikingly, other studies demonstrated that the Tat 
system tolerates significant changes in substrate surface hydrophobicity (Jones et al., 
2016). This study suggested that the Tat proofreading mechanism senses structural 
flexibility of a substrate rather than the surface characteristics. Evidently, the Tat 
proofreading mechanism is not well understood.  
 
The aim of the study was to increase the understanding of the Tat export systemÕs 
proofreading ability, using a simple model substrate to create various mutations in order to 
change (i) the surface characteristics (ii) or the addition of unfolded domains. Export 
assays were used to see which variants are exported and which are rejected. To analyse the 
proofreading capacity we chose a de novo-designed BT6 maquette protein substrate (Farid 
et al., 2014). The structure of the so-called maquette BT6 we used is shown in Figure 17. 
BT6 shares no sequence identity with natural substrates and the complexity was minimized 
to increase engineering freedom (Farid et al., 2014). The protein consists of four α-helix 
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loops that form a hydrophobic cavity that accommodates two cofactors. The BT6 interior 
maintains bis-histidine ligation sites to coordinate two heme b co-factors.  
 
We have previously shown that the Tat translocase is able to recognize and distinguish 
between folded and unfolded BT6 maquette substrates (Sutherland et al., 2018). In chapter 
3, we tested whether there is a difference in translocation of fully folded (BT6), partially 
folded (BT6M1), and unfolded BT6 (TorA-BT6M0) variants. The folding state of the BT6 
maquettes was affected by reducing the number of bound hemes. The resulting hypothesis 
is that the Tat translocase must sense differences in structural flexibility of BT6 maquette 
proteins. This data suggest that the de novo-designed BT6 substrate is an ideal candidate to 
study the Tat systems proofreading mechanism. In addition, altering natural substrate 
residues can have unpredictable effects on protein function and conformation; whereas the 
effect of altering residues of a de novo designed substrate is more predictable. 
 
In this study, we examined the Tat systemÕs proofreading ability by using BT6 maquette. 
BT6 substrates were mutated in order to change the surface characteristics to probe the 
tolerance of the Tat systemÕs proofreading mechanism. Figure 17 shows the secondary and 
tertiary structure of the di-heme binding BT6 maquette protein. The results suggest that the 
Tat proofreading system does not sense a global unfolded state of the substrate but has the 
ability to sense localised unfolded regions. 
 




Figure 17 Secondary and tertiary structure of the di-heme binding BT6 protein. 
(A) The ribbon diagram of the overall structure of the two-heme binding maquette BT6 
protein shows four identical α-helix loops (green). The loops accommodate four histidine 
residues to ligate two heme b molecules (red).  (B) The electrostatic potential map of the 
BT6 outer surface shows the positively charged (red), negatively charged (blue) and 
uncharged (grey) residues. (C) The hydrophilic (purple) and hydrophobic (yellow) outer 
surface residues are shown in the hydrophobicity map.   
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4.2 Results  
 
The Tat system does not tolerate changes in substrate surface hydrophobicity of BT6 
maquette 
 
There is a possibility that the Tat translocase rejects proteins containing hydrophobic 
surface patches (Richter et al., 2007). It has been speculated that the presence of 
hydrophobic surface patches prevents transport. The hydrophobic interior of a substrate 
could be revealed in unfolded or partially folded substrates. There is a possibility that the 
Tat components sense the hydrophobic interior, which is normally sequestered in a fully 
folded state. Richter et al. (2007) demonstrated that Tat substrates were rejected upon 
insertion of a short hydrophobic sequence. We therefore first tested whether introducing 
hydrophobic patches on the surface of a fully folded BT6 maquette (BT6-3NLeu) affected 
the export by the Tat translocase. An N-terminal Tat signal peptide TorA and a C-terminal 
6x His-tag were fused to the maquette protein and Table 15 lists the amino acid sequence 
of BT6-3NLeu with the substitution shown in bold.  
 
Figure 17C shows the predicted surface hydrophobicity map of the fully folded two-heme 
binding BT6 maquette (WT). The outer surface is predicted to be relatively hydrophilic 
with the hydrophilic surface residues displayed in purple and the hydrophobic surface 
residues in yellow. We substituted 3 hydrophilic charged surface residues (Asp, Lys, GLu) 
with leucine in the N-terminal domain (D9L, K13L, E16L). Figure 18A shows the altered 
hydrophilic outer surface residues (purple) on the predicted ribbon diagram.  
 
The hydrophobicity mutant was cloned into pEXT22 and expression was induced with 0.5 
mM IPTG. 3 hours post induction the cells were harvested and fractionated into 
cytoplasmic, membrane and periplasmic fractions (C/M/P). Figure 18B shows that the 
Chapter 4: BT6 surface residues variants 
 
 87 
BT6-3NLeu BT6 variant is rejected by the Tat translocase. There is no mature sized band 
of BT6-3NLeu (17 kDa) observed in the periplasmic fraction (P). Unprocessed precursor 
with a higher molecular weight (21 kDa) is observed in the cytoplasmic (C) and membrane 
(M) fraction. It is more likely that the overall weak signal intensity of the bands is caused 
by a technical problem rather than a lack of protein expression as the data also shows weak 
presence of the positive control ÔBT6Õ. Thus, increasing the outer surface hydrophobicity 
of BT6 maquette is not tolerated by the Tat translocase. However, the outer surface 
alterations might perturb the folding of the substrate, which might result in the Tat 
proofreading mechanism to reject the substrate because it is not folded properly. Moreover, 
by fractionating the cells into a cytoplasmic, membrane and periplasmic fraction we cannot 
assess whether the protein was not translocated due to possible inclusion body formation. 
This can be determined by harvesting a fourth cell fraction, the insoluble fraction.  
 
Figure 18 Changes in substrate surface hydrophobicity of BT6 is not tolerated  
(A) Structure of the BT6 maquette hydrophobicity variant (BT6-3NLue). The altered 
hydrophilic outer surface residues (purple) are shown on the ribbon diagram. 3 hydrophilic 
surface residues were substituted with leucine in the N-terminal domain (D9L, K13L, 
E16L). (B) The cells were fractioned to cytoplasmic (C), membrane (M) and periplasmic 
(P) fractions. The fractions were immunoblotted using a C-terminal His antibody. The 
molecular mass markers (kDa) are shown on the left and the expected size of precursor 
and mature bands on the right side of the blot. A precursor-sized band (21 kDa) can be 
seen in the cytoplasmic and membrane fraction, which is, unprocessed BT6-3NLeu BT6 
maquette.   
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Addition of an unfolded C-terminal domain is not tolerated by the Tat system 
 
Previous studies suggested that the addition of an unfolded element to a folded substrate 
aborts export by the Tat system (Jones et al., 2016). A 26-residue unfolded domain, chosen 
at random, was added to the C-terminus of a folded scFv protein. Tat detected the addition 
of the unfolded domain and the protein was rejected. Jones et al (2016) demonstrated that 
the additional domain did not affect the confirmation of the core scFvM whereas the 
additional domain forms an unfolded region. This was indicated by secondary structure 
modelling using the Phyre2 program (Kelley et al., 2015).  
 
In this study, we tested whether the addition of different sized domains to a fully folded 
BT6 maquette affects export. Therefore, we designed three BT6 variants by adding 26 
residues (SNVIIIIITNKDPNSSSVDLAAALE), 13 residues (SNVIIIIITNKDP) or 6 
residues (SNVIII) to the C-terminus of BT6 maquette (WT). As described previously, an 
N-terminal TorA signal peptide and a C-terminal 6x His-tag were fused to the BT6 
variants.  
 
Figure 19 shows that there is no mature sized band of (17 kDa) observed for any of the  
three BT6 variants in the periplasmic fraction (P). The Tat substrates are degraded in the 
cytoplasm when export to the periplasm does not take place. However, the blots show a 
decrease in signal intensity when the length of the unfolded domains increases. This 
indicates that there might be a correlation between how unfolded the Tat substrate is and 
the efficiency of degradation. In summary, Tat can detect the presence of an additional 6-, 
13- and 26-residue C-terminal unfolded domain and aborts translocation of these BT6 
maquette variants.  
 




Figure 19 An addition of an unfolded domain to a folded BT6 is rejected by the Tat 
system. The immunoblots show BT6 maquette variants containing an additional unfolded 
domain. The cells were fractionated to cytoplasmic (C), membrane (M) and periplasmic 
(P) fractions. The fractions were immunoblotted using a C-terminal His antibody. The 
molecular mass markers (kDa) are shown on the left side of the blot. No mature sized (17 
kDa) bands were observed in the periplasmic fraction (P). The different immunoblots show 




Chapter 4: BT6 surface residues variants 
 
 90 
The Tat system is highly tolerant of changes in substrate surface charge 
 
We tested whether changes on the substrateÕs outer surface electrostatic potential (figure 
17B) affects efficient export to the periplasm by the Tat translocase. It has been suggested 
that the Twin-arginine translocase is highly tolerant towards surface charge changes (Jones 
et al., 2016). However, the Tat translocase might sense certain outer surface characteristics 
as unfolded.  
 
To test whether alterations in the surface charge of maquette BT6 affects export, four BT6 
mutants with altered outer surface characteristic were designed (figure 20A). Two mutants 
were designed with 2 or 4 positively charged Lysine residues substituted to 2 or 4 
negatively charged Aspartic acid residues (denoted BT6-2Asp and BT6-4Asp). In contrast, 
two mutants were designed with 2 or 4 negatively charged Aspartic acid residues 
substituted to 2 or 4 positively charged Lysine residues (denoted BT6-2Lys and BT6-
4Lys). An N-terminal Tat signal peptide TorA and a C-terminal 6x His-tag were fused to 
the BT6 electrostatic potential mutants.   





Figure 20 Changes in substrate surface electrostatic potential of BT6 is highly tolerated 
(A) Representation of the altered outer surface residues of the BT6 maquette variants: 
BT6-2Lys, BT6-4Lys, BT6-2Asp and BT6-4Asp. The substituted residues (negative = red 
and blue = positive) are shown on the simulated ribbon diagram. The two left mutants had 
2 and 4 negatively charged residues substituted to 2 and 4 positively charged residues 
(denoted BT6-2Lys and BT6-4Lys). In contrast, the 2 and 4 positively charged residues of 
the two right mutants were substituted to 2 or 4 negatively charged residues (denoted 
BT6-2Asp and BT6-4Asp). (B) The immunoblots of the BT6 variants shows mature sized 
bands of (17 kDa) for BT6-2Lys, BT6-4Lys and BT6-2Asp in the periplasmic fraction (P). 
There is no mature sized band in the periplasmic fraction observed for BT6-4Asp. (C) The 
color of the purified BT6 variant (BT6-2Lys, BT6-4Lys and BT6-2Asp) from the periplasmic 
fraction by immobilized metal affinity chromatography (IMAC). The intense red color 
indicates that BT6-2Lys and BT6-4Lys accommodate two hemes and therefore are fully 
folded. BT6-2Asp had an orange color, which suggest this BT6 variant only 
accommodates one heme.  




Figure 21 UV-visible absorbance spectra of BT6-2Lys and BT6-4Lys 
The absorbance spectra of BT6-2Lys (red) and BT6-4Lys (blue) compared to the 
previously published absorbance spectra of BT6 (black). BT6-2Lys and BT6-4Lys show 
high similarity with the spectrum of the di-heme binding BT6, suggesting that the two BT6 
mutants are accommodating two heme cofactors.  
 
Figure 20B shows that there is a mature sized band of (17 kDa) observed for BT6-2Lys, 
BT6-4Lys and BT6-2Asp in the periplasmic fraction (P). The 3 mutants are all exported 
efficiently. There is no mature sized band in the periplasmic fraction observed for BT6-
4Asp. It is unknown whether the export of BT6-4Asp by Tat was blocked due to the 
altered outer surface. The outer surface changes might have perturbed folding of the BT6 
variant.  
 
In order to test whether the surface changes of the exported BT6 variants introduced 
structural changes we purified BT6-2Lys, BT6-4Lys and BT6-2Asp from the periplasmic 
fraction by immobilized metal affinity chromatography (IMAC). Figure 20C shows the 
color of the purified BT6 variants. Previously, it has been demonstrated that a fully folded 
(2 heme binder) purified BT6 sample has an intense red color, a partially folded (1 heme 
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binder) BT6 sample has an orange color and an unfolded (no heme binder) is colorless 
(Sutherland et al., 2018). After purification the intense red color indicated that BT6-2Lys 
and BT6-4Lys accommodate two hemes and therefore are fully folded (figure 21). BT6-
2Asp had an orange color, which suggests this BT6 variant only accommodates one heme.  
 
 
Figure 22 UV-visible absorbance spectra of purified BT6-2Asp 
The absorbance spectra of BT6-2Asp (orange) compared to the previously published 
absorbance spectra of BT6 (black), BT6M1 (red), TorA-BT6M0 (blue). There is high 
similarity between the spectrum of BT6M1 (one heme binder) and BT6-2Asp, suggesting 
that Bt6-2Asp only accommodates one heme.  
 
Figure 22 shows the absorbance spectra of BT6, BT6M1, TorA-BT6M0 and BT6-2Asp 
normalized at 280nm to demonstrate that BT6-2Asp only accommodates one heme. There 
is high similarity between the spectrum of BT6M1 (one heme binder) and BT6-2Asp. 
Efficient export of fully folded BT6 was demonstrated, whereas BT6M1 is exported with 
moderate efficiency.  
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Figure 23 shows a time course expression assay of BT6, BT6-2Asp and BTM1. The cells 
where induced with IPTG and the periplasmic fraction was harvested after different time 
points (60, 120, 300 min). The figure shows a mature 17 kDa BT6 and a faint mature 
BT6M1 band in the periplasm. However, the mature one heme binding BT6-2Asp bands 
are more intense which indicates that it is exported even more efficiently than the non-
mutated fully folded BT6. Note that the BT6-2Asp protein runs higher on SDS gels, 
presumably due to the presence of additional negative charges.  
 
Figure 23 The alteration of two positively charged residues into two negatively charged 
residues results in an increase of export. An Immunoblot of BT6, BT6-2Asp and BT6M1 is 
shown. W3110 ÔTatExpressÕ cells where induced with (o.5mM) IPTG and the periplasmic 
fraction was harvested after different time points (60, 120, 300 min). Mature sized 17kDa 
bands of BT6, BT6-Asp and a faint mature BT6M1 band were observed in the periplasm. 
However, the mature one heme binding BT6-2Asp bands are more intense which 
indicates that it is exported more efficiently than the fully folded BT6.  
 
1D NMR indicates that BT6-2Asp is generally less tightly folded than BT6, but has a 
specific region that is more tightly folded 
 
We purified the maquette variants and subjected them to NMR  analysis because the nature 
of the technique is very sensitive to the structure and dynamics of molecules at the atomic 
scale on timescales of ms-ns. However, the spectra of the maquettes are complicated 
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because of the presence of heme groups with a high spin FeIII present (low spin heme 
groups only occur when O2 is bound to the hemeÕs Fe
III ion). This leads to two processes 
occurring as hemes are bound to the maquettes. The first is that the presence of heme 
group in the maquette may increase the ÔfoldednessÕ or order of the protein leading to an 
increase in chemical shift dispersion and a broadening of the proteins peaks to the line 
width expected for a protein of this size. In the case of the maquettes  (mass ~ 21 kDa) we 
may predict a linewidth of somewhere around 18Hz for an amide or 0.03 ppm at 600 MHz 
(Cavenagh et al, 2006) assuming only dipole-dipole relaxation is present and making the 
approximation that the protein is approximately spherical.  
 
The second effect is that the lone pair from the paramagnetic centre in the heme can lead to 
extreme shifts for nuclei both within the porphyrin ring that encloses it and also in nearby 
residues in the protein. On top of this the paramagnetic centre present in the heme can also 
cause broadening due to increased T2 relaxation. In interpretation of the results it is 
assumed based on the observed data and previous analysis that TorA-BT6M0 contains no 
heme and so is not broadened, but that BT6, BT6M1 and BT6-2Asp are all bound to heme 
to some extent and so show broadening and extreme shifts. Examples of these extreme 
shifts can be seen in figure 24 for the low field region of their spectra, with broad dispersed 
peaks being observed between 9.5 and 10.5 ppm.  
 




Figure 24 1D-1H-NMR spectra suggest that BT6-2Asp is more folded than BT6M1 and 
BT6 1D 1H NMR spectra of BT6, BT6M1, TorA-BT6M0, and BT6-2Asp measured at 298K 
and 600MHz in 90%H2O/10%D2O using a DPFGSE water supressed pulse sequence. 
The peak marked with a * is presumed to be from a small molecule contaminant.  
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The spectrum of TorA-BT6M0 is relatively sharp and has a narrower overall envelope for 
the amide and aliphatic sidechain protons indicating that it is at least partially folded (it is 
still too broad and dispersed to be a fully unfolded spectrum). On the other hand BT6 and 
BT6M1 both show broadening of the envelope for the amide and aliphatic sidechain 
protons compared with TorA-BT6M0 showing that FeIII heme groups are bound and also 
possibly suggesting an increase in the structuring of the protein (BT6M1 is somewhat 
sharper but still well dispersed, most probably because there is less relaxation from the 
single bound heme-FeIII group). The mutant protein BT6-2Asp also shows similar 
broadening of the aliphatic and amide envelopes similar to BT6M1 suggesting that the 
structure present is similar to that in BT6M1.  
 
However, analysis of the extremely shifted peaks in the proteins above 9.5 ppm (Figure 
25) may suggest that a more subtle and interesting analysis can be made. For both BT6M1 
and especially BT6 a number of broad peaks are observed in this region which could be 
attributed to highly shifted peaks from the heme and the protein due to aromatic ring 
currents and hyperfine shifts from the heme-FeIII moiety in a similar fashion to those 
observed in previous studies (Du et al., 2003). However, the observed peaks are 
considerably broader than those observed in Du et al leading to the conclusion that there is 
some movement of the heme within the structure of the maquette leading to the heme 
taking up multiple orientations which leads to further broadening due to exchange effects. 
It can also be seen that these peaks cannot be attributed to just the tryptophan side chains 
which are also present in this region as area of the observed peaks appears to be too large 
to be consistent with the 4 tryptophan peaks present (the area of the region 9.5-10.5 ppm is 
1/32nd of the amide and aromatic ring region; 6.1-9.5 ppm whereas it should be ~1/70th). 
However, analysis of the same region in the protein BT6-2Asp shows two additional peaks 
at 10.05 ppm, which are entirely consistent with two of the tryptophan residues present in 
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the protein. As these peaks are not observed in the spectra of any other proteins studied this 
suggests that there is an ordering around two of the tryptophans (if it was an ordering of 
the heme group it would be expected that many more signals would be observed). 
Furthermore, the linewidths observed (10 Hz) are not inconsistent with the peaks expected 
from the tryptophans of a protein of mass. It could be suggested, as an alternative that the 
peaks could be caused by a decrease of order as this can also sharpen peaks, however, as 
there is no other sign of sharpening in the overall envelope of the protein this seems 
unlikely.  
 
Thus, the BT6-2Asp variant yielded unexpected information. With BT6-2Asp and BT6M1, 
the NMR data raise the possibility that a localised domain differs in terms of 
conformational flexibility, and that this domain may include unspecified Trp residues in 
the BT6 protein. The inference is that this domain is particularly rigid in the BT6-2Asp 
variant, and that the Tat system accepts this variant as folded because the domain is one of 
the primary interaction sites during the binding/ proofreading process. Therefore, overall it 
can be suggested that BT6-2Asp is more ordered and structured than BT6M1 and possibly 
even BT6.  In order to confirm this suggested hypothesis additional data is necessary. For 
example, the acquired NMR data can by validated by measuring the difference in structural 
stability of BT6-2Asp and BT6M1 by preforming circular dichroism (CD) spectroscopy 
assays. Exposing the BT6 substrates to a temperature gradient can assess the 
thermostability. BT6 substrates with a more rigid structural conformation will be more 
tolerant to higher temperatures compared to the less tightly folded substrates. Herewith the 
thermal stability of the two BT6 scaffolds can be compared. Moreover, 15N NMR or 
coupled 1H -15N NMR spectroscopy analysis could be performed in order to gain more 
sensitive structural data on the structural confirmation and the location of the specific 
region that is possibly more tightly folded 




Figure 25 1D-1H-NMR spectra 
BT6M1, TorA-BT6M0, and BT6-2Asp measured at 298K and 600MHz in 
90%H2O/10%D2O using a DPFGSE water supressed pulse sequence. A blow-up of the 
region between 9.5 and 12.5ppm for each of the 1D spectra is displayed.  
 





The Tat translocase exports folded and cofactor containing proteins from the cytoplasm to 
the periplasm. It is not well understood how the Tat translocase senses the folding state of 
a substrate and how it prevents premature export to the periplasm. In this study, we 
investigated whether TatÕs remarkable proofreading system senses outer surface residues 
as unfolded by using a de-novo co-factor binding ÔmaquetteÕ protein. We therefore 
designed a variety of BT6 maquette mutants with various alterations on the substrateÕs 
outer surface. Export assays reveal whether the mutants were accepted or rejected by the 
Tat components.  
 
We designed a mutant where we introduced hydrophobic patches on the surface (BT6-
3NLeu). The export assay showed that changes in hydrophobicity were not tolerated by the 
Tat translocase. No export to the periplasm was observed. Unfortunately, no analysis of the 
folding state of this mutant has been possible. Moreover, it is thus uncertain whether the 
protein was rejected because of the hydrophobic outer surface patches or because the 
alterations perturb folding. Additional analysis on the structural confirmation of BT6-
3NLeu could not be performed, as there was not enough protein to analyse. Most likely the 
limited presence of the protein was due to degradation of the BT6-3NLeu precursor as Tat 
recruits proteases after rejection of a Tat substrate (Matos et al., 2008).  
 
We tested whether the Tat components will reject a folded substrate that contains an 
unfolded domain. Three BT6 mutants were designed with an additional 6-, 13- or 26-
residue C-terminal unfolded domain (BT6-C-term26, BT6-C-term13 and BT6-C-term6). 
Tat sensed all three different sized unfolded domains, suggesting that in this case, the Tat 
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system senses conformational flexibility and has the ability to sense relatively short 
unfolded domains attached to a small de-novo designed α-helical protein.  
 
To measure TatÕs tolerance towards alterations of the outer surface charges we designed 
four different mutants. We designed two mutants with two or four negatively charged 
residues substituted to two and four positively charged residues (denoted BT6-2Lys and 
BT6-4Lys). Moreover, we designed two more mutants where two or four positively 
charged residues were substituted to two or four negatively charged residues (denoted 
BT6-2Asp and BT6-4Asp). BT6-4Asp was rejected by the Tat system, however the folding 
state of this variant is unclear. In contrast, BT6-2Lys, BT6-4Lys and BT6-2Asp were 
efficiently exported to the periplasm. These results suggest that Tat proofreading is tolerant 
of a range of both positively- and negatively-charged residues on the surface of substrate 
proteins.   
 
The BT6-2Asp variant yielded unexpected information. As with BT6-2Lys and BT6-4Lys, 
this variant was efficiently exported, but whereas the former were shown to bind two heme 
molecules it is clear that BT6-2Asp binds only one, and this protein should therefore be 
partially unfolded, as was clearly shown for the other 1-heme mutant, BT6M1 (Sutherland 
et al., 2018). 1D-NMR data confirm that this is the case: BT6-2Asp and BT6M1 have 
nearly identical spectra which shows that at a general level their folding states are very 
similar indeed. We conclude that the Tat proofreading system does not assess the overall 
folding status of the substrate, but rather must respond to the folding state of localised 
domains in the substrate.  
 
With BT6-2Asp and BT6M1, we believe that one of these important domains is one of the 
few regions that differ in terms of conformational flexibility, and the NMR data 
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furthermore raise the possibility that this domain may include unspecified Trp residues in 
the BT6 protein. The inference is that this domain is particularly rigid in the BT6-2Asp 
variant, and that the Tat system accepts this variant as folded because the domain is one of 
the primary interaction sites during the binding/ proofreading process. 











Co-translational folding of Tat dependent proteins monitored in 
vivo and in vitro.  
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5.1 Introduction  
 
As previously described, the twin arginine translocase (Tat) transports folded proteins 
across membranes. Tat is located in the inner membrane of bacteria, archaea, thylakoid 
membranes of plant plastids and mitochondria of plants (Bogsch et al., 1998). Tat 
substrates play an important role in energy metabolism, formation of the cell envelope, 
iron and phosphate acquisition, cell division and cell motility (Hinsley et al., 2001). The 
rationale for using Tat is not well understood. However, various reasons have been 
described for substrates to be translocated by the Tat system.  
 
In order to bypass an extra mechanism to export the cofactor to the periplasm, some Tat 
dependent substrates fold around a co-factor in the cytoplasm prior to translocation (Berks, 
1996). In addition, by insertion of metal ions in the cytoplasm, Tat dependent substrates 
avoid competition between metal ions that compete for insertion into the active site (Tottey 
et al., 2008). The third rationale for the use of Tat is a so-called hitchhiker co-translocation 
mechanism. Several Tat dependent proteins form hetero-oligomeric complexes in the 
cytoplasm when a subunit binds a twin arginine containing subunit to form a dimeric 
protein (Rodrigue et al., 1999). Moreover, there is data suggesting that, in archaea, Tat 
exports monomers and cofactor-less proteins because of their fast folding kinetics (Rose et 
al., 2002).  
 
In this study we tested whether Tat substrates fold in a co- or post-translational manner in 
order to determine how rapidly Tat substrates fold prior to translocation. To test whether 
Tat substrates fold co-translationally and if so at what point during translation they fold we 
performed arrest-peptide (AP)-mediated force measurements. 
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In recent years, several amino acid sequences have been found to interact with the 
ribosomal exit tunnel and therefore stall protein synthesis (Ito et al., 2010). So-called 
Ôarrest sequencesÕ are involved in cellular processes like the regulation of SecA secretion 
carried out by secretion motor SecM in E. coli (Nakatogawa et al, 2004). Synthesized 
SecM stalls its own translation leading to an increased translation of SecA (Nakatogawa et 
al, 2001). The 17-residue long arrest peptide (AP) FSTPVWISQAQGIRAGP is essential 
for the stalling, which happens when the last proline codon is positioned at the A site of the 
ribosome (Nakatogawa et al., 2002, Muto et al., 2006, Garza-Snchez et al., 2006). If 
however, there is dynamic or interaction of the nascent chain outside of the ribosomal exit 
tunnel, e.g. membrane protein insertion, protein translocation or protein folding, ribosomal 
stalling can be overcome and translation can continue beyond the AP (Ismail et al., 2013). 
The mechanism of arrest release was later termed as ÔpullingÕ model, which was originally 
suggested for SecM (Butkus et al., 2003).  
 
 
Figure 26 Design of constructs used in this study. 
Substrates containing signal peptide with both a RR or a KK motif were designed. The 
substrate is placed linker (L) residues upstream of the C-terminal E. coli SecM AP. An 
additional 23-residues segment is added to the C-terminus in order to obtain a clean 
separation between arrested and full-length protein on a SDS PAGE gel. An HA tag was 
added for immunoprecipitation.  
 




Figure 27 Arrest-peptide (AP)-mediated force measurement assay of the substrates 
(A) The principle of arrest peptide (AP)-mediated measurement assay. The protein 
domain (green) is placed L residues (black) upstream of the C-terminal E. coli SecM AP 
(red). An additional 23-residues C-terminal domain (grey) was introduced to separate the 
arrested and the full-length version of the protein on a SDS-PAGE gel. Three constructs 
with different L values are displayed (L1, L2, and L3). No or low pulling force (F) is 
generated at L1 and L3 as the protein did not fold yet at L1, and the protein is already 
folded at L3 when the ribosome reaches the AP. At L2 there is a folding event that 
generates a pulling force (F) on the nascent chain. (B) Image of an expression provided 
by Felix Nicolaus, Stockholm University. Full-length (FLc) and arrested-length (Ac) controls 
are indicated. Substitution of the crucial proline in SecM to a stop codon or alanine 
generates Ac or FLc respectively. The full-length protein can only be visualised if pulling 
forces prevents AP-mediated stalling, leading to a continued translation beyond the SecM 
AP. At L2, mainly full-length protein is visible whereas at L1 and L3 most of the protein is 
arrested. The fraction full-length (fFL) can be plotted as a function of L to create a pulling 
force profile.  
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Translational APs, especially SecM have already been proven suitable to study the 
integration propensity of an artificial hydrophobic segment (8L/11A) during transition 
through the lateral gate of the SecY translocon in E. coli. This technique measures pulling 
forces acting on transmembrane segments during integration into the membrane. In 
addition, these force measurements have further been used to investigate the insertion of 
single transmembrane helices of multi-spanning membrane proteins into the E. coli inner 
membrane (Cymer et al., 2013). More recently, the pulling force measurements of stalled 
ribosome-nascent chain complexes (RNCs) have been used to study co-translational 
folding of proteins (Nilsson et al., 2015).  
 
In this study, the AP from the E. coli SecM was used as a force sensor to study the folding 
kinetics of three Tat dependent substrates, human growth hormone (hGH), maquette BT6 
and a natural substrate SufI. A variable linker (L) between the substrates and SecM AP 
was added, which was also previously used for in vivo studies (Ismail et al., 2013, Cymer 
and von Heijne, 2013).  
 
The design of the constructs is shown in Figure 26. The force profiles of the series of 
constructs generated by varying the number of residues (L) between the AP and the 
substrate provide a direct insight into the folding transition that the substrate undergoes as 
it is translated by the ribosome (figure 27). Substrates with a signal peptide containing a 
KK-motif in place of the normal RR-motif were also constructed as interaction of the 
substrate with the Tat translocon might also trigger a ÔpullingÕ force, in which case the 
absence of the RR-motif would remove this force due to failure to interact with the Tat 
translocon. Previous cryo-EM (electron microscopy) studies showed that the substrate is 
located inside the ribosome tunnel at Lmax < 27 residues (Nilsson et al., 2015).  
 
Chapter 5: Co-translational folding 
 
 108 
Both in vivo and in vitro pulse-labelling analyses were performed. The same constructs 
were used for both the in vivo and in vitro analyses (figure 26). For in vitro assays the 
constructs were cloned into a pET plasmid expressed using the PURExpress¨ in vitro  
protein synthesis kit. During a coupled transcription/translation reaction for 15 minutes, 
proteins were labelled with [35S]-methionine. For in vivo assays the constructs were cloned 
into a pING plasmid comprising an arabinose-inducible promoter and expressed in E. coli 
MC1061 cells. Following the induction of the cells with arabinose for 5 minutes the cells 
were pulse-labelled with [35S]-methionine for 2 minutes. For immunoprecipitation, a HA-
tag (amino acid sequence: YPYDVPDYA) was introduced upstream of the SecM AP. The 
proteins were resolved on a SDS-PAGE to visualise the protein bands using a Fuji FLA-
3000 phosphor imager and the ImageJ software. The proteins were quantified by using the 
EasyQuant software. All experiments were repeated in duplicate.  
 
Translation stalling at the AP is overcome by a folding event due to an increased tension 
on the nascent chain upstream of the arrest peptide. This event will increase the fraction of 
the full-length protein, fFL, determined on the SDS-PAGE gel (figure 27B). The full-length 
protein (FL) can only be visualised if pulling forces prevents AP-mediated stalling, leading 
to a continued translation beyond the SecM AP. Then, the fFL can be used to measure the 
force initiated by the folding event at a certain linker length (L). In the absence of a pulling 
force acting on the nascent chain an arrested (A) band will be visible. The fFL is calculated 
by using the following calculation: fFL = FL / (FL + A). Plotting the fFL versus L can 
generate a so-called force profile, which shows how the folding force varies with the 
distance of the folding protein to the ribosome exit tunnel.  
 
In addition, we investigated whether the Tat system can recognize and translocate 
substrates that fold co-translationally. ADR1a, Spectrin R16, superoxide dismutase 
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(SOD1), and protein G binding domain fold in a co-translational manner. ADR1a is a 
small zinc-finger domain protein that can fold inside the ribosome exit tunnel (Hedman et 
al., 2015). Spectrin R16 serves for structural purposes (e.g. cytoskeletal interactions) 
(Nilsson et al., 2017). SOD1 is an important antioxidant in nearly all living cells exposed 
to oxygen and the Protein G binding domain is the B1 binding domain of Streptococcal 
protein G for binding of the human Fc fragment of IgG (SOD1 and Protein G is 
unpublished data). A TorA signal peptide was fused to the N-terminus for periplasmic 
localization by the Tat system and for immunodetection a 6xHis tag was fused to the C-
terminus. The constructs were cloned into a low copy pEXT22 plasmid and expressed in E. 
coli BL21 (DE3) and W3110 Tat Express cells. Export assays revealed whether the Tat 
system has the ability to export substrates that fold co-translationally.  
  





Force profile of BT6 in vitro suggests a co-translational folding event  
 
To investigate whether Tat dependent substrates fold co- or post-translationally, we tested 
the previously described four α-helix di-heme binding BT6 maquette substrate. As 
described in chapter 3, BT6 maquette is a cofactor containing substrate, which folds inside 
the cytoplasm and is efficiently translocated to the periplasm in a Tat system dependent 
manner. A series of constructs was designed in which BT6 was inserted variable linker (L) 
residues upstream of the E. coli SecM AP comprising a critical C-terminal proline residue, 
where translation stalls. An additional 23 residues followed by a stop codon were inserted 
downstream of the AP (figure 26). In addition to the series of BT6 constructs, full-length 
(FLc) and arrested (Ac) controls were tested. If no pulling force is acting on the nascent 
chain when the ribosome reaches the AP, the translation will stall resulting in a short 
arrested protein. In contrast, only if a pulling force acts on the nascent chain at the precise 
moment when the ribosome reaches the proline codon, stalling will be overcome and 
mostly the full-length protein will be produced (figure 27).  
 
The fraction of full-length (fFL) was plotted as a function of L to create a pulling force 
profile (figure 28). To differentiate between pulling forces caused by a folding event or a 
possible interaction with the Tat components two BT6 maquette variants were tested. One 
BT6 construct contained a native twin arginine TorA signal peptide, whereas the second 
BT6 construct contained a twin lysine TorA signal peptide. In vivo translation of these two 
BT6 maquette variants in E. coli MC1061 cells was performed in duplicate and showed a 
similar force profile. The force profile shows that the fFL starts to increase at L ≈ 45 
residues. There is a peak at L ≈ 50 residues after which it returns at the baseline at L ≈ 60 
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residues. It has to be mentioned that the increased fFL values is only minimal. However, 
this data indicates a co-translational folding event of BT6 maquette. Possible interaction 
with the Tat components during translation was not visible as both BT6 variants show a 
similar force profile. The reason for a limited fFL increase can be due the presence of 
chaperones that might inhibit co-translational folding, such as GroEL (Nilsson et al., 
2016).  
 
To generate a stronger force profile, in vitro translation of BT6 was performed in duplicate 
using the PURE in vitro translation system. Therefore the constructs were cloned into a 
high copy pET vector. In this study only the twin arginine TorA BT6 maquette was used, 
as there are no Tat components present in the in vitro translation reaction mix. Figure 28 
shows the pulling force profile of BT6 in vitro, presenting that the fFL starts to increase at L 
≈ 35 residues to reach a sharp peak at L ≈ 40 residues. An increase of pulling force from L 
≈ 30 residues is reasonable as 30 aa is the approximate length of a nascent that the 
ribosome exit tunnel can accommodate. Therefore, at L ≈ 30 residues, BT6 is supposed to 
be completely outside the ribosome, which gives the protein enough conformational space 
to fold. For the in vitro force profile, a more significant increase in fFL is detectable, 
compared to the fFL values of the in vivo expression. The lack of proteases and chaperones 
results in a stronger pulling force acting on the nascent chain. It has to be mentioned that 
BT6 has to fold around two heme b cofactors to fold completely, which is absent in the in 
vitro translation system. Therefore the force profile does not represent complete folding of 
BT6 resulting in weaker fFL values. Hence, the in vitro expression should be repeated in the 
presence of heme in order to see the complete folding event. Another noticeable difference 
is that the in vitro fFL peak is shifted compared to the in vivo fFL peak. Previous studies have 
demonstrated that this occurs in the absence of chaperones, such as trigger factor (Nilsson 
et al., 2016).  
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We suggest that BT6 substrates might fold co-translationally as force acting on the nascent 
chain can be determined in vivo and more specifically in vitro when the protein emerges 
from the ribosome exit tunnel. In vivo, the force profiles of the two TorA-BT6 variants 
showed a similar curve, indicating that there was no detectable interaction with the Tat 
components during translation and folding by the pulling force measurements. It is 
possible that there is interaction with the Tat components, which however is not significant 
enough to be captured by the AP-mediated force measurements assay. 
 
Figure 28 Pulling force profile of BT6 in vitro and in vivo  
The fraction full-length (fFL) was plotted as a function of L to create the force profile. The 
force profile of TorA-RR-BT6 (black) and TorA-KK-BT6 (blue) constructs translated in vivo 
in E. coli MC1061 cells is shown. These force profiles show that the fFL starts to increase 
at L ≈ 35 residues. There is a peak at L ≈ 50 residues after which it returns at the baseline 
at L ≈ 60 residues. The force profile of TorA-RR-BT6 translated in the PURExpress¨ in 
vitro system is indicated in red. The fFL starts to increase at L ≈ 30 residues to reach a 
sharp peak at L ≈ 40 residues. 
 
 
Chapter 5: Co-translational folding 
 
 113 
Pulse labelling assay of hGH in vitro and in vivo suggests a co-translational folding event  
 
In addition to the previously discussed force profile of BT6 maquette we tested the 
heterologous human growth hormone (hGH). hGH is a cofactor less protein that can fold 
inside the cytoplasm and is efficiently exported by the Tat system (Alanen et al., 2015). A 
similar series of constructs, with varying amounts of L residues, was designed as described 
for BT6. In addition, two hGH variants, TorA-RR-hGH and TorA-KK-hGH, were tested to 
identify possible forces caused by interaction with the Tat components.  
 
In vivo translation of these two hGH variants in E. coli MC1061 cells was performed in 
duplicate and fairly identical force profiles were seen. The fraction full-length (fFL) was 
plotted as a function of L to create a pulling force profile (figure 29). The fFL starts to 
increase when the protein emerges from the ribosome exit tunnel at L ≈ 35 residues going 
through a maximum at Lmax ≈ 40 - 45 residues after which it returns back to the baseline at 
L ≈ 60 residues. This rather significant peak suggests a co-translational folding of hGH 
outside of the ribosome exit tunnel in vivo. As observed for BT6, a possible interaction 
with the Tat components during translation could not be detected by using this technique 
as both hGH variants show a similar force profile.  
 
To investigate co-translational folding in the absence of inhibiting chaperones the TorA-
RR-hGH constructs were cloned into a pET vector for translation in the PURExpress¨ in 
vitro system. The constructs were translated in the absence and presence of a disulfide 
bond enhancer, as hGH is a protein that contains disulfide bonds in the native state. 
Surprisingly, the in vitro pulling force profile of hGH shows that the fFL already starts to 
increase at L ≈ 26. At this stage of translation the protein is still inside the relatively 
narrow ribosome exit tunnel. The force profile goes through a peak at L ≈ 30 - 35 residues 
Chapter 5: Co-translational folding 
 
 114 
when the protein has emerged from the ribosome exit tunnel. Only the PURExpress¨ 
reaction mix, containing the disulfide bond enhancer, enables disulfide bond formation for 
complete folding resulting in an overall higher pulling force. Because the chaperones, 
trigger factor and GroEL, reduce the force on the nascent chain in vivo, the in vitro fFL peak 
has higher values and is shifted to shorter linker lengths compared to the in vivo fFL peak, 
as it was seen for BT6 as well.  
 
The fact that the pulling force in the in vitro assay never reaches zero values could be 
explained by interaction of the emerging proteins with the surface of the ribosome. The 
tested proteins have an overall negatively charged surface in the folded state, which results 
in repelling dynamics at the negatively charged ribosome surface. These dynamics could in 
turn lead to pulling force on the nascent chain even after folding has taken place. However, 
this cannot be seen in vivo since chaperones might shield the nascent chain from 
interaction with the ribosome.  
 
The data indicates that hGH might fold co-translationally as force acting on the nascent 
chain can be determined in vivo and in vitro. Moreover, the data implicates that 
preliminary folding can already take place inside the ribosome exit tunnel. However, it is 
theoretically unlikely that the rather large hGH can already fold at this stage. We therefore 
propose that either first folding intermediates start to form before the protein has 
completely left the tunnel or the high number of negatively charged residues already 
interact with the surface of the ribosome. It remains to be uncertain whether interaction 
with the Tat components occurs during translation, as it was not detected using the force 
measurements assay. 
  




Figure 29 Pulling force profile of hGH in vitro and in vivo 
The in vivo force profiles TorA-RR-hGH (black) and TorA-KK-hGH (blue) show that the fFL 
starts to increase at L max ≈ 30 Ð 35 residues. There is a peak at Lmax ≈ 40 - 45 residues 
after which it returns at the baseline at L ≈ 60 residues. TorA-RR-hGH was translated in 
the PURE in vitro system in the presence (red) and absence (green) of a disulfide bond 
enhancer. The fFL starts to increase at L ≈ 26 residues to reach a peak at L ≈ 35 residues. 
In vitro, higher fFL values were measured in the presence of a disulfide bond enhancer.  
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Pulse labelling assay of SufI suggests a possible co-translational interaction with Tat  
 
In addition to the force profiles of BT6 maquette and hGH we tested the natural E. coli 
model Tat substrate SufI (FtsP). The SufI protein is frequently used as a model substrate 
for studies of the Tat system due to the favourable properties, as it is water soluble, 
monomeric and it does not require cofactor insertion during folding. As before a series 
number of constructs, with varying amounts of L residues and both RR and KK variants 
were tested.  
 
In vivo translation of these two SufI variants in E. coli MC1061 cells was performed in 
duplicate. The fraction full-length (fFL) was plotted as a function of L to create a pulling 
force profile (figure 30). Unfortunately, no significant pulling force could be detected for 
SufI KK. This observation is reasonable as SufI is a significantly larger protein than BT6 
and hGH and therefore needs more space outside of the ribosomal exit tunnel. However, it 
has been seen that multi-domain proteins can fold co-translationally (Zhang and Ignatova, 
2011). Another interesting observation is the fact that even though the fFL values are weak, 
the force profile of the SufI-RR variant shows higher fFL values compared to the force 
profile of the SufI-KK variant. The different force profiles might be caused by a possible 
interaction with the Tat components during translation, as only the SufI-RR variant can be 
recognized and translocated by the Tat system.  
 
Another indication for force initiated by interaction with the Tat components is the in vitro 
force profile of the two SufI variants (figure 31). The in vitro force profile shows a very 
weak increase in fFL as seen for the in vivo expression assays. However, the difference is 
that the force profile of SufI-RR and SufI-KK in vitro are similar. The fact that Tat 
Chapter 5: Co-translational folding 
 
 117 
components are absent in the in vitro expression assay might be the reason why we see 
similar force profiles if the force is initiated by interaction with Tat.  
 
The data we obtained does not give indication for a co-translational folding event, however 
the assay provides first insight in the interaction of SufI with the Tat components. One 
reason why there is no detectable folding of SufI is that it is too large in order to be folded 
in the set-up that we choose. Introducing longer linker length downstream of SufI to give it 
more conformational freedom around the ribosomal exit tunnel could solve this issue. 
Another reason in vivo could be that the folding is inhibited by chaperones or initial 
interactions with Tat.  
 
 
Figure 30 Pulling force profile of SufI in vivo  
The SufI constructs were translated in vivo in E. coli MC1061 cell. The force profiles of 
both SufI-RR (black) and SufI-KK (blue) show overall weak pulling force. The force profile 
shows that there is stronger force acting on the nascent chain of the SufI-RR variant 
compared to SufI-KK.   




Figure 31 Pulling force profile of SufI in vitro 
The in vitro force profiles of SufI-RR (black) and SufI-KK (blue) are shown. The fraction 
full-length (fFL) was plotted as a function of L to create the force profile. No pulling force 
acting on the nascent chain was detected using the AP-mediated force measurements 
assay. The force profiles both SufI variants show a similar curve.   
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The Tat translocase can translocate co-translationally folded proteins 
 
To determine whether the Tat translocase exports co-translationally folded proteins we 
cloned four different proteins into a low copy pEXT22 plasmid. The proteins of interest, 
ADR1a, R16, SOD and protein G B1 binding domain, fold in a co-translational manner. 
For immunodetection a 6xHis tag was fused to the C-terminus and a TorA signal peptide 
was fused to the N-terminus for periplasmic localization by the Tat system. The constructs 
were expressed in E. coli BL21 (DE3) and W3110 Tat Express cells (Browning et al., 
2017). Export assays revealed whether the Tat system has the ability to export co-
translationally folded substrates. Expression assay with ADR1a, R16, SOD and protein G 
B1 binding domain were performed to test whether the Tat system can export co-
translationally folded substrates. The cells were induced with 0.5 mM IPTG and 3 hours 
post induction the cells were harvested and fractionated into cytoplasmic, membrane and 
periplasmic fractions (C/M/P). The presence of the substrates in the cell fractions was 
determined by immunoblotting.  
 
Figure 31 shows the results of the export assay of ADR1a in E. coli BL21 (DE3) and 
W3110 Tat Express cells. It is to mention that ADR1a is a very small protein, which is 
difficult to detect on a SDS PAGE gel. Therefore, the low molecular weight proteins were 
separated using tricine protein gels. Despite using tricine gels, the image does not show a 
3.5-kDa mature sized band in the periplasmic fraction (P). In addition, no precursor 
proteins were detected in the cytoplasmic (C) or membrane (M) fractions. ADR1a is a 
cofactor containing protein and folds around a Zn2+ ion. It remains unclear whether ADR1a 
was rejected by the Tat system due to the lack of Zn2+ ions in the cytoplasm. However, the 
small size of ADR1a might be the limiting factor in visualizing exported protein to the 
periplasm as it might run off the SDS gel too quickly to analyse. 




Figure 32 The Tat system does not export the zinc cofactor binding ADR1a. 
E. coli BL21 (DE3) and W3110 Tat Express cells were fractioned to cytoplasmic (C), 
membrane (M) and periplasmic (P) fractions. The fractions were immunoblotted using a 
C-terminal His antibody. The molecular mass markers (kDa) are shown on the left. The 
export assay of the ADR1a protein shows no mature sized bands of (3.5 kDa) in the 
periplasmic fractions (P). There are no precursor proteins visible in the cytoplasmic (C) 
and membrane (M) fraction observed for BT6-4Asp.  
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As mentioned previously we tested whether three more cotranslational folders can be 
exported by the Tat translocase system. The export assay was performed in the manner as 
described for ADR1a and fractionated into cytoplasmic, membrane and periplasmic 
fractions (C/M/P). The substrates present in the three different cell fractions were 
visualised by immunoblotting using a C-terminal his antibody. 
 
The results of the export assay of, R16, SOD and protein G B1 domain are shown in figure 
32. The results of the expression in E. coli W3110 Tat Express cells are displayed in figure 
32A, whereas figure 32B shows the results of the export assay in E. coli BL21 (DE3). The 
expected molecular weight of the substrates is 13.4 kDa for R16, 11.9 kDa for SOD and 7 
kDa for Protein G B1 domain. The proteins were separated using SDS-PAGE gels, as the 
molecular weight of the proteins is not as low as for ADR1a. Figure 32A shows mature 
sized bands for R16, SOD and Protein G B1 domain after expression in E. coli W3110 Tat 
Express cells. Unprocessed precursor bands are present in the cytoplasmic (C) and 
membrane (M) fraction. In addition, also after expression in E. coli BL21 (DE3) cells, 
mature sized bands are visible the periplasmic fractions of all three different substrates.  
 
This data shows that substrates that undergo co-translational folding can be recognised and 
translocated by the Tat system. This can be an indication that some substrates might be 
exported by the Tat system because of their fast folding kinetics. Due to the rapid folding 
within the cytoplasm the Sec translocase system is incompetent to export these substrates. 
This might result in the targeting of the folded substrates by the Tat system.  




Figure 33 Export of co-translationally folded substrates by the Tat system  
(A) Representation of the expression of R16, SOD and Protein G B1 domain. The cells 
were fractioned to cytoplasmic (C), membrane (M) and periplasmic (P) fractions and these 
fractions were immunoblotted using a C-terminal His antibody. The molecular mass 
markers (kDa) and the expected size of mature bands are indicated alongside of the blot. 
The expected mature sizes of the substrates are 13.4 kDa for R16, 11.9 kDa for SOD and 
7 kDa for Protein G B1 domain. (A) The immunoblot of the cell fractions after expression 
in E. coli W3110 Tat Express cells. Mature sized bands are visible in the periplasmic 
fractions of R16, SOD and Protein G B1 domain. For all three substrates precursor bands 
are present in the cytoplasmic (C) and membrane (M) fraction. (B) The immunoblot of the 
cell fractions after expression in E. coli BL21 (DE3) cells. As observed after expression in 
W3110 Tat Express cells, mature sized bands are visible in the periplasmic fractions of 
R16, SOD and Protein G B1 domain. Despite sporadic unspecific binding of the antibody, 
precursor bands are present in the cytoplasmic (C) and membrane (M) fraction for all 
three substrates.   





Most of the secretory substrates are translocated via the Sec pathway. Unfortunately, the 
Sec system cannot translocate those substrates that fold rapidly within the cytoplasm. 
Therefore, the Tat system exports proteins in a folded state, however the rationale for why 
these proteins cannot be exported in an unfolded state by the Sec pathway is not well 
understood. Only a limited amount of reasons for the use of the Tat system are described, 
such as co-factor insertion, avoidance of metal ion competition and hetero-oligomeric 
complex formation (Palmer and Berks, 2012). Some proteins fold in the cytoplasm because 
they require reducing conditions for folding and therefore are unable to fold in the 
oxidising environment of the periplasm. For archeae, it has been suggested that substrates 
are translocated to the periplasm by the Tat system because of their rapid folding kinetics 
(Rose et al., 2002). Nevertheless, the rationale for using the Tat system is not well 
understood. In this study, we tested whether the Tat system exports substrates because of 
their possible rapid folding kinetics in E. coli. Therefore, we investigated whether Tat 
dependent substrates fold co- or posttranslationally by using AP-mediated force 
measurements. The three Tat substrates used in this study were BT6 maquette, hGH, SufI.  
 
In vivo expression assays with BT6, showed increased pulling forces at L = 45 indicating a 
possible co-translational folding event after the protein has emerged from the ribosome 
exit tunnel. We tested BT6 substrates with a twin-arginine signal peptide as well as 
substrates with a twin-lysine signal peptide variant to investigate whether folding or an 
interaction with the Tat components initiated the force acting on the nascent chain. 
However, possible interaction with the Tat components during translation was not visible, 
as the force profile of these two TorA signal peptide variants showed a similar curve. To 
avoid chaperones that might inhibit co-translational folding, we investigated the force 
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profile of BT6 in vitro. The pulling force profile of BT6 in vitro showed a stronger force 
profile where the fFL starts to increase at L ≈ 30 residues. Even though, the in vitro 
expression was done in the absence of the BT6 binding cofactor heme b. We suggest that 
this data indicates that BT6 substrates might fold co-translationally, as force acting on the 
nascent chain was seen in vivo and more specifically in vitro when the protein emerges 
from the ribosome exit tunnel. The force profiles of the two TorA-BT6 variants showed a 
similar curve, indicating that there was no detectable interaction with the Tat components 
during translation and folding by the pulling force measurements. It is possible that there is 
interaction with the Tat components, which however is not significant enough to be 
captured by the AP-mediated force measurements assay. 
 
Similar in vivo and in vitro force profiles were observed for the expression assays with 
hGH, albeit with a stronger pulling force acting on the nascent chain. This might be due to 
different chaperones needed for the folding of hGH and BT6 which might interfere with 
the folding process. In addition, there is a noticeable difference between the in vitro and in 
vivo data of BT6 and hGH. The in vitro fFL peaks are shifted compared to the in vivo fFL 
peaks. Previous studies have demonstrated that this occurs in the presence of chaperones, 
such as Trigger factor and GroEL (Nilsson et al., 2016).  
 
The in vivo force profile data of the natural Tat substrate SufI did not show a folding event. 
Surprisingly, the force profile of the SufI-RR variant shows higher fFL values compared to 
the force profile of the SufI-KK variant in vivo. The different in vivo force profiles and the 
in vitro data might suggest a possible interaction of SufI with the Tat components during 
translation.  
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In addition to the force profiles, export assays revealed that the co-translational folding 
substrates, R16, SOD1 and Protein G B1 binding domain, could be exported via the Tat 
pathway. Only for ADR1a, efficient export to the periplasm was not detected. It might be 
possible that ADR1a did exported by the Tat system but was not detected because of the 
very low molecular weight of this protein (3.5 kDa). A second reason for no visible export 
to the periplasm could be a lack of zinc within the cytoplasm, which is required for folding 
of ADR1a. The force profile of ADR1a was done in vitro in the presence of an access of 
zinc (Nilsson et al., 2015). This could suggest that ADR1a was not exported by the Tat 
system due to insufficient folding because of the lack of zinc cofactors. Optimization of the 
export assays of ADR1a is necessary to confirm whether the Tat system has the ability to 
export a small zinc finger binding domain protein.  
 













Final discussion  
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In Gram-negative bacteria, more than one third of the proteome are secreted across the 
inner and outer membrane (Economou, 2010a). In E. coli, the twin arginine translocase 
(Tat) is one of the major pathways to transport proteins from the cytoplasm to the 
periplasm. Despite the periplasm being the site of function for a lot of secretory proteins, 
some of these proteins require folding in the cytoplasm. The Tat system only allows export 
of folded proteins for which it consists of a proofreading and quality control mechanism. 
Various studies have demonstrated the Tat systemÕs ability to reject unfolded proteins 
(Robinson et al., 2011, Maurer et al., 2009). However, it is not well understood how the 
Tat proofreading mechanism is able to determine the folding state of a substrate. The aim 
of this study was to increase our understanding on what the Tat proofreading mechanism 
can sense in order to ÔproofreadÕ the substrateÕs structural conformation.  
 
Only a limited amount of reasons for the use of the Tat system are described, such as co-
factor insertion, avoidance of metal ion competition and hetero-oligomeric complex 
formation (Palmer and Berks, 2012). Some proteins fold in the cytoplasm because they 
require reducing conditions for folding and therefore are unable to fold in the oxidising 
environment of the periplasm. For archeae, it has been suggested that substrates are 
translocated to the periplasm by the Tat system because of their rapid folding kinetics 
(Rose et al., 2002). Nevertheless, the rationale for using the Tat system is not well 
understood. In this study, we tested whether possible rapid folding kinetics of Tat 
substrates could be another reason for using Tat in addition to the previously described 
reasons. Therefore, we investigated whether Tat dependent substrates fold co- or 
posttranslationally by using AP-mediated force measurements. In this chapter the major 
findings in this study will be summarised.   
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Probing the quality control mechanism of the twin-arginine translocase with folding 
variants of a de novo-designed heme protein. 
 
The first chapter in this study probed the quality control mechanism of the Tat system with 
folding variants of a de novo designed substrate, denoted BT6 maquette. This was 
accomplished by reducing the number of heme cofactors in order to perturb the folding 
state of BT6 maquette. Therefore, two BT6 folding variants were generated by point 
mutations affecting the heme binding sites to prevent the ligation of 1 or two heme 
cofactors (figure 9).  
 
Export assays revealed that the Tat system has the ability to recognize and export BT6 
maquette substrates (figure 10). Moreover, there seems to be a correlation between the 
conformational flexibility and the export efficiency of the folding variants (figure 12). The 
Tat proofreading mechanism rejected the unfolded heme deficient BT6M0 (figure 10) and 
the partially folded one heme binding BT6M1 substrate was exported in a less efficient 
manner (figure 11). In addition, the heme content has an effect on the conformational 
flexibility of BT6 maquette proteins as confirmed by 1H NMR spectroscopy and CD 
spectroscopy analysis (figure 14). However, in order to determine whether the Tat system 
rejected BT6M0, additional experiments are required. There is a possibility that the 
BT6M0 substrate was aggregated and is present in inclusion bodies. This can be 
determined by harvesting a fourth cell fraction, the insoluble fraction.  
 
In order to confirm the presence or absence of an interaction of BT6 substrates with the Tat 
components, FRET or cross-linking studies could be applied. This would give information 
on whether the substrates and Tat are in close vicinity. However, such approaches are 
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rather time-consuming and would add alterations to the structure, which might affect the 
proofreading mechanism of Tat.  
 
In summary, the results of this study suggest that the Tat system can recognize the BT6 
maquette proteins and that the proofreading mechanism can discriminate between folded 
states. This suggests that the Tat proofreading pathway involves interactions between Tat 
components and the substrate at the membrane surface to sense the structural flexibility 
and overall export competence of a substrate. This cascade of interactions can sense 
flexible conformations, resulting in the rejecting of an unfolded substrate. This study 
shows that BT6 maquette is an ideal candidate to study the Tat systems proofreading 
mechanism. By using BT6 in future studies, our understanding of the proofreading 
mechanism will increase. This proof-of-principle technique we will allow us to probe the 
tolerance of the Tat systems proofreading mechanism. 
 
The twin-arginine proofreading ability of Escherichia coli can sense localized 
unfolded regions of a man-made maquette protein variant. 
 
After determining that BT6 maquette is an ideal candidate to study the Tat proofreading 
mechanism, we tested whether Tat can sense outer surface characteristics as unfolded by 
BT6. Therefore a variety of BT6 maquette mutants were designed with altered outer 
surface residues. In this study, BT6 substrates with an altered surface electrostatic 
potential, an increased surface hydrophobicity, and with an additional unfolded domain 
were tested. Export assays revealed whether the mutants were accepted or rejected by the 
Tat proofreading mechanism.  
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The export of the BT6 variants with an increased surface hydrophobicity and an additional 
unfolded domain was perturbed. However, it is uncertain whether Tat rejected the protein 
due to hydrophobic surface patches or the folded state as the alterations in surface 
hydrophobicity might have counteracted the folding of BT6. In order to determine whether 
the introduction of the hydrophobic surface patch perturbed the folding of this BT6 variant, 
additional experiments need to be performed. In the future this protein could be expressed 
in vitro as initial attempts to purify the protein after an in vivo expression failed. We 
suspect that the protein degrades too quickly to analyse due to proteases recruited by Tat 
after rejection of the protein. In vitro, there are no proteases present to degrade the protein 
resulting in a higher protein concentration after expression and purification. The overall 
conformational state of the purified BT6 variant can be investigated by using 1D NMR and 
CD spectroscopy experiments. This will give us more information on why the Tat system 
did not export this variant.  
 
The majority of the variants with alterations in the surface electrostatic potential were 
exported efficiently by the Tat system. This data shows that the Tat proofreading is tolerant 
to an increase in both positively- and negatively-charged residues on the surface of 
substrate proteins. These findings correspond with other studies, which have suggested that 
the Tat proofreading mechanism is tolerant to surface charge (Jones et al., 2016).  
 
Surprisingly, spectroscopic measurements revealed that one BT6 variant with an increased 
negatively charged surface only binds one heme. Previously we have shown that the heme 
content has an effect on the conformational flexibility of BT6 maquette proteins. However, 
1D NMR data suggests that this one heme binding BT6 variant is possibly more tightly 
folded than the di-heme binding BT6. Therefore we suggest that the proofreading 
mechanism of the Tat translocase has the ability to sense structural flexibility rather than 
Chapter 6: Final discussion 
 
 131 
outer surface characteristics. Moreover, the Tat system might sense localised flexible 
regions rather than a global unfolded state of the substrate.  
 
In this study, we have shown that the Tat proofreading mechanism has the ability to sense 
the localised unfolded regions to assess the conformational state of the substrate. In order 
to increase our insight of these unfolded regions, 15N NMR or coupled 1H -15N NMR 
spectroscopy analysis could be performed as a more sensitive alternative to the 1H NMR 
spectroscopy analysis performed in this study. The data of these additional experiments in 
addition to the data presented in this study will increase our understanding of the Tat 
proofreading mechanism. Moreover, the previously discussed methods such as FRET and 
cross-linking studies can give more insight into the dynamics of the proofreading 
mechanism of the Tat system. In addition, the mechanism of the Tat proofreading ability 
remains unclear as we are lacking structural data of the Tat(A)BC complex interacting with 
the Tat substrates. Further high-resolution structural analysis of the Tat components is 
needed in order to test the proofreading ability of the different Tat components and to 
determine which domains are responsible for proofreading the structural conformation. 
Hopefully, the relatively new electron cryomicroscopy (Cryo-EM) technique will broaden 
our structural knowledge on the different Tat components in the near future. Mutagenesis 
studies on the Tat substrates and Tat components can lead to an increased insight in the Tat 
proofreading mechanism. Finally, this study and previous studies primarily focused on 
heterologous and artificial proteins. Therefore, mutagenesis studies on native Tat 
substrates as described in this study will be a valuable addition to our knowledge.  
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Co-translational folding of Tat dependent proteins monitored in vivo and in vitro. 
 
In the third study, we tested whether E. coli Tat substrates fold co- or posttranslationally by 
using AP-mediated force measurements. The obtained force profile of the BT6 substrates 
might indicate co-translational folding, as force acting on the nascent chain was seen in 
vitro when the protein emerges from the ribosome exit tunnel. Moreover, a possible 
interaction with the Tat components during translation and folding was not detected. 
However this possibility is not excluded, as the force generated by the interaction with Tat 
might not be significant enough to be captured by the AP-mediated force measurements 
assay.  
 
Compared to the force profile of BT6, stronger pulling force acting on the nascent chain 
was observed for hGH. Possibly, because hGH and BT6 require different chaperones, 
which might interfere differently with the folding process. Interestingly, the pulling forces 
probably generated by folding were reduced and detected later in vivo during translation.  
This was previously described in studies that demonstrated that this occurs in the presence 
of chaperones, such as Trigger factor and GroEL (Nilsson et al., 2016). Furthermore, a 
noticeable increase of the folding force was observed when expressed in vitro in the 
presence of disulfide bond enhancer, which helps hGH to form its disulfide bonds.  
 
We also tested whether the natural E. coli Tat substrate SufI folds co- or 
posttranslationally. Surprisingly, a possible interaction of SufI with the Tat components 
was detected in the in vivo force profile as the native SufI-RR variant shows higher pulling 
force values compared to the force profile of the SufI-KK mutant. In addition, the in vitro 
expression in the absence of Tat components showed similar force profiles, suggesting a 
possible interaction of SufI with the Tat components during translation.  




Export assays of co-translationally folding substrates revealed that the Tat system could 
export most of these substrates (SOD1, R16 and Protein G B1 domain). A small zinc finger 
binding protein, ADR1a, could not be exported according to immunoblot data. However, 
the substrate might have not been able to fold in the cytoplasm due to a lack of zinc, which 
is required for folding. Moreover, the substrate might have been exported but could not be 
detected because of the very low molecular weight of this protein (3.5 kDa). Nilsson et al., 
(2015) demonstrated the force profile of ADR1a expressed in vitro in the presence of an 
access of zinc. Moreover, an additional N-terminal domain was added to the substrate for 
visualisation. We suggest that optimization of the export assays of ADR1a is necessary to 
confirm whether the Tat system has the ability to export a small zinc finger binding 
domain protein.  
 
In this study, we identified when Tat substrates fold in the cytoplasm and at what stage 
they interact with the Tat substrates. Although this increased our understanding on the 
folding kinetics and Tat mediated translocation of Tat substrates, it also did raise additional 
questions. The data presented in this study suggests a possible interaction of the E. coli 
native Tat substrate with the Tat components. In vivo expression assays of the SufI-RR and 
SufI-KK variant in Δtat cells will reveal whether interaction with Tat increases pulling 
force acting on the SufI-RR nascent chain. In addition, in vivo expression assays of the 
SufI-RR and SufI-KK variant in ÔTat ExpressÕ cells will also reveal whether interaction 
with Tat components takes place. Even though force acting on the nascent chain of BT6 
was detected in vitro, the heme b cofactor was not present to complete folding. In order to 
further investigate co-translational folding of BT6 in vitro expression assays are needed in 
the presence of the heme b cofactor. Furthermore, the addition of chaperones, such as 
GroEL and trigger factor, to the in vitro expression assays of BT6 and hGH will confirm 
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that chaperones might inhibit folding in the in vivo assays performed in this study. Finally, 
it could be useful to perform electron cryomicroscopy (Cryo-EM) studies in order to 
confirm whether the tested Tat substrates fold and interact with Tat in a co-translational 
manner. Also, cross-linking experiments could be useful to see whether there is early co-
translational interaction with Tat. This study will act as a platform for further research and 
provides a significant starting point for studying the Tat translocase system in the future.  
 
It has to be mentioned that the pulling force measurement technique is a relatively new 
technique, which needs to be optimised. This technique has only been used to study two 
events in the cell (cotranslational protein folding and membrane protein insertion). 
Therefore it has to be optimised in order to study other events such as: protein-protein 
interaction. Different arrest peptides, linker lengths, expression methods, etc. need to be 
tested in order to study different events in the cell. This is important to continue 
investigating a possible interaction of Tat substrates with the Tat components using the 
pulling force measurement technique.  
 
Proposed pathway for the translation, folding and proofreading of Tat substrates. 
 
The aim of this study was to investigate what exactly Tat senses in order to reject or accept 
a substrate for translocation to the periplasm. Based on the data demonstrated in this study 
we propose the pathway Tat substrates undergo from translation by the ribosome to 
proofreading by the Tat components. In chapter 5 we demonstrate that, some Tat substrates 
can already start to fold co-translationally. Moreover a Tat substrate can possibly be 
targeted co-translationally hence the signal peptide can be recognised when the substrate is 
still synthesised.  
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Previous studies demonstrated that the signal peptide is recognised by the TatBC complex. 
Following substrate binding, the TatBC complex recruits TatA components upon which 
proofreading possibly takes place (Rocco et al., 2012) In chapter 3 and 4 we have shown 
that the Tat proofreading mechanism has the ability to sense the conformational flexibility 
of the substrate. We suggested that the Tat components could sense flexible conformations 
by a cascade of interactions between the substrate and Tat components. The exact 
mechanism on how and when the Tat components can sense the conformational state 
remains unclear.  
 
Because of the possible co-translational targeting, the Tat components can rapidly 
proofread the conformational flexibility of the substrate in order to translocate the substrate 
to the periplasm. This will increase the export efficiency as the co-translationally folded 
substrates can be exported in a faster manner.  
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Constructs used for BT6 studies 
Plasmid name Description Reference 
pKRK7 pEXT22 TorA-hGH-His6 (Alanen et al., 2015) 
pAJ21 pEXT22 TorA-BT6    (Sutherland et al., 2018) 
pGS01 pEXT22 TorA-BT6M1 (H53A) (Sutherland et al., 2018) 
pAJ25 pEXT22 TorA-BT6M0 (H53A, H88A) (Sutherland et al., 2018) 
pAJ26 pEXT22 TorA-KK-BT6 (Sutherland et al., 2018) 
pAJ27 pEXT22 TorA-KR-BT6 (Sutherland et al., 2018) 
pDM12 pEXT22 TorA-BT6-2Asp (K5D, K13D) This study 
pDM13 pEXT22 TorA-BT6-4Asp (K5D, K13D, 
K75D, K83D)  
This study 
pDM14 pEXT22 TorA-BT6-2Lys (D9K, D23K) This study 
pDM15 pEXT22 TorA-BT6-4Lys (D9K, D23K, 
D79K, D93K) 
This study 
pDM19 pEXT22 TorA-BT6-3NLeu (D9L, K13L, 
E16L) 
This study 
pDM18 pEXT22 TorA-BT6-C-term26 (AdditionalÐ
SNVIIIIITNKDPNSSSVDLAAALE) 
This study 
pDM16 pEXT22 TorA-BT6-C-term13 (Additional Ð 
SNVIIIIITNKDP) 
This study 
pDM17 pEXT22 TorA-BT6-C-term6 (Additional Ð 
SNVIII)                   
This study 
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Constructs used for co-translation folding studies 
Plasmid name Description Reference 
pDM26 pEXT22 TorA-ADR1a This study 
pDM27 pEXT22 TorA-R16 This study 
pDM28 pEXT22 TorA-SOD1 This study 
pDM29 pEXT22 TorA-ProteinG This study 
pDM31 pEXT22 hGH TorA-KK This study 
pDM32 pEXT22 SufI-KK This study 
pDM33 pEXT22 BT6 TorA-KK This study 
pDM38 pING BT6h2 TorA-RR L26 This study 
pDM39 pING BT6h2 TorA-RR L30 This study 
pDM40 pING BT6h2 TorA-RR L35 This study 
pDM41 pING BT6h2 TorA-RR L40  This study 
pDM42 pING BT6h2 TorA-RR L45 This study 
pDM43 pING BT6h2 TorA-RR L50 This study 
pDM44 pING BT6h2 TorA-RR L55 This study 
pDM45 pING BT6h2 TorA-RR L60 This study 
pDM46 pING BT6h2 TorA-RR L30 FL This study 
pDM47 pING BT6h2 TorA-RR L30 A This study 
pDM48 pING BT6h2 TorA-RR L60 FL This study 
pDM49 pING BT6h2 TorA-RR L60 A This study 
pDM50 pING BT6h2 TorA-KK L26 This study 
pDM51 pING BT6h2 TorA-KK L30 This study 
pDM52 pING BT6h2 TorA-KK L35 This study 
pDM53 pING BT6h2 TorA-KK L40 This study 
Appendix II: Constructs used for co-translation folding studies 
 
 163 
Plasmid name Description Reference 
pDM54 pING BT6h2 TorA-KK L45 This study 
pDM55 pING BT6h2 TorA-KK L50 This study 
pDM56 pING BT6h2 TorA-KK L55 This study 
pDM57 pING BT6h2 TorA-KK L60 This study 
pDM58 pING BT6h2 TorA-KK L30 FL This study 
pDM59 pING BT6h2 TorA-KK L30 A  This study 
pDM60 pING BT6h2 TorA-KK L60 FL This study 
pDM61 pING BT6h2 TorA-KK L60 A This study 
pDM62 pING hGH TorA-RR L26 This study 
pDM63 pING hGH TorA-RR L30 This study 
pDM64 pING hGH TorA-RR L35 This study 
pDM65 pING hGH TorA-RR L40 This study 
pDM66 pING hGH TorA-RR L45 This study 
pDM67 pING hGH TorA-RR L50 This study 
pDM68 pING hGH TorA-RR L55 This study 
pDM69 pING hGH TorA-RR L60 This study 
pDM70 pING hGH TorA-RR L30 FL This study 
pDM71 pING hGH TorA-RR L30 A This study 
pDM72 pING hGH TorA-RR L60 FL This study 
pDM73 pING hGH TorA-RR L60 A This study 
pDM74 pING hGH TorA-KK L26 This study 
pDM75 pING hGH TorA-KK L30 This study 
pDM76 pING hGH TorA-KK L35 This study 
pDM77 pING hGH TorA-KK L40  This study 
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Plasmid name Description Reference 
pDM78 pING hGH TorA-KK L45 This study 
pDM79 pING hGH TorA-KK L50 This study 
pDM80 pING hGH TorA-KK L55 This study 
pDM81 pING hGH TorA-KK L60 This study 
pDM82 pING hGH TorA-KK L30 FL This study 
pDM83 pING hGH TorA-KK L30 A This study 
pDM84 pING hGH TorA-KK L60 FL This study 
pDM85 pING hGH TorA-KK L60 A This study 
pDM86 pING SufI RR L26 This study 
pDM87 pING SufI RR L30 This study 
pDM88 pING SufI RR L35 This study 
pDM89 pING SufI RR L40 This study 
pDM90 pING SufI RR L45 This study 
pDM91 pING SufI RR L50 This study 
pDM92 pING SufI RR L55 This study 
pDM93 pING SufI RR L60 This study 
pDM94 pING SufI RR L30 FL This study 
pDM95 pING SufI RR L30 A  This study 
pDM96 pING SufI RR L60 FL This study 
pDM97 pING SufI RR L60 A This study 
pDM98 pING SufI KK L26 This study 
pDM99 pING SufI KK L30 This study 
pDM100 pING SufI KK L35 This study 
pDM101 pING SufI KK L40 This study 
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Plasmid name Description Reference 
pDM102 pING SufI KK L45 This study 
pDM103 pING SufI KK L50 This study 
pDM104 pING SufI KK L55 This study 
pDM105 pING SufI KK L60 This study 
pDM106 pING SufI KK L30 FL This study 
pDM107 pING SufI KK L30 A This study 
pDM108 pING SufI KK L60 FL This study 
pDM109 pING SufI KK L60 A This study 
pDM110 pET BT6h2 TorA-RR L26 This study 
pDM111 pET BT6h2 TorA-RR L30 This study 
pDM112 pET BT6h2 TorA-RR L35 This study 
pDM113 pET BT6h2 TorA-RR L40  This study 
pDM114 pET BT6h2 TorA-RR L45 This study 
pDM115 pET BT6h2 TorA-RR L50 This study 
pDM116 pET BT6h2 TorA-RR L55 This study 
pDM117 pET BT6h2 TorA-RR L60 This study 
pDM118 pET BT6h2 TorA-RR L30 FL This study 
pDM119 pET BT6h2 TorA-RR L30 A This study 
pDM120 pET BT6h2 TorA-RR L60 FL This study 
pDM121 pET BT6h2 TorA-RR L60 A This study 
pDM122 pET BT6h2 TorA-KK L26 This study 
pDM123 pET BT6h2 TorA-KK L30 This study 
pDM124 pET BT6h2 TorA-KK L35 This study 
pDM125 pET BT6h2 TorA-KK L40 This study 
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Plasmid name Description Reference 
pDM126 pET BT6h2 TorA-KK L45 This study 
pDM127 pET BT6h2 TorA-KK L50 This study 
pDM128 pET BT6h2 TorA-KK L55 This study 
pDM129 pET BT6h2 TorA-KK L60 This study 
pDM130 pET BT6h2 TorA-KK L30 FL This study 
pDM131 pET BT6h2 TorA-KK L30 A  This study 
pDM132 pET BT6h2 TorA-KK L60 FL This study 
pDM133 pET BT6h2 TorA-KK L60 A This study 
pDM134 pET hGH TorA-RR L26 This study 
pDM135 pET hGH TorA-RR L30 This study 
pDM136 pET hGH TorA-RR L35 This study 
pDM137 pET hGH TorA-RR L40 This study 
pDM138 pET hGH TorA-RR L45 This study 
pDM139 pET hGH TorA-RR L50 This study 
pDM140 pET hGH TorA-RR L55 This study 
pDM141 pET hGH TorA-RR L60 This study 
pDM142 pET hGH TorA-RR L30 FL This study 
pDM143 pET hGH TorA-RR L30 A This study 
pDM144 pET hGH TorA-RR L60 FL This study 
pDM145 pET hGH TorA-RR L60 A This study 
pDM146 pET hGH TorA-KK L26 This study 
pDM147 pET hGH TorA-KK L30 This study 
pDM148 pET hGH TorA-KK L35 This study 
pDM149 pET hGH TorA-KK L40  This study 
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Plasmid name Description Reference 
pDM150 pET hGH TorA-KK L45 This study 
pDM151 pET hGH TorA-KK L50 This study 
pDM152 pET hGH TorA-KK L55 This study 
pDM153 pET hGH TorA-KK L60 This study 
pDM154 pET hGH TorA-KK L30 FL This study 
pDM155 pET hGH TorA-KK L30 A This study 
pDM156 pET hGH TorA-KK L60 FL This study 
pDM157 pET hGH TorA-KK L60 A This study 
pDM158 pET SufI RR L26 This study 
pDM159 pET SufI RR L30 This study 
pDM160 pET SufI RR L35 This study 
pDM161 pET SufI RR L40 This study 
pDM162 pET SufI RR L45 This study 
pDM163 pET SufI RR L50 This study 
pDM164 pET SufI RR L55 This study 
pDM165 pET SufI RR L60 This study 
pDM166 pET SufI RR L30 FL This study 
pDM167 pET SufI RR L30 A  This study 
pDM168 pET SufI RR L60 FL This study 
pDM169 pET SufI RR L60 A This study 
pDM170 pET SufI KK L26 This study 
pDM171 pET SufI KK L30 This study 
pDM172 pET SufI KK L35 This study 
pDM173 pET SufI KK L40 This study 
Appendix II: Constructs used for co-translation folding studies 
 
 168 
Plasmid name Description Reference 
pDM174 pET SufI KK L45 This study 
pDM175 pET SufI KK L50 This study 
pDM176 pET SufI KK L55 This study 
pDM177 pET SufI KK L60 This study 
pDM178 pET SufI KK L30 FL This study 
pDM179 pET SufI KK L30 A This study 
pDM180 pET SufI KK L60 FL This study 
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The Escherichia coli Tat system transports a range of folded proteins across the 
plasma membrane. It preferentially exports correctly folded proteins, so clearly 
has the ability to discriminate between folding states, but the underlying 
proofreading mechanism is poorly understood. We used a simple, de novo 
designed substrate to test the importance of surface charge and structural 
dynamics. A 4-helix 'maquette' termed BT6 has been previously shown to be 
exported by Tat, but only when correctly folded around two heme b molecules; a 
partially folded 1-heme variant (BT6M1) was very poorly exported, while a zero-
heme form (BT6M0) was not exported at all. Here, we show that significant 
changes to the BT6 surface charge, involving substitution of 2 or 4 Asp residues 
by Lys (creating BT6-2Lys and BT6-4Lys), or 2 Lys residues by Asp (BT6-2Asp), 
had little effect on export. This demonstrates that extensive surface charge 
variations do not influence the proofreading of this protein by Tat. Exported BT6-
2Lys and BT6-4Lys were each shown to contain 2 heme molecules, suggesting 
that they are properly folded, whereas BT6-2Asp contains only 1 heme. 
Surprisingly, BT6-2Asp is exported far more efficiently than the other single-heme 
form, BT6M1, and indeed more efficiently than the 'wild type' BT6 2-heme 
protein. 1D-NMR analysis demonstrates that BT6M1 and BT6-2Asp are folded to 
very similar extents in overall terms, with any differences confined to specific 
localisations. Overall, BT6 is considerably more folded than either. These data 
show that the Tat system's proofreading mechanism does not sense a 
substrate's overall folding status, and we propose instead that Tat prefentially 
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senses the folding status of localised regions. We further show that even small 
sequences appended to the C-terminus can block transport.  
Introduction 
The Tat system is an unusual protein transport system that operates in most 
bacterial cytoplasmic membranes. In E. coli the system minimally consists of 
three integral membrane proteins, TatA, TatB and TatC, and Tat dependent 
substrates are characterised by an N-terminal signal peptide containing a 
conserved twin arginine (RR) motif. After translocation of the precursor protein to 
the periplasm, the signal peptide is cleaved by signal peptidase (reviewed by 
xxx). A key feature of the system is its ability to transport fully folded proteins, 
and the system is indeed able to preferentially transport correctly folded proteins; 
numerous studies have shown that the Tat system possesses a 'proofreading' 
capability that enables it to reject incorrectly folded proteins (Robinson et al., 
2011, Maurer et al., 2009, DeLisa et al., 2003). 
 
The mechanism of this proofreading activity remains poorly understood. It has 
been shown that the Tat system tolerates minor structural changes as long as a 
near-native tertiary structure is present (Alanen et al., 2015). Furthermore, it has 
been suggested that the system senses hydrophobicity rather than the folded 
state of substrates (Richter et al., 2007). However, other studies demonstrated 
that the Tat system can tolerate significant changes in substrate surface 
hydrophobicity in a folded heterologous substrate (Jones et al., 2016).  
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The aim of this study was to study the Tat export systemÕs proofreading ability, 
using a simple model substrate to introduce (i) changes in the surface 
characteristics, (ii) alterations to the folding state (iii) additional unfolded domains. 
Export assays were used to see which variants are exported and which are 
rejected. To analyse the proofreading capacity we chose a de novo-designed 
'maquette' protein substrate (Farid et al., 2014). The structure of the 'BT6' variant 
of the maquette is shown in Figure 1A. BT6 shares no sequence identity with 
natural substrates and the complexity was minimized to increase engineering 
freedom (Farid et al., 2014). The protein consists of four α-helices that enclose a 
hydrophobic cavity that accommodates cofactors. The BT6 interior contains bis-
histidine ligation sites for binding 2 molecules of heme b.  
 
We have previously shown that the Tat translocase is able to recognize and 
distinguish between folded and unfolded BT6 maquette substrates (Sutherland et 
al., 2018). That study tested whether there is a difference in translocation of fully 
folded (BT6), partially folded (BT6M1), and unfolded BT6 (TorA-BT6M0) variants. 
The folding state of the BT6 maquettes was affected by reducing the number of 
bound hemes. The resulting hypothesis is that the Tat translocase must sens     
differences in structural flexibility of the proteins. 
 
In this study, we examined the Tat systems proofreading ability by using BT6 
maquette. BT6 substrates were mutated in order to change the surface 
characteristics to probe the tolerance of the Tat systems proofreading 
mechanism. The results suggest that the Tat proofreading system does not 
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sense a global unfolded state of the substrate but instead sneses the folding 
state of specific, localised regions of the protein. 
 
Materials and methods 
 
Plasmids and bacterial strains 
 
Table 1 shows the constructs that were synthesised with a C-terminal 6xhistidine 
tag by GeneArt (Life Technologies, Thermo Fisher Scientific, UK). Constructs 
were ligated into pEXT22 by restriction cloning. Restriction digest was carried out 
in a 50 µl reaction with 1 µg of template DNA, 1 µl Buffer 3.1 (New England 
Biolabs, UK), 1.5 µl NdeI and incubated at 37 ¡C for 30 min before adding 1 µl 
BamHI and incubating for another 1.5 h at 37 ¡C. Digestion products where 
separated on 1% (w/v) agarose (Bio-Rad Laboratories Ltd., USA) gels by 
electrophoresis for 30 min at 150 V. Bands were visualised upon UV exposure 
and bands of interest were excised using a scalpel blade before being purified 
with QIAprep Gel Extraction kit (Qiagen, Hilden, Germany) according to 
manufacturerÕs instructions. Purified DNA fragments were ligated into vector 
pEXT22 using T4 DNA ligase (Roche). Insert and vector were mixed in a 3:1 ratio 
with 1 µl ligase buffer and 1 µl T4 ligase, before incubation overnight in Biometra 
T3 Thermocycler. After ligation 5 µl ligation product was used to transform 50 µl 
E. coli DH5α and W3110 competent cells.  
 
  
Appendix VI: First author paper (ready for submission) 
 
 177 
Cell culture and fractionation 
 
5 ml LB medium (10 g/L sodium chloride, 10 g/L tryptone, 5 g/L yeast extract) 
containing 100 µg/mL kanamycin was inoculated with a single colony of the E. 
coli strains carrying the respective plasmids and grown overnight at 37 ¡C, 200 
rpm. 50 mL of fresh LB medium containing 100 µg/mL kanamycin was then 
inoculated with the overnight culture to OD600 = 0.05. Cultures were then grown 
at 37 ¡C, 200 rpm to OD600 = 0.5 before induction with 0.5 mM IPTG. 3 hours 
post induction an amount equivalent to OD600 = 10 was collected and fractionated 
into Cytoplasm (C), Membrane (M), and Periplasm (P) fractions. The periplasmic 
fraction was collected using the EDTA/lysozyme/cold osmotic shock and 
centrifugation method (Matos et al., 2014). The spheroplast pellet was then 
washed by resuspension in buffer containing 50 mM Tris-Acetate (pH 8.2), 250 
mM sucrose and 10 mM MgSO4 and centrifuged at 14,000 rpm, 4 ¡C, 5 min. The 
resulting pellet was then resuspended in buffer containing 50mM Tris-Acetate, 
2.5 mM EDTA (pH 8.2) and sonicated for 6 x 10 s, 8 µm amplitude (Soniprep 
150plus, Sanyo Gallenkamp, Loughborough, UK). The sonicated samples were 
then centrifuged at 70,000 rpm, 4 ¡C, 30 min. The supernatant was taken as the 
cytoplasmic fraction (C) and the pellet was resuspended in buffer containing 50 
mM Tris-Acetate, 2.5 mM EDTA (pH 8.2) to obtain the Membrane fraction (M). All 
cell fractions were stored frozen at Ð 20 ¡C.  
 
  





The fractionation protein samples were transferred to PVDF-membranes (GE 
Healthcare, Buckinghamshire, UK). The PVDF membranes were then blocked 
overnight at 4 ¡C with PBS-T containing 5% (w/v) dried skimmed milk and 
immunoblotted with C-terminal His antibodies. The membranes were then 
washed with 1x PBS-tween20 (0.1%) before incubation with 3.5 µl 6x-His C-
terminal Tag HRP antibody (New England Biolabs, UK) in 20 mL 1x PBS 
tween20 (0.1%) for 1 hour. Membranes were washed and proteins were 
visualised using an ECL (enhanced chemiluminescence) kit (Biorad, Herts, UK) 
according to the manufacturerÕs instructions. A BioRad chemiluminescence 
imager and corresponding software was used to develop the membranes.  
 
Export assay for purification of BT6 variants 
 
For the purification of the BT6 variants the pEXT22 vectors BT6, BT6M1, TorA-
BT6m0, BT6-2Lys, BT6-4Lys and BT6-2Asp were transformed into the E. coli 
W3110 ÔTatExpressÕ cell line (2). Transformed cells were grown in 50 ml LB 
medium (10g/L sodium chloride, 10g/L tryptone, 5 g/L yeast extract) containing 
100 µg/mL kanamycin was inoculated with a single colony and grown overnight 
at 37 ¡C, 200 rpm. 400 mL fresh LB medium and 100 µg/mL kanamycin were 
inoculated with overnight culture to OD600 = 0.05. Cultures were then grown at 30 
¡C, 200 rpm to OD600 = 0.5 before induction of plasmid with 0.5mM IPTG and 
cultures were incubated for 24 h, and harvested by centrifugation (4000 rpm, 20 
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min, 4 ¡C). To obtain the periplasmic fraction cells were resuspended in 10 mL 
buffer containing 100 mM Tris-acetate pH 8.2, 500 mM sucrose, 5 mM EDTA pH 
8.0) and 10 mL ice-cold dH2O before addition of 800 µl hen egg white lysozyme 
(1 mg/mL) followed by incubation on ice for 10 min. To stabilise the inner 
membrane 800 µl 1 M MgSO4 was added to the solution before centrifugation 
(14,000 rpm, 20 min, 4 ¡C). The supernatant was taken to collect the periplasmic 
fraction. The spheroplast pellet was resuspended in 10 mL 0.5 M 
Sodiumphosphate buffer (pH 7.3) and protease inhibitor (cOmplete Mini Protease 
Inhibitor, Roche) was added. Cells were sonicated for 6 x 30 s, 8 µm amplitude 
(Soniprep 150plus, Sanyo Gallenkamp, Loughborough, UK) and centrifuged 
(14,000 rpm, 20 min, 4 ¡C). The supernatant was collected as the spheroplast 
fraction.  
 
Purification of Tat-exported proteins from E. coli periplasm 
 
IMAC Sepharose Fast Flow Column (GE Healthcare) was used to purify the BT6 
variants. After equilibration of the column with 20 mM Sodium Phosphate, 
periplasmic and spheroplastic fractions were applied to the column. The column 
was washed with 20 mL of buffer containing 25 mM imidazole, 0.5M NaCl, 20mM 
Sodiumphosphate, pH 7.3. BT6 variants were eluted with 9 mL buffer containing 
a gradient of 100 Ð 200 mM imidazole, 50 mM EDTA, 20 mM Sodiumphosphate 
pH 7.3. The elution fractions were collected and concentrated using Vivaspin 
centrifugal concentrators (Sartorius). 
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1D-1H-NMR spectra  
 
1D-1H NMR spectra of BT6, BT6M1, TorA-BT6M0 and BT6-2Asp were acquired 
on a Bruker Advance III 600MHz spectrometer with a cryogenically cooled probe 
at 298K. Water supressed spectra were acquired using a Double Pulse Field 
Gradient Selected Excitation Experiment (DPFGSE) (Hwang and Shaka, 1995). 
All experiments were acquired with the same parameters. Spectra were acquired 
using 2048 complex points with a spectral width of 9615Hz, an inter-scan delay 
of 1s and 2048 repetitions for improved signal to noise. Data were processed in 
topspin 3.5pl7. All spectra were zero filled once, apodised with an exponential 
function (LB=3) and the residual water signal was supressed with a convolution 





BT6 is an ideal model substrate for studies on Tat proofreading because the 
protein is simple, tightly folded and efficiently exported in E. coli when a Tat-
specific TorA signal peptide is attached. The protein's conformation is tightly 
constrained by ligation to 2 heme molecules (at both ends of the protein as 
shown in Fig. 1). The 2-heme protein (BT6) is efficiently exported by Tat whereas 
a variant that binds only 1 heme (BT6M1) is very poorly exported, and a no-heme 
variant (BT6M0) is not exported at all (Sutherland et al, 2018). Clearly, Tat 
senses the less tightly folded status of the mutated forms. In this study we 
Appendix VI: First author paper (ready for submission) 
 
 181 
created a series of new mutated forms in order to further analyse this 
proofreading capability, and where possible we purified the proteins to determine 
whether they contain 0, 1 or 2 hemes. For the purposes of this study we label 2 
heme-containing variants as 'folded'. Figure 1 shows the structure, surface 
electrostatis potential and surface hydrophobicity map of the fully folded two-
heme binding, BT6. The outer surface is predicted to be relatively hydrophilic with 
the hydrophilic surface residues displayed in purple and the hydrophobic surface 
residues in yellow.  
 
The Tat system tolerates changes in substrate surface charge 
 
We first tested whether changes in the substrateÕs outer surface electrostatic 
potential (Figure 1B) affects export to the periplasm by the Tat translocase. In a 
study using an scFv as substrate, it was suggested that the Tat system is highly 
tolerant towards surface charge changes (Jones et al., 2016). However, the Tat 
translocase might sense certain outer surface characteristics as unfolded, and 
we therefore created four BT6 mutants with altered outer surface characteristics 
(Figure 2A). Two mutants were designed with 2 or 4 Lys residues substituted by 
Asp residues (denoted BT6-2Asp and BT6-4Asp); these substitutions thus 
change original BT6 protein's charge by -4 and -8, respectively. In contrast, 
another two mutants were designed with 2 or 4 Asp residues substituted by Lys 
(denoted BT6-2Lys and BT6-4Lys). The proteins were expressed in E. coli with 
an N-terminal TorA signal peptide TorA and a C-terminal 6x His-tag, and Figure 
2B shows BT6-2Lys, BT6-4Lys and BT6-2Asp are all efficiently exported with a 
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mature size band observed in the periplasm (P). Note that the BT6-2Asp mature 
protein has a different mobility (it migrates more slowly than the 17 kDa BT6) due 
to the charge difference. There is no mature sized band in the periplasmic 
fraction with BT6-4Asp, showing that these mutations completely block export.  
 
Efficient export usually indicates that the protein contains 2 heme molecules and 
is folded, but it was considered important to test this point so we purified BT6-
2Lys, BT6-4Lys and BT6-2Asp from the periplasmic fraction by immobilized 
metal affinity chromatography (IMAC). Figure 2C shows the color of the purified 
BT6 variants. Previously, it has been demonstrated that purified BT6 has an 
intense red color, the partially folded BT6M1 has an orange color and an 
unfolded (no heme) BT6M0 variant is colorless (Sutherland et al., 2018). After 
purification, the intense red color indicated that BT6-2Lys and BT6-4Lys contain 
two hemes and are therefore folded (the absorption spectra are shown in 
supplementary Figure 1). In contrast, BT6-2Asp had an orange color, which 
indicates that this BT6 variant only accommodates one heme.  
 
We confirmed this point by comparing absorbance spectra of purified BT6, 
BT6M1, BT6M0 and BT6-2Asp, normalized at 280nm, using the procedure 
adopted by Sutherland et al (2018). The BT6-2Asp and BT6M1 spectra are 
essentially identical (and very different to that of BT6), confirming that both 
contain only one heme (Figure 3). Unfortunately, the cytoplasmic BT6-4Asp 
protein could not be purified in sufficient quantity for analysis and we therefore 
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cannot determine whether the lack of export of this variant is due to changes on 
the surface of the protein or effects on folding. 
 
This results obtained with BT6-2Asp are unexpected because this protein was 
exported with high efficiency (Figure 2), yet contains only a single heme, which 
implies partial unfolding. To address this point in more detail we directly 
compared the export kinetics of the BT6, BT6-2Asp and the previously-
characterised single-heme BT6M1 precursor forms in a time-course analysis. 
The cells were induced with IPTG and the periplasmic fraction was harvested 
after 60, 120, and 300 min. Figure 4 confirms that TorA-BT6 is exported much 
more efficiently than TorA-BT6M1, as observed by Sutherland et al. (2018); the 
BT6 periplasmic band is clearly detectable even at the earlier time points 
whereas the BT6M1 band is barely detectable at any stage of the time course. 
However, TorA-BT6-2Asp is exported even more efficiently that the non-mutated 
BT6 form, with export essentially complete at the earliest time point and the band 
far stronger on the immunoblot. BT6-2Asp is certainly exported far more 
efficiently than the other single-heme protein, BT6M1. 
 
1D NMR indicates that BT6-2Asp is generally less tightly folded than BT6, but 
has a specific region that is more tightly folded 
 
We purified the BT6 variants and subjected them to 1D-NMR analysis because 
the nature of the technique is very sensitive to the structure and dynamics of 
molecules at the atomic scale on timescales of ms-ns. However, the spectra of 
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the maquettes are complicated because of the presence of heme groups with a 
high spin FeIII present (low spin heme groups only occur when O2 is bound to the 
hemes FeIII ion). This leads to two processes occurring as hemes are bound to 
the BT6 proteins. The first is that the presence of a heme group in the maquette 
may increase the ÔfoldednessÕ or order of the protein leading to an increase in 
chemical shift dispersion and a broadening of the proteins peaks to the line width 
expected for a protein of this size. In the case of the maquettes (mass ~ 21 kDa) 
we may predict a linewidth of somewhere around 18Hz for an amide or 0.03 ppm 
at 600 MHz (Cavenagh et al, 2006) assuming that only dipole-dipole relaxation is 
present and making the approximation that the protein is approximately spherical. 
 
The second effect is that the lone pair from the paramagnetic centre in the heme 
can lead to extreme shifts for nuclei both within the porphyrin ring that encloses it 
and also in nearby residues in the protein. On top of this the paramagnetic centre 
present in the heme can also cause broadening due to increased T2 relaxation. 
In interpretation of the results it is assumed based on the observed data and 
previous analysis that BT6M0 contains no heme and so is not broadened, but 
that BT6, BT6M1 and BT6-2Asp are all bound to heme to some extent and so 
show broadening and extreme shifts. Examples of these extreme shifts can be 
seen in Figure 5A for the low field region of their spectra, with broad dispersed 
peaks being observed between 9.5 and 10.5 ppm.  
 
A comparison of the 1D NMR specta for BT6M1 and BT6-2Asp shows that they 
are almost identical, while the BT6 and BT6-2Asp spectra show clear differences. 
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As reported by Sutherland et al (2018), BT6 and BT6M1 both show broadening of 
the envelope for the amide and aliphatic side chain protons compared with TorA-
BT6M0 showing that FeIII heme groups are bound and also possibly suggesting 
an increase in the structuring of the protein (BT6M1 is somewhat sharper but still 
well dispersed, most probably because there is less relaxation from the single 
bound heme-FeIII group). The mutant protein BT6-2Asp also shows similar 
broadening of the aliphatic and amide envelopes similar to BT6M1 suggesting 
that the structure present is very similar in most respects to that in BT6M1.  
 
However, analysis of the extremely shifted peaks in the proteins above 9.5 ppm 
(Figure 5B) may suggest that a more subtle and interesting analysis can be 
made. For both BT6M1 and especially BT6 a number of broad peaks are 
observed in this region which could be attributed to highly shifted peaks from the 
heme and the protein due to aromatic ring currents and hyperfine shifts from the 
heme-FeIII moiety in a similar fashion to those observed in previous studies (Du 
et al., 2003). However, the observed peaks are considerably broader than those 
observed in Du et al leading to the conclusion that there is some movement of 
the heme within the structure of the maquette leading to the heme taking up 
multiple orientations which leads to further broadening due to exchange effects. It 
can also be seen that these peaks cannot be attributed to just the tryptophan side 
chains which are also present in this region as the area of the observed peaks 
appears to be too large to be consistent with the 4 tryptophan peaks present (the 
area of the region 9.5-10.5 ppm is 1/32nd of the amide and aromatic ring region; 
6.1-9.5 ppm whereas it should be 1 ~70th). However, analysis of the same region 
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in the protein BT6-2Asp shows two additional peaks at 10.05 ppm, which are 
entirely consistent with two of the tryptophan residues present in the protein. As 
these peaks are not observed in the spectra of any other proteins studied this 
suggests that there is an ordering around two of the tryptophans (if it was an 
ordering of the heme group it would be expected that many more signals would 
be observed). Furthermore, the linewidths observed (10 Hz) are not inconsistent 
with the peaks expected from the tryptophans of a protein of mass. It could be 
suggested, as an alternative that the peaks could be caused by a decrease of 
order as this can also sharpen peaks, however, as there is no other sign of 
sharpening in the overall envelope of the protein this seems unlikely. Therefore, 
overall it can be suggested that a specific region in BT6-2Asp is more ordered 
and structured than BT6M1 and possibly BT6.  
 
Addition of even a short C-terminal unfolded domain is not tolerated by the Tat 
system 
 
Previous studies suggested that the addition of an unfolded element to a folded 
substrate blocks export by the Tat system (Jones et al., 2016); a 26-residue 
unfolded domain was added to the C-terminus of a folded scFv protein and the 
protein was completely rejected. In this study, we capitalised on the highly folded 
nature of BT6 to test whether the addition of variably-sized unfolded polypeptide 
chains to a fully folded BT6 maquette affects export. We created three BT6 
variants in which 26 residues (SNVIIIIITNKDPNSSSVDLAAALE), 13 residues 
(SNVIIIIITNKDP) or 6 residues (SNVIII) were added to the C-terminus of TorA-
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BT6. As described previously, an N-terminal Tat signal peptide TorA and a C-
terminal 6x His-tag were fused to the BT6 variants. Figure 6 shows that there is 
no mature sized band of (17 kDa) observed for any of the three BT6 variants in 
the periplasmic fraction (P). The Tat substrates are degraded in the cytoplasm 
when export to the periplasm does not take place.  
 
The C-terminal extensions were not predicted to affect folding and we attempted 
to test this directly. The low levels of cytoplasmic protein precluded purification of 
large quantities but the 3 proteins were partially purified from cytoplasmic 
extracts and Fig. 6B shows absorption spectra. Although the spectra are not as 
clean as those obtained for the periplasmic proteins (Fig. 3), each shows a peak 
at 412 nm that is indicative of heme binding. The data strongly suggest that Tat 
can detect the presence of an additional 6-, 13- or 26-residue C-terminal 




The Tat system exports folded and cofactor-containing proteins from the 
cytoplasm to the periplasm, and it somehow senses the folding state of a 
substrate and prevents premature export to the periplasm. The details of this 
process are, however, lacking and we are particularly interested knowing what 
Tat recognizes as 'unfolded' before rejecting a substrate. Does Tat sense folding 
dynamics, and reject proteins that are insufficiently rigid, and if so does it 
somehow sample the entire protein or only certain regions? We also wanted to 
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address whether significant changes in surface charge distribution could have an 
effect. In this study, we investigated this remarkable proofreading system using a 
de novo co-factor binding ÔmaquetteÕ protein. We designed a variety of BT6 
variants with alterations on the substrateÕs outer surface, tested whether they 
were fully or partially folded, and used export assays to determine whether the 
mutants were accepted or rejected by the Tat components.  
 
The initial export assays with BT6-2Lys and BT6-4Lys showed that the Tat 
system tolerated substantial changes in charge with no detectable effect on 
export efficiency. The 4 mutations on the surface of BT6-4Lys result in a 
substantial change in charge (a net change of +8 within a small protein) and 
these data suggest that major changes in surface charge can be tolerated. The 
BT6-4Asp mutant was not exported, but we cannot determine whether this is due 
to associated changes in folding. 
 
The BT6-2Asp variant yielded unexpected information. As with BT6-2Lys and 
BT6-4Lys, this variant was efficiently exported, but whereas the former were 
shown to bind two heme molecules it is clear that BT6-2Asp binds only one, and 
this protein should therefore be partially unfolded, as was clearly shown for the 
other 1-heme mutant, BT6M1 (Sutherland et al., 2018). 1D-NMR data confirm 
that this is the case: BT6-2Asp and BT6M1 have nearly identical spectra which 
shows that at a general level their folding states are very similar indeed. We 
conclude that the Tat proofreading system does not assess the overall folding 
status of the substrate, but rather must respond to the folding state of localised 
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domains in the substrate. With BT6-2Asp and BT6M1, we believe that one of 
these important domains is one of the few regions that differ in terms of 
conformational flexibility, and the NMR data furthermore raise the possibility that 
this domain may include unspecified Trp residues in the BT6 protein. The 
inference is that this domain is particularly rigid in the BT6-2Asp variant, and that 
the Tat system accepts this variant as folded because the domain is one of the 
primary interaction sites during the binding/ proofreading process. 
 
Finally, we tested whether the Tat components will reject a folded substrate that 
contains an unfolded domain of varying length. Three BT6 mutants were 
designed with an additional 6-, 13- or 26-residue C-terminal unfolded 'tail' (BT6-
Cterm26, BT6-Cterm13 and BT6-Cterm6). Tat rejected all of these proteins, 
strongly suggesting that in this case, the Tat system has the ability to sense 
relatively short unfolded domains attached to a small α-helical protein. Analysis 
of the BT6 structure (Fig. 1) shows that the N- and C-termini are in close 
proximity, and these C-terminal extensions are therefore likely to be close to the 
Tat apparatus when the N-terminal signal peptide mediates binding.  This may 
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Table showing plasmids used to express BT6 variants for this study  
Name                 Reference 
TorA-BT6                                           (G. Sutherland et al., 2018) 
TorA-BT6M1 (H53A)                            (G. Sutherland et al., 2018)  
TorA-BT6M0 (H53A, H88A)                           (G. Sutherland et al., 2018) 
TorA-BT6-2Asp (K5D, K13D)                                           This study 
TorA-BT6-4Asp (K5D, K13D, K75D, K83D)                                 This study 
TorA-BT6-2Lys (D9K, D23K)                                   This study 
TorA-BT6-4Lys (D9K, D23K, D79K, D93K)                                 This study 
TorA-BT6-3NLeu (D9L, K13L, E16L)                                  This study 
TorA-BT6-C-term26 (AdditionalÐSNVIIIIITNKDPNSSSVDLAAALE) This study                  
TorA-BT6-C-term13 (Additional Ð SNVIIIIITNKDP)        This study 
TorA-BT6-C-term6  (Additional Ð SNVIII)                     This study           
  





Figure 1. Secondary and tertiary structure of the two-heme binding 
maquette BT6 protein. (A) Ribbon diagram of the overall structure of the two-
heme binding maquette BT6 protein shows four identical α-helix loops (green). 
The loops accommodate four histidine residues which ligate two heme b 
molecules (red).  (B) The electrostatic potential map of the BT6 outer surface 
shows positively charged (red), negatively charged (blue) and uncharged (grey) 
residues. (C) Hydrophilic (purple) and hydrophobic (yellow) outer surface 
residues are shown in the hydrophobicity map.  
 
Figure 2. Changes in substrate surface electrostatic potential of BT6 
maquette (WT) are tolerated by the Tat system. (A). Representation of the 
altered outer surface residues of the BT6 maquette variants: BT6-2Lys, BT6-
4Lys, BT6-2Asp and BT6-4Asp. The substituted residues (negative = red and 
blue = positive) are shown on the ribbon diagram. Two of the variants had 2 or 4 
Asp residues substituted by 2 and 4 Lys residues (denoted BT6-2Lys and BT6-
4Lys). In contrast, the 2 or 4 Lys residues of the other variants were substituted 
by 2 or 4 Asp residues (denoted BT6-2Asp and BT6-4Asp). (B). The four 
variants, bearing TorA signal peptides, were expressed in E. coli and cells were 
fractionated into cytoplasm, membrane and periplasm (C, M, P). The samples 
were analysed by SDS-PAGE and immunoblotting using antibodies to the 6-His 
tag on the Ctermini of the proteins. (C). The BT6 variants (BT6-2Lys, BT6-4Lys 
and BT6-2Asp) were purified from the periplasmic fraction by immobilized metal 
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affinity chromatography (IMAC). The intense red color indicates that BT6-2Lys 
and BT6-4Lys accommodate two hemes and are fully folded. BT6-2Asp has an 
orange color, which indicates that this BT6 variant accommodates only one 
heme.  
 
Figure 3. UV-visible absorbance spectra of purified BT6-2Asp confirms the 
presence of a single heme. The absorbance spectra of BT6-2Asp (orange) 
compared to the previously published absorbance spectra of BT6 (black), BT6M1 
(red), TorA-BT6M0 (blue)(G. A. Sutherland <i>et al.</i>, 2018). There is high 
similarity between the spectrum of BT6M1 (one heme binder) and BT6-2Asp, 
indicating that BT6-2Asp accommodates one molecule of heme.  
 
Figure 4. BT6-2Asp is exported far more efficiently than BT6M1, and slightly 
more efficiently than BT6. TorA-BT6, TorA-BT6M1 and TorA-BT6-2Asp were 
expressed in E. coli as detailed in Figure 2, and the periplasmic fraction was 
prepared after 60, 120, and 300 min induction with IPTG). Samples were 
analysed by SDS-PAGE and immunoblotting. 
 
Figure 5. 1D-1H-NMR spectra suggest that folding of a restricted domain in 
BT6-2Asp enhances export efficiency. 1D 1H NMR spectra of BT6, BT6M1, 
TorA-BT6M0, and BT6-2Asp measured at 298K and 600MHz in 90% H2O /10% 
D2O using a DPFGSE water suppressed pulse sequence. Panel A: comparison 
of the spectra for BT6 and BT6-2Asp, and BT6-2Asp and BT6M1;  the peak 
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marked with a * is presumed to be from a small molecule contaminant. Panel B: 
blow-up of the region between 9.5 and 12.5 ppm for each of the 1D spectra.  
 
Figure 6. An addition of an unfolded domain to folded BT6 maquette (WT) is 
rejected by the Tat translocase.  A: 3 variants of TorA-BT6 were expressed 
expressed in W3110 cells, containing C-terminal extensions of 6, 13 and 26 
residues (termed BT6-Cterm6, BT6-Ctermm13 and BT6-Cterm26). Expression 
was induced with IPTG for 3 hours and cells were then fractionated to yield 
cytoplasmic (C), membrane (M) and periplasmic (P) fractions. The fractions were 
immunoblotted using a C-terminal His antibody. Molecular mass markers (kDa) 
are shown on the left side of the blot. B: cytoplasmic extracts were prepared from 
cells expressing the 3 variants, and were subjected to IMAC chromatography. 
The eluates were concentrated and absorbance spectra were obtained as in Fig. 
3.  
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